Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - GAMG [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - hTERT-RPE1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - JURKAT [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - OE19 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - SuSa [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" "Single Cell Type RNA - Alveolar cells type 1 [NX]" "Single Cell Type RNA - Alveolar cells type 2 [NX]" "Single Cell Type RNA - B-cells [NX]" "Single Cell Type RNA - Basal glandular cells [NX]" "Single Cell Type RNA - Basal keratinocytes [NX]" "Single Cell Type RNA - Bipolar cells [NX]" "Single Cell Type RNA - Cardiomyocytes [NX]" "Single Cell Type RNA - Cholangiocytes [NX]" "Single Cell Type RNA - Ciliated cells [NX]" "Single Cell Type RNA - Club cells [NX]" "Single Cell Type RNA - Collecting duct cells [NX]" "Single Cell Type RNA - Cone photoreceptor cells [NX]" "Single Cell Type RNA - Cytotrophoblasts [NX]" "Single Cell Type RNA - Distal tubular cells [NX]" "Single Cell Type RNA - Ductal cells [NX]" "Single Cell Type RNA - Early spermatids [NX]" "Single Cell Type RNA - Endothelial cells [NX]" "Single Cell Type RNA - Enterocytes [NX]" "Single Cell Type RNA - Erythroid cells [NX]" "Single Cell Type RNA - Exocrine glandular cells [NX]" "Single Cell Type RNA - Extravillous trophoblasts [NX]" "Single Cell Type RNA - Fibroblasts [NX]" "Single Cell Type RNA - Glandular cells [NX]" "Single Cell Type RNA - granulocytes [NX]" "Single Cell Type RNA - Hepatocytes [NX]" "Single Cell Type RNA - Hofbauer cells [NX]" "Single Cell Type RNA - Horizontal cells [NX]" "Single Cell Type RNA - Intestinal endocrine cells [NX]" "Single Cell Type RNA - Ito cells [NX]" "Single Cell Type RNA - Kupffer cells [NX]" "Single Cell Type RNA - Late spermatids [NX]" "Single Cell Type RNA - Leydig cells [NX]" "Single Cell Type RNA - Macrophages [NX]" "Single Cell Type RNA - Melanocytes [NX]" "Single Cell Type RNA - monocytes [NX]" "Single Cell Type RNA - Mucus-secreting cells [NX]" "Single Cell Type RNA - Muller glia cells [NX]" "Single Cell Type RNA - Pancreatic endocrine cells [NX]" "Single Cell Type RNA - Paneth cells [NX]" "Single Cell Type RNA - Peritubular cells [NX]" "Single Cell Type RNA - Proximal tubular cells [NX]" "Single Cell Type RNA - Rod photoreceptor cells [NX]" "Single Cell Type RNA - Sertoli cells [NX]" "Single Cell Type RNA - Smooth muscle cells [NX]" "Single Cell Type RNA - Spermatocytes [NX]" "Single Cell Type RNA - Spermatogonia [NX]" "Single Cell Type RNA - Suprabasal keratinocytes [NX]" "Single Cell Type RNA - Syncytiotrophoblasts [NX]" "Single Cell Type RNA - T-cells [NX]" "Single Cell Type RNA - Undifferentiated cells [NX]" "Single Cell Type RNA - Urothelial cells [NX]" ATP5F1A "ATP5A, ATP5A1, ATP5AL2, ATPM, hATP1, OMR, ORM" ENSG00000152234 "ATP synthase F1 subunit alpha" P25705 18 46080248-46104334 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Cytotrophoblasts: 678.0;Distal tubular cells: 994.7;Proximal tubular cells: 716.2;Syncytiotrophoblasts: 483.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013067, HPA040622, HPA044202" Enhanced Supported Mitochondria NA NA 51000000 Mitochondria "CAB013067: AB_221511, HPA040622: AB_2677048, HPA044202: AB_2678855" "unprognostic (3.08e-2)" "unprognostic (9.13e-2)" "unprognostic (1.84e-2)" "unprognostic (3.54e-1)" "unprognostic (6.36e-2)" "unprognostic (2.61e-1)" "unprognostic (1.89e-2)" "unprognostic (6.79e-2)" "unprognostic (8.31e-2)" "unprognostic (4.79e-2)" "unprognostic (7.30e-3)" "unprognostic (1.50e-2)" "prognostic favorable (1.22e-15)" "unprognostic (4.60e-3)" "unprognostic (2.06e-1)" "unprognostic (1.77e-1)" "unprognostic (4.87e-3)" 30.1 60.0 34.7 30.3 45.8 22.4 33.9 52.6 65.0 27.0 52.1 20.5 39.3 55.6 25.2 30.5 44.4 30.0 27.9 196.2 31.4 36.1 94.0 64.8 25.2 40.2 42.3 31.8 28.6 49.0 73.2 35.9 25.7 41.5 28.3 54.9 37.6 42.6 42.8 182.2 34.0 50.4 36.6 22.6 32.1 46.7 24.0 19.9 45.6 35.1 99.7 41.1 31.5 26.4 58.7 110.9 17.9 64.5 44.2 63.6 124.8 43.2 44.1 58.7 55.1 71.5 79.5 65.1 50.1 71.1 77.2 67.7 66.0 34.2 102.6 30.7 60.6 41.4 80.7 101.1 76.9 72.1 45.6 56.8 67.8 56.9 81.7 46.9 143.4 64.4 73.2 54.0 55.6 58.0 62.1 79.6 55.7 54.7 60.7 66.0 45.0 73.7 70.6 55.0 42.4 46.6 73.0 68.3 138.6 104.7 105.9 59.8 55.8 36.7 45.9 61.5 57.6 59.1 83.8 46.3 42.5 36.8 22.3 43.6 69.7 59.6 66.1 42.4 86.3 45.2 11.8 64.5 17.9 43.5 58.2 55.8 58.7 52.4 47.5 110.9 44.0 63.6 52.8 6.7 44.2 52.2 54.0 58.9 124.8 34.7 45.8 52.6 65.0 31.4 36.1 42.3 31.8 41.5 19.9 157.8 126.7 0.0 0.0 0.0 0.0 0.0 0.0 175.3 184.2 162.3 0.0 678.0 994.7 285.1 0.0 0.0 0.0 0.0 236.7 359.7 0.0 0.0 82.5 0.0 363.9 0.0 0.0 0.0 0.0 0.0 0.0 64.5 0.0 313.8 0.0 0.0 195.3 0.0 0.0 716.2 0.0 0.0 0.0 0.0 0.0 0.0 483.5 0.0 0.0 0.0 ATP5F1B "ATP5B, ATPSB" ENSG00000110955 "ATP synthase F1 subunit beta" P06576 12 56638175-56646068 "Enzymes, Plasma proteins, Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" Translocase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cytotrophoblasts: 693.2;Distal tubular cells: 1049.5;Proximal tubular cells: 698.1;Syncytiotrophoblasts: 952.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001520, HPA001528, CAB017527" Enhanced Enhanced Mitochondria NA NA 100000000 Mitochondria "CAB017527: AB_1121153, HPA001520: AB_1078243, HPA001528: AB_1078242" "prognostic unfavorable (7.17e-6)" "unprognostic (5.69e-2)" "unprognostic (1.08e-2)" "unprognostic (7.24e-2)" "unprognostic (8.39e-2)" "unprognostic (1.84e-2)" "unprognostic (2.12e-3)" "unprognostic (1.92e-2)" "unprognostic (8.19e-3)" "unprognostic (2.38e-2)" "unprognostic (1.44e-2)" "unprognostic (2.11e-2)" "prognostic favorable (1.43e-9)" "unprognostic (2.79e-1)" "unprognostic (3.22e-1)" "unprognostic (1.33e-1)" "unprognostic (3.30e-2)" 41.3 66.2 32.4 34.1 53.4 39.3 33.1 55.4 92.6 26.1 73.0 34.4 36.1 68.1 27.9 28.5 58.6 28.5 36.9 225.0 33.2 34.9 95.2 85.7 28.3 39.2 40.5 35.5 25.1 42.7 85.2 30.1 31.3 69.6 29.0 78.5 42.8 64.7 38.1 236.2 42.3 74.6 35.5 24.9 33.5 51.0 31.4 18.3 47.5 38.4 123.6 45.8 36.6 32.8 41.2 91.7 40.2 90.1 36.3 46.6 105.6 66.5 81.0 64.4 99.3 58.1 62.1 113.8 67.7 63.2 117.1 66.8 131.5 74.3 118.4 73.4 83.4 49.0 89.2 135.6 82.1 106.1 55.5 93.9 129.9 75.6 80.6 72.0 145.2 92.0 76.1 82.9 91.5 118.2 89.2 96.2 88.4 116.9 136.5 98.2 61.7 107.5 85.4 108.4 88.2 156.0 103.7 72.1 150.9 127.5 118.6 73.7 65.5 103.5 148.2 115.1 70.7 139.1 109.8 65.2 46.1 51.4 67.3 73.1 65.9 81.9 122.5 69.4 97.2 70.6 40.2 64.6 34.6 40.2 80.6 44.9 41.2 38.0 42.7 91.7 31.7 31.1 36.7 17.8 36.3 90.1 46.3 46.6 105.6 32.4 53.4 55.4 92.6 33.2 34.9 40.5 35.5 69.6 18.3 125.0 160.8 0.0 0.0 0.0 0.0 0.0 0.0 188.7 149.0 263.5 0.0 693.2 1049.5 441.8 0.0 0.0 0.0 0.0 323.3 482.8 0.0 0.0 133.7 0.0 535.7 0.0 0.0 0.0 0.0 0.0 0.0 117.6 0.0 490.5 0.0 0.0 298.7 0.0 0.0 698.1 0.0 0.0 0.0 0.0 0.0 0.0 952.2 0.0 0.0 0.0 ATP5F1C "ATP5C, ATP5C1, ATP5CL1" ENSG00000165629 "ATP synthase F1 subunit gamma" P36542 10 7788129-7807815 "Plasma proteins, Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cytotrophoblasts: 423.9;Distal tubular cells: 754.4;Ductal cells: 393.1;Proximal tubular cells: 726.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060949 Approved NA NA 2600000 "HPA060949: AB_2684395" "unprognostic (1.81e-2)" "unprognostic (8.34e-2)" "unprognostic (3.87e-2)" "unprognostic (1.69e-2)" "unprognostic (2.17e-2)" "unprognostic (1.64e-1)" "unprognostic (2.65e-2)" "unprognostic (8.94e-2)" "unprognostic (2.60e-1)" "unprognostic (1.31e-3)" "unprognostic (1.62e-1)" "unprognostic (4.12e-1)" "prognostic favorable (9.26e-4)" "unprognostic (2.47e-1)" "unprognostic (1.92e-1)" "unprognostic (8.30e-2)" "unprognostic (4.08e-2)" 35.3 75.5 30.9 24.4 33.5 23.1 31.4 27.8 38.7 26.1 48.5 20.3 25.7 45.3 27.6 30.4 48.2 22.2 30.5 138.0 29.5 28.5 98.2 70.9 21.6 21.4 30.3 28.1 22.9 46.9 43.3 23.3 38.8 43.6 26.7 52.1 26.9 46.2 29.2 98.1 24.9 64.5 33.6 23.2 30.4 38.1 18.0 18.7 45.8 35.7 97.9 34.1 39.7 23.1 42.0 75.7 57.5 75.5 41.0 51.3 59.2 43.1 39.5 39.7 33.0 36.0 47.8 37.1 31.1 28.7 58.4 57.4 78.0 42.7 47.8 23.9 39.6 14.3 48.7 46.7 51.6 51.4 32.4 57.5 51.2 27.1 68.3 27.8 27.7 37.3 37.9 36.2 35.2 19.2 50.7 68.3 48.1 40.3 33.7 57.2 63.6 65.1 32.0 25.5 91.7 32.0 42.4 29.8 65.4 98.9 42.8 21.2 25.9 28.5 61.3 55.1 46.4 65.5 45.6 32.7 24.7 31.1 53.4 33.1 22.5 27.9 38.8 35.6 41.8 19.8 57.5 55.4 46.0 33.6 71.9 38.5 42.0 38.2 36.2 75.7 32.1 31.8 34.6 17.7 41.0 75.5 50.8 51.3 59.2 30.9 33.5 27.8 38.7 29.5 28.5 30.3 28.1 43.6 18.7 110.2 82.5 0.0 0.0 0.0 0.0 0.0 0.0 119.1 111.5 204.1 0.0 423.9 754.4 393.1 0.0 0.0 0.0 0.0 332.8 348.6 0.0 0.0 89.5 0.0 367.4 0.0 0.0 0.0 0.0 0.0 0.0 78.1 0.0 245.3 0.0 0.0 290.9 0.0 0.0 726.6 0.0 0.0 0.0 0.0 0.0 0.0 311.0 0.0 0.0 0.0 ATP5F1D ATP5D ENSG00000099624 "ATP synthase F1 subunit delta" P30049 19 1241746-1244826 "Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "skeletal muscle: 337.3" "Cell type enhanced" "Detected in many" 12 "Distal tubular cells: 1442.3;Exocrine glandular cells: 487.7;Proximal tubular cells: 1282.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002865 Approved NA NA 4200000 "HPA002865: AB_1078244" "unprognostic (4.80e-2)" "unprognostic (9.34e-2)" "unprognostic (7.77e-2)" "prognostic favorable (1.23e-4)" "unprognostic (1.64e-2)" "unprognostic (1.95e-1)" "unprognostic (4.63e-2)" "unprognostic (6.75e-2)" "unprognostic (1.38e-1)" "unprognostic (2.91e-1)" "prognostic favorable (4.60e-4)" "unprognostic (6.95e-2)" "prognostic favorable (3.46e-5)" "unprognostic (1.52e-1)" "unprognostic (1.14e-1)" "unprognostic (3.74e-1)" "unprognostic (3.49e-2)" 30.4 25.7 27.4 13.7 30.1 19.5 19.8 22.6 51.7 14.4 36.7 16.7 16.0 42.7 14.3 14.9 23.9 15.3 18.1 59.3 25.9 20.6 33.3 51.8 12.2 33.4 25.6 24.1 15.2 46.5 15.5 18.4 12.4 28.5 17.6 14.1 17.9 48.1 23.1 337.3 24.3 33.2 21.1 14.5 19.2 33.4 10.2 9.8 21.5 23.0 60.6 22.9 17.6 14.5 67.7 78.2 33.9 64.6 52.8 64.3 50.8 24.4 13.4 4.2 15.7 4.9 7.2 15.7 16.8 7.1 10.0 7.3 14.0 6.5 24.9 10.9 5.8 2.5 21.1 4.7 17.5 1.3 17.2 45.6 15.0 16.5 18.2 12.2 26.3 22.4 14.3 4.8 4.0 5.6 5.6 10.6 16.8 21.8 19.9 4.6 37.2 28.5 19.0 18.2 15.7 66.3 27.2 11.1 51.7 16.6 16.2 16.8 19.3 11.2 17.9 27.7 1.7 13.3 12.5 15.3 9.1 12.5 21.9 13.9 51.0 25.7 9.2 16.9 12.5 13.7 33.9 64.6 27.1 50.7 61.3 61.1 64.8 64.3 55.7 72.1 67.7 59.9 54.9 22.5 52.8 49.0 78.2 62.0 50.8 27.4 30.1 22.6 51.7 25.9 20.6 25.6 24.1 28.5 9.8 14.9 23.1 0.0 0.0 0.0 0.0 0.0 0.0 9.4 17.0 361.2 0.0 333.1 1442.3 304.6 0.0 0.0 0.0 0.0 487.7 366.7 0.0 0.0 4.7 0.0 365.7 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 232.6 0.0 0.0 350.7 0.0 0.0 1282.8 0.0 0.0 0.0 0.0 0.0 0.0 285.4 0.0 0.0 0.0 ATP5F1E ATP5E ENSG00000124172 "ATP synthase F1 subunit epsilon" P56381 20 59025467-59032382 "Disease related genes, Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" Hydrolase "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Distal tubular cells: 2893.1;Hofbauer cells: 2375.8;monocytes: 2569.9;Proximal tubular cells: 2056.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.73e-1)" "unprognostic (6.30e-2)" "unprognostic (8.16e-2)" "unprognostic (9.04e-2)" "unprognostic (2.16e-1)" "unprognostic (1.92e-3)" "unprognostic (7.88e-3)" "unprognostic (2.51e-1)" "unprognostic (5.01e-2)" "unprognostic (6.41e-2)" "unprognostic (4.35e-2)" "unprognostic (2.85e-1)" "prognostic unfavorable (2.82e-4)" "unprognostic (3.98e-1)" "unprognostic (3.21e-1)" "unprognostic (1.67e-1)" "unprognostic (2.44e-2)" 47.2 58.1 41.9 58.8 44.2 65.7 55.2 26.9 43.7 19.4 40.2 15.6 29.5 50.5 22.1 29.4 29.8 16.6 29.6 93.2 33.0 33.1 43.6 42.2 41.0 56.9 42.8 26.5 17.8 44.1 13.0 44.0 22.3 40.0 22.4 21.8 16.6 32.9 25.6 133.3 15.7 48.5 40.4 42.8 41.8 42.4 23.5 21.4 26.7 29.7 60.3 24.9 22.3 28.6 48.8 85.9 103.7 63.8 32.6 54.2 88.6 28.6 9.4 19.6 17.9 18.6 17.5 13.1 30.7 11.5 20.1 13.0 29.4 28.4 15.6 37.5 15.2 32.2 27.8 13.4 23.3 13.4 12.8 14.4 52.4 21.4 25.3 17.0 36.8 47.3 18.5 20.6 12.1 15.2 20.1 14.9 21.2 19.5 22.7 11.4 26.6 46.9 57.4 6.6 42.3 38.9 23.1 27.8 30.0 20.4 15.7 19.7 29.7 51.5 54.7 59.6 17.6 36.4 60.6 51.9 42.3 44.7 27.9 41.3 36.4 46.2 46.4 41.0 23.0 23.2 66.1 59.6 102.8 36.0 63.8 34.2 48.8 44.1 40.4 50.6 41.4 35.6 39.7 103.7 32.6 62.8 85.9 54.2 88.6 41.9 44.2 26.9 43.7 33.0 33.1 42.8 26.5 40.0 21.4 479.4 532.6 0.0 0.0 0.0 0.0 0.0 0.0 721.4 532.3 1064.3 0.0 617.9 2893.1 877.4 0.0 0.0 0.0 0.0 1043.7 805.3 0.0 0.0 324.4 0.0 2375.8 0.0 0.0 0.0 0.0 0.0 0.0 681.8 0.0 2569.9 0.0 0.0 1179.5 0.0 0.0 2056.5 0.0 0.0 0.0 0.0 0.0 0.0 493.8 0.0 0.0 0.0 ATP5MC1 "ATP5G, ATP5G1" ENSG00000159199 "ATP synthase membrane subunit c locus 1" P05496 17 48892765-48895871 "Predicted intracellular proteins, Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 117.9" "Cell type enhanced" "Detected in many" 15 "Cytotrophoblasts: 349.4;Distal tubular cells: 1228.5;Proximal tubular cells: 646.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 210.8" "Low region specificity" "Detected in all" NA NA "unprognostic (3.43e-2)" "prognostic favorable (3.88e-4)" "unprognostic (6.60e-2)" "unprognostic (2.09e-1)" "unprognostic (8.73e-2)" "unprognostic (4.92e-2)" "unprognostic (3.04e-2)" "unprognostic (2.53e-1)" "unprognostic (1.25e-1)" "unprognostic (6.09e-3)" "unprognostic (9.42e-3)" "unprognostic (9.78e-2)" "prognostic favorable (8.24e-6)" "unprognostic (2.07e-2)" "unprognostic (5.60e-2)" "unprognostic (1.95e-1)" "unprognostic (2.33e-1)" 11.7 19.2 29.2 16.4 34.2 12.4 17.6 15.8 35.4 13.6 46.8 9.5 11.1 28.3 13.5 24.7 22.2 16.0 13.0 117.9 26.2 21.6 47.9 33.0 11.2 18.3 23.0 28.5 11.0 27.7 15.5 15.0 10.4 27.8 12.3 47.0 10.8 29.5 16.4 103.8 14.3 43.2 19.7 16.1 11.4 21.3 6.1 13.2 8.7 17.3 106.0 21.5 10.4 12.9 67.5 86.3 13.8 52.9 39.3 49.6 49.7 49.3 66.7 21.2 30.9 23.4 28.6 31.3 27.2 22.9 36.4 36.0 44.3 35.6 54.4 65.8 23.5 38.7 45.1 38.0 47.6 54.2 44.7 50.9 52.7 44.1 88.4 16.4 62.8 26.5 23.1 32.5 38.6 42.8 19.6 40.9 44.5 31.4 36.9 41.9 50.8 59.4 29.4 13.2 210.8 65.9 37.9 55.3 87.5 69.2 28.1 31.5 22.9 20.4 43.9 23.1 33.7 64.5 42.9 22.6 23.0 31.6 34.7 34.6 33.7 37.9 72.0 33.1 49.8 27.2 9.1 52.9 13.8 32.2 44.5 38.8 67.5 37.0 34.6 70.1 54.5 49.6 43.1 2.9 39.3 25.7 86.3 31.2 49.7 29.2 34.2 15.8 35.4 26.2 21.6 23.0 28.5 27.8 13.2 44.7 79.4 0.0 0.0 0.0 0.0 0.0 0.0 97.7 91.0 260.0 0.0 349.4 1228.5 161.3 0.0 0.0 0.0 0.0 257.7 210.1 0.0 0.0 67.4 0.0 239.2 0.0 0.0 0.0 0.0 0.0 0.0 40.7 0.0 126.2 0.0 0.0 170.7 0.0 0.0 646.5 0.0 0.0 0.0 0.0 0.0 0.0 185.9 0.0 0.0 0.0 ATP5MC2 ATP5G2 ENSG00000135390 "ATP synthase membrane subunit c locus 2" Q06055 12 53632726-53677408 "Predicted intracellular proteins, Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Distal tubular cells: 1493.8;Hofbauer cells: 948.2;Proximal tubular cells: 1347.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051469 Approved NA NA "HPA051469: AB_2681496" "unprognostic (1.48e-1)" "unprognostic (1.06e-1)" "unprognostic (3.01e-1)" "unprognostic (3.37e-3)" "unprognostic (1.65e-1)" "unprognostic (8.42e-2)" "unprognostic (2.97e-3)" "unprognostic (2.29e-1)" "unprognostic (2.83e-1)" "unprognostic (3.45e-3)" "unprognostic (3.78e-2)" "unprognostic (5.71e-2)" "unprognostic (3.32e-3)" "unprognostic (3.41e-1)" "unprognostic (2.22e-1)" "unprognostic (1.42e-1)" "unprognostic (7.09e-2)" 39.1 60.1 52.8 34.8 48.0 49.7 64.3 47.4 72.1 46.4 57.0 49.5 38.2 50.3 57.0 63.3 52.3 71.2 48.2 107.6 45.9 43.7 60.3 60.1 46.8 105.6 49.3 57.9 67.3 99.2 47.9 50.8 34.0 42.2 46.4 73.3 49.7 69.1 43.1 165.8 50.3 45.4 53.3 51.3 51.6 57.4 38.1 32.9 82.1 46.2 92.9 67.0 47.4 41.7 112.1 133.4 30.2 96.4 71.7 99.0 126.2 27.5 59.0 62.3 56.3 43.0 105.1 29.3 24.3 54.7 72.6 49.8 20.1 65.2 33.4 59.7 47.5 23.6 26.6 79.6 56.3 64.6 55.9 95.3 91.2 47.6 41.4 93.6 69.3 45.5 116.7 83.9 70.3 117.2 117.6 93.2 41.0 64.6 98.9 73.6 72.2 70.7 169.1 53.1 58.4 65.9 71.5 59.1 83.0 88.5 34.7 32.5 59.6 32.8 38.2 81.8 56.9 123.9 126.6 44.5 35.6 49.1 27.3 37.6 51.8 43.3 24.3 53.0 73.2 54.4 30.2 96.4 27.1 68.9 89.6 75.8 112.1 89.2 73.6 133.4 99.5 99.0 81.4 22.0 71.7 79.5 103.0 92.7 126.2 52.8 48.0 47.4 72.1 45.9 43.7 49.3 57.9 42.2 32.9 169.7 211.4 0.0 0.0 0.0 0.0 0.0 0.0 396.2 325.3 500.7 0.0 597.2 1493.8 365.1 0.0 0.0 0.0 0.0 588.0 662.7 0.0 0.0 206.9 0.0 948.2 0.0 0.0 0.0 0.0 0.0 0.0 161.9 0.0 664.6 0.0 0.0 433.3 0.0 0.0 1347.7 0.0 0.0 0.0 0.0 0.0 0.0 424.6 0.0 0.0 0.0 ATP5MC3 ATP5G3 ENSG00000154518 "ATP synthase membrane subunit c locus 3" P48201 2 175176258-175184607 "Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 189.6" "Cell type enhanced" "Detected in many" 12 "Cytotrophoblasts: 786.5;Distal tubular cells: 2259.7;Extravillous trophoblasts: 831.6;Hofbauer cells: 886.9;Proximal tubular cells: 1680.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (4.45e-3)" "unprognostic (1.67e-1)" "prognostic favorable (9.90e-4)" "unprognostic (1.67e-3)" "unprognostic (3.01e-2)" "prognostic unfavorable (6.01e-4)" "unprognostic (3.46e-2)" "unprognostic (6.03e-3)" "unprognostic (1.42e-2)" "unprognostic (7.90e-2)" "unprognostic (4.71e-2)" "unprognostic (1.06e-1)" "prognostic favorable (2.31e-6)" "unprognostic (2.86e-1)" "unprognostic (3.93e-1)" "unprognostic (4.55e-2)" "unprognostic (2.31e-2)" 26.1 26.7 26.6 26.3 28.7 19.8 34.3 26.9 50.9 15.7 51.1 11.4 23.6 61.7 17.4 22.2 38.9 15.5 28.7 189.6 25.8 27.4 63.9 60.8 21.2 34.8 31.1 31.5 13.6 28.4 36.7 19.0 16.8 27.6 17.1 53.3 16.6 34.2 25.0 115.7 20.0 47.3 24.6 18.5 17.6 31.9 12.3 15.8 21.8 19.1 95.9 27.7 19.3 20.2 38.5 78.8 22.6 59.9 34.5 37.2 66.1 33.7 30.2 45.6 50.3 39.1 34.8 51.3 31.3 33.0 44.3 38.7 90.2 28.3 84.3 37.0 34.9 49.0 44.7 57.3 54.1 46.9 35.4 52.8 67.7 44.1 114.0 30.1 87.5 41.0 37.4 41.8 50.0 31.9 34.2 44.4 40.8 73.0 40.5 48.4 46.3 67.5 73.9 59.9 81.6 94.6 53.0 42.1 82.7 86.3 76.8 40.9 26.0 25.2 68.6 68.2 68.1 41.3 71.5 29.6 7.4 35.4 0.2 43.0 32.0 40.4 72.9 42.5 52.8 33.0 17.6 53.4 22.6 33.3 59.9 33.6 38.5 35.3 36.1 78.8 30.4 33.5 35.9 6.2 34.5 53.7 58.3 37.2 66.1 26.6 28.7 26.9 50.9 25.8 27.4 31.1 31.5 27.6 15.8 163.8 131.1 0.0 0.0 0.0 0.0 0.0 0.0 238.3 230.9 294.8 0.0 786.5 2259.7 429.4 0.0 0.0 0.0 0.0 326.9 831.6 0.0 0.0 81.4 0.0 886.9 0.0 0.0 0.0 0.0 0.0 0.0 111.5 0.0 358.9 0.0 0.0 350.5 0.0 0.0 1680.5 0.0 0.0 0.0 0.0 0.0 0.0 577.8 0.0 0.0 0.0 ATP5MD "bA792D24.4, DAPIT, MGC14697, USMG5" ENSG00000173915 "ATP synthase membrane subunit DAPIT" Q96IX5 10 103389041-103396466 "Predicted membrane proteins" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Distal tubular cells: 1135.7;Ductal cells: 625.1;Exocrine glandular cells: 623.7;monocytes: 754.8;Pancreatic endocrine cells: 789.0;Proximal tubular cells: 951.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044798 Supported Mitochondria NA NA Mitochondria "HPA044798: AB_2679091" "unprognostic (4.41e-2)" "unprognostic (3.08e-2)" "unprognostic (2.59e-1)" "unprognostic (7.93e-2)" "unprognostic (1.65e-1)" "unprognostic (1.95e-2)" "unprognostic (1.63e-1)" "unprognostic (1.51e-1)" "unprognostic (5.67e-2)" "unprognostic (1.57e-2)" "unprognostic (7.41e-2)" "unprognostic (1.01e-1)" "unprognostic (3.32e-2)" "unprognostic (1.74e-1)" "unprognostic (4.66e-2)" "unprognostic (7.46e-2)" "unprognostic (1.03e-2)" 48.0 46.2 91.7 26.2 67.0 26.6 56.1 33.5 71.7 38.4 77.9 21.2 29.2 43.8 22.1 72.3 56.3 28.8 31.0 131.5 67.8 57.4 79.3 92.5 24.6 27.7 65.2 44.4 19.7 58.1 21.1 38.2 25.9 46.0 30.0 75.8 23.4 52.7 43.3 146.9 22.4 57.3 39.1 41.4 26.1 40.9 20.2 30.7 22.9 31.3 125.5 39.8 41.2 28.9 71.3 109.1 101.2 85.2 50.7 76.6 66.4 60.6 64.4 61.0 72.7 68.2 85.7 39.9 58.4 73.7 59.7 66.8 103.7 67.7 34.9 33.9 66.0 47.2 62.2 57.1 59.5 82.4 45.8 102.5 36.2 83.0 115.9 66.3 73.8 56.2 69.1 93.4 53.6 84.8 102.3 76.9 56.6 47.4 58.3 99.7 94.1 59.9 127.2 45.3 93.2 109.2 38.9 37.2 54.3 141.9 98.9 23.1 53.5 30.8 47.3 84.0 89.1 42.0 68.6 43.5 29.6 45.3 44.8 76.4 61.5 100.4 58.2 62.5 75.8 22.3 101.2 65.9 88.7 55.9 85.2 63.3 71.3 76.6 65.7 73.3 51.5 65.9 65.6 55.8 50.7 80.6 109.1 71.7 66.4 91.7 67.0 33.5 71.7 67.8 57.4 65.2 44.4 46.0 30.7 196.5 169.5 0.0 0.0 0.0 0.0 0.0 0.0 222.1 167.2 368.2 0.0 256.1 1135.7 625.1 0.0 0.0 0.0 0.0 623.7 361.7 0.0 0.0 109.3 0.0 478.9 0.0 0.0 0.0 0.0 0.0 0.0 129.1 0.0 754.8 0.0 0.0 789.0 0.0 0.0 951.7 0.0 0.0 0.0 0.0 0.0 0.0 255.7 0.0 0.0 0.0 ATP5ME ATP5I ENSG00000169020 "ATP synthase membrane subunit e" P56385 4 672436-674338 "Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 221.8" "Cell type enhanced" "Detected in many" 9 "Collecting duct cells: 840.9;Distal tubular cells: 1465.6;Proximal tubular cells: 1359.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035010 Enhanced Supported Mitochondria NA NA 220000 Mitochondria "HPA035010: AB_10669853" "unprognostic (1.42e-1)" "unprognostic (4.93e-2)" "unprognostic (1.46e-1)" "unprognostic (1.66e-1)" "unprognostic (3.44e-1)" "unprognostic (1.23e-1)" "unprognostic (6.95e-2)" "unprognostic (7.92e-2)" "unprognostic (3.32e-1)" "unprognostic (1.35e-3)" "unprognostic (1.21e-2)" "unprognostic (2.41e-2)" "unprognostic (2.46e-3)" "unprognostic (6.89e-2)" "unprognostic (2.18e-1)" "unprognostic (2.48e-1)" "unprognostic (6.45e-3)" 41.2 48.1 69.3 30.8 69.0 34.4 34.2 27.7 67.6 29.3 66.6 28.2 44.4 60.0 20.5 34.1 40.1 23.1 31.6 95.8 62.0 49.2 47.5 68.9 25.8 25.2 68.6 48.7 26.2 57.9 24.5 26.6 19.6 62.2 23.9 43.9 17.8 40.7 37.2 221.8 22.3 55.6 45.8 67.2 23.3 40.7 14.1 47.7 10.9 22.1 98.7 28.1 18.9 31.1 166.1 148.1 142.2 135.7 107.4 127.6 158.4 49.9 47.3 68.2 55.5 57.4 53.4 38.0 48.7 39.0 37.0 32.9 45.4 49.5 25.9 46.9 51.5 60.1 32.0 54.9 76.8 20.3 22.9 101.4 76.2 87.7 113.3 59.7 97.0 33.6 66.2 45.1 42.4 43.0 57.8 45.2 51.7 63.0 28.4 41.9 72.0 83.6 127.1 80.1 88.1 123.8 51.0 49.8 56.4 70.7 87.2 66.2 52.0 35.4 47.7 54.0 44.7 54.5 66.9 52.4 33.3 31.6 29.3 67.9 66.4 109.5 81.9 48.9 66.9 36.4 103.7 135.7 142.2 98.5 112.1 101.0 166.1 121.1 109.2 135.4 123.2 110.3 110.3 122.3 107.4 97.7 148.1 127.6 158.4 69.3 69.0 27.7 67.6 62.0 49.2 68.6 48.7 62.2 47.7 142.9 207.3 0.0 0.0 0.0 0.0 0.0 0.0 337.3 224.1 840.9 0.0 343.2 1465.6 413.4 0.0 0.0 0.0 0.0 598.1 265.5 0.0 0.0 112.8 0.0 580.0 0.0 0.0 0.0 0.0 0.0 0.0 109.4 0.0 485.1 0.0 0.0 478.0 0.0 0.0 1359.9 0.0 0.0 0.0 0.0 0.0 0.0 229.9 0.0 0.0 0.0 ATP5MF "ATP5J2, ATP5JL" ENSG00000241468 "ATP synthase membrane subunit f" P56134 7 99448475-99466331 "Predicted intracellular proteins, Predicted membrane proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Cytotrophoblasts: 700.3;Distal tubular cells: 1212.0;Hofbauer cells: 681.7;monocytes: 591.5;Proximal tubular cells: 993.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067267, HPA070412" Approved Supported "Nuclear membrane,Mitochondria" NA NA 1400000 Mitochondria "Nuclear membrane" "HPA067267: AB_2685815, HPA070412: AB_2686266" "unprognostic (2.43e-2)" "unprognostic (1.42e-1)" "unprognostic (1.23e-2)" "unprognostic (1.90e-1)" "unprognostic (4.55e-3)" "prognostic unfavorable (2.58e-4)" "unprognostic (1.28e-2)" "unprognostic (3.77e-2)" "unprognostic (6.19e-2)" "unprognostic (2.31e-3)" "unprognostic (2.58e-1)" "unprognostic (3.65e-2)" "unprognostic (6.88e-3)" "unprognostic (9.24e-2)" "unprognostic (4.90e-2)" "unprognostic (2.52e-1)" "unprognostic (5.78e-2)" 42.4 49.0 68.0 36.6 52.0 46.4 42.8 37.3 58.8 30.7 62.7 19.0 39.9 62.9 21.2 41.2 57.4 24.8 36.6 94.5 53.9 49.8 59.6 93.5 30.0 35.5 54.6 43.6 20.7 63.6 16.3 36.7 33.4 36.3 35.0 47.3 30.9 57.1 45.2 178.8 27.8 61.5 24.6 33.0 35.6 43.4 58.3 25.5 52.9 37.9 98.0 37.6 27.8 30.2 68.3 129.7 117.2 104.1 58.3 84.0 140.0 86.7 76.6 64.6 104.3 50.9 51.7 40.9 57.6 44.9 61.9 67.1 81.3 80.2 81.4 60.8 35.7 105.4 53.5 71.4 66.0 66.2 58.6 91.7 55.1 122.5 104.8 38.4 93.9 63.1 58.9 63.7 53.8 57.0 54.2 58.9 70.6 111.7 89.7 64.8 203.9 140.4 163.0 91.9 174.2 90.2 62.9 53.9 139.1 130.5 96.5 62.1 68.5 75.4 186.6 54.5 100.7 47.0 121.9 49.9 54.5 87.2 90.0 84.0 51.4 118.1 169.8 63.1 91.9 83.7 90.0 104.0 117.2 54.2 104.1 51.7 68.3 63.5 61.0 129.7 56.9 55.8 59.5 49.7 58.3 79.2 102.7 84.0 140.0 68.0 52.0 37.3 58.8 53.9 49.8 54.6 43.6 36.3 25.5 20.8 44.7 0.0 0.0 0.0 0.0 0.0 0.0 93.7 67.1 366.4 0.0 700.3 1212.0 418.8 0.0 0.0 0.0 0.0 501.7 525.7 0.0 0.0 59.3 0.0 681.7 0.0 0.0 0.0 0.0 0.0 0.0 46.9 0.0 591.5 0.0 0.0 502.5 0.0 0.0 993.9 0.0 0.0 0.0 0.0 0.0 0.0 364.9 0.0 0.0 0.0 ATP5MG "ATP5JG, ATP5L" ENSG00000167283 "ATP synthase membrane subunit g" O75964 11 118401154-118431496 "Predicted intracellular proteins, Predicted membrane proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Cytotrophoblasts: 1200.8;Distal tubular cells: 2463.7;Hofbauer cells: 1173.9;monocytes: 1183.1;Proximal tubular cells: 1669.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA044629 Approved Supported Mitochondria NA NA 590000 Mitochondria "HPA044629: AB_2679028" "unprognostic (1.70e-1)" "unprognostic (2.40e-2)" "unprognostic (2.21e-1)" "unprognostic (5.45e-2)" "unprognostic (1.61e-1)" "unprognostic (3.27e-2)" "unprognostic (3.90e-2)" "unprognostic (8.19e-2)" "unprognostic (5.13e-2)" "unprognostic (1.01e-1)" "unprognostic (1.90e-1)" "unprognostic (7.41e-2)" "prognostic favorable (4.09e-5)" "unprognostic (6.26e-2)" "unprognostic (2.56e-1)" "unprognostic (1.50e-2)" "unprognostic (3.05e-2)" 32.3 42.4 45.3 31.8 46.7 36.0 39.6 38.1 40.4 25.6 39.0 21.1 30.3 33.8 33.9 40.4 27.9 26.5 30.1 85.8 37.5 38.4 55.6 42.6 29.1 41.9 39.2 23.6 31.3 70.1 25.8 31.1 23.6 28.3 26.3 41.5 39.0 71.9 29.5 68.4 20.9 39.5 47.3 27.8 30.7 29.5 17.9 15.7 53.2 33.7 60.2 43.7 30.0 23.6 42.7 54.6 30.8 48.0 32.5 53.5 98.1 21.4 11.1 29.3 28.4 25.4 28.4 23.5 22.0 25.0 20.2 21.5 28.1 34.8 42.6 46.0 23.9 31.7 27.4 29.5 30.8 22.5 34.0 19.4 67.3 10.5 16.9 26.0 38.2 32.3 30.2 29.2 24.9 23.7 23.8 27.1 32.3 30.7 35.7 28.1 38.4 53.4 47.7 18.6 60.6 31.0 36.7 24.6 46.8 52.5 18.5 23.3 17.6 33.2 53.8 16.2 33.9 39.1 35.7 26.6 16.7 18.7 14.3 25.1 16.3 22.3 43.3 12.4 44.6 20.8 28.8 48.0 30.8 27.1 33.3 39.3 42.7 42.9 35.5 49.9 34.6 53.5 40.2 24.0 32.5 31.5 54.6 45.8 98.1 45.3 46.7 38.1 40.4 37.5 38.4 39.2 23.6 28.3 15.7 336.5 314.3 0.0 0.0 0.0 0.0 0.0 0.0 345.3 306.0 579.3 0.0 1200.8 2463.7 680.9 0.0 0.0 0.0 0.0 858.6 734.2 0.0 0.0 238.3 0.0 1173.9 0.0 0.0 0.0 0.0 0.0 0.0 317.5 0.0 1183.1 0.0 0.0 798.2 0.0 0.0 1669.9 0.0 0.0 0.0 0.0 0.0 0.0 837.4 0.0 0.0 0.0 ATP5MPL "6.8PL, C14orf2, MLQ, MP68" ENSG00000156411 "ATP synthase membrane subunit 6.8PL" P56378 14 103912288-103928269 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Distal tubular cells: 1357.9;Hofbauer cells: 793.2;Proximal tubular cells: 1064.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058978, HPA060520" Approved Supported "Nucleoli fibrillar center,Mitochondria" NA NA Mitochondria "Nucleoli fibrillar center" "HPA058978: AB_2683867, HPA060520: AB_2684302" "unprognostic (1.37e-1)" "unprognostic (1.42e-3)" "unprognostic (1.55e-1)" "unprognostic (2.30e-1)" "unprognostic (2.11e-1)" "unprognostic (1.20e-2)" "unprognostic (1.75e-2)" "unprognostic (1.69e-1)" "unprognostic (1.62e-1)" "prognostic favorable (6.80e-4)" "unprognostic (1.34e-2)" "unprognostic (5.48e-2)" "unprognostic (1.34e-3)" "unprognostic (9.26e-2)" "unprognostic (1.50e-1)" "unprognostic (1.57e-1)" "unprognostic (4.14e-2)" 23.1 34.5 69.4 19.3 64.3 40.2 34.9 31.0 91.7 21.0 43.0 16.0 26.8 44.1 16.5 39.1 27.3 21.3 20.5 87.5 57.5 44.7 43.0 45.2 15.7 28.6 54.0 41.4 22.1 38.2 17.2 29.2 20.5 30.4 22.1 45.6 20.1 28.9 30.3 117.3 17.3 33.6 24.6 28.5 19.5 25.8 17.5 24.4 18.9 23.6 58.9 30.9 18.4 17.2 51.8 63.1 91.6 91.0 32.8 54.6 98.1 37.9 43.8 38.0 36.1 45.5 47.3 37.5 29.7 33.7 37.3 32.7 37.8 27.0 39.8 31.4 30.4 30.1 32.4 48.9 35.8 50.6 32.9 49.3 44.4 37.1 58.1 30.1 53.6 30.9 49.6 48.8 25.3 27.1 42.9 41.9 53.7 26.9 42.7 41.0 112.7 51.8 76.6 29.7 88.5 83.8 33.3 33.2 36.1 56.8 54.0 32.9 39.3 24.9 46.7 56.0 43.9 57.8 63.8 22.5 14.7 23.0 39.6 24.3 32.8 55.7 55.7 34.4 30.6 24.7 54.8 91.0 55.0 37.5 68.0 41.7 51.8 47.8 42.3 63.1 43.6 54.6 48.4 91.6 32.8 65.0 61.2 46.5 98.1 69.4 64.3 31.0 91.7 57.5 44.7 54.0 41.4 30.4 24.4 205.4 192.2 0.0 0.0 0.0 0.0 0.0 0.0 269.0 169.5 392.6 0.0 537.4 1357.9 448.4 0.0 0.0 0.0 0.0 495.8 570.0 0.0 0.0 86.0 0.0 793.2 0.0 0.0 0.0 0.0 0.0 0.0 158.5 0.0 585.3 0.0 0.0 512.8 0.0 0.0 1064.7 0.0 0.0 0.0 0.0 0.0 0.0 593.8 0.0 0.0 0.0 ATP5PB ATP5F1 ENSG00000116459 "ATP synthase peripheral stalk-membrane subunit b" P24539 1 111448864-111462773 "Predicted intracellular proteins, Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 83.6" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 297.5;Distal tubular cells: 391.3;Extravillous trophoblasts: 335.0;Hofbauer cells: 328.7;Proximal tubular cells: 348.8;Syncytiotrophoblasts: 290.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046067, HPA057347" Enhanced Supported Mitochondria "Intracellular and membrane" NA NA 640000 Mitochondria "HPA046067: AB_10960850, HPA057347: AB_2683416" "unprognostic (4.18e-1)" "unprognostic (6.83e-2)" "unprognostic (1.10e-3)" "unprognostic (1.73e-2)" "unprognostic (3.56e-2)" "unprognostic (8.18e-2)" "unprognostic (8.52e-3)" "unprognostic (8.82e-2)" "unprognostic (3.67e-2)" "unprognostic (7.18e-3)" "unprognostic (3.29e-1)" "unprognostic (2.92e-1)" "prognostic favorable (3.26e-9)" "prognostic favorable (8.07e-4)" "unprognostic (1.60e-1)" "unprognostic (2.62e-1)" "unprognostic (1.93e-1)" 11.6 16.0 16.8 11.4 22.6 8.0 10.4 30.7 28.8 10.7 30.0 10.4 11.3 16.1 14.4 10.7 21.1 13.7 9.7 57.1 16.4 15.4 30.5 26.2 10.2 14.2 16.1 15.5 12.6 15.3 18.0 13.3 16.3 22.8 13.4 17.8 9.8 20.4 12.4 83.6 9.7 25.4 13.7 13.9 13.7 13.1 11.4 10.1 18.7 18.6 34.0 15.4 15.5 11.5 8.3 10.8 4.3 10.0 5.9 11.9 22.9 15.3 3.5 13.0 10.1 8.4 7.6 8.4 17.0 18.8 17.7 14.7 6.2 7.8 20.9 15.8 11.1 3.8 16.0 18.9 21.0 15.8 16.6 7.4 20.9 4.9 4.1 6.1 26.3 21.1 6.6 9.0 19.4 18.2 4.1 14.1 2.9 18.4 9.2 10.1 7.1 44.9 6.1 9.9 4.0 24.0 11.6 40.6 8.2 14.0 5.2 9.5 3.0 13.2 18.9 13.9 3.1 15.2 9.5 13.6 8.3 14.7 16.2 16.8 12.7 12.1 49.8 20.1 20.0 15.5 1.9 10.0 4.3 9.7 6.4 8.6 7.5 10.8 9.2 10.8 8.3 11.9 7.3 2.9 5.9 5.0 5.9 9.0 22.9 16.8 22.6 30.7 28.8 16.4 15.4 16.1 15.5 22.8 10.1 62.5 73.9 0.0 0.0 0.0 0.0 0.0 0.0 136.5 105.8 118.7 0.0 297.5 391.3 205.2 0.0 0.0 0.0 0.0 172.3 335.0 0.0 0.0 82.5 0.0 328.7 0.0 0.0 0.0 0.0 0.0 0.0 69.8 0.0 172.3 0.0 0.0 151.6 0.0 0.0 348.8 0.0 0.0 0.0 0.0 0.0 0.0 290.7 0.0 0.0 0.0 ATP5PD "ATP5H, ATP5JD, ATPQ" ENSG00000167863 "ATP synthase peripheral stalk subunit d" O75947 17 75038863-75046985 "Predicted intracellular proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Distal tubular cells: 968.2;Proximal tubular cells: 714.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042777, HPA048459" Enhanced Supported Mitochondria NA NA 1600000 Mitochondria "HPA042777: AB_2678160, HPA048459: AB_2680402" "unprognostic (1.37e-1)" "unprognostic (4.41e-2)" "unprognostic (1.70e-3)" "unprognostic (1.32e-1)" "unprognostic (1.54e-1)" "unprognostic (4.81e-2)" "unprognostic (7.21e-2)" "unprognostic (1.99e-1)" "unprognostic (1.29e-1)" "unprognostic (2.03e-2)" "unprognostic (2.72e-1)" "unprognostic (8.72e-2)" "unprognostic (2.56e-2)" "unprognostic (1.42e-1)" "unprognostic (3.26e-1)" "unprognostic (1.73e-1)" "unprognostic (4.29e-2)" 38.8 38.5 54.3 28.6 48.6 25.6 37.8 34.5 50.4 30.0 52.9 19.6 33.2 46.6 25.8 47.4 58.9 25.7 31.0 143.6 47.7 44.8 78.8 86.2 24.8 29.2 45.7 39.2 28.5 43.3 38.5 29.8 35.4 40.3 33.1 53.1 35.4 56.8 36.3 184.2 35.5 59.9 39.1 32.8 32.7 40.4 15.7 21.3 30.3 48.7 88.5 33.7 45.8 29.0 72.5 100.7 90.9 103.8 54.9 100.0 86.2 63.5 55.8 42.8 55.7 69.8 85.4 57.5 54.7 72.2 61.4 58.6 43.6 50.0 43.1 36.4 68.4 57.9 58.0 51.5 71.7 82.4 20.9 43.7 44.0 46.5 85.9 68.7 56.0 28.9 72.5 57.1 49.9 71.4 49.1 81.7 33.7 45.8 58.8 75.4 61.7 55.4 63.0 32.6 146.1 79.4 39.4 124.0 79.9 126.9 62.2 43.1 47.4 64.6 103.0 87.1 66.8 102.1 57.2 42.1 76.5 53.5 66.4 63.8 47.3 37.3 44.1 68.5 56.3 49.2 67.2 90.5 90.9 58.3 103.8 67.4 72.5 100.0 71.6 100.7 57.6 90.9 83.5 50.7 54.9 83.1 89.8 94.6 86.2 54.3 48.6 34.5 50.4 47.7 44.8 45.7 39.2 40.3 21.3 160.8 115.9 0.0 0.0 0.0 0.0 0.0 0.0 186.0 188.8 246.0 0.0 327.6 968.2 259.9 0.0 0.0 0.0 0.0 330.1 269.2 0.0 0.0 81.4 0.0 401.2 0.0 0.0 0.0 0.0 0.0 0.0 121.7 0.0 364.3 0.0 0.0 268.3 0.0 0.0 714.6 0.0 0.0 0.0 0.0 0.0 0.0 281.2 0.0 0.0 0.0 ATP5PF "ATP5, ATP5A, ATP5J, ATPM, CF6" ENSG00000154723 "ATP synthase peripheral stalk subunit F6" P18859 21 25716503-25735673 "Plasma proteins, Predicted intracellular proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Distal tubular cells: 2012.7;Proximal tubular cells: 1143.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031069 Supported Supported Mitochondria NA NA 720000 Mitochondria "HPA031069: AB_10603676" "unprognostic (3.52e-2)" "unprognostic (1.33e-1)" "unprognostic (1.46e-1)" "unprognostic (4.57e-2)" "unprognostic (1.14e-1)" "unprognostic (7.87e-2)" "unprognostic (1.43e-1)" "unprognostic (6.32e-2)" "unprognostic (1.48e-1)" "unprognostic (4.87e-2)" "unprognostic (1.77e-1)" "unprognostic (8.83e-2)" "prognostic favorable (2.37e-5)" "unprognostic (1.93e-1)" "unprognostic (9.20e-2)" "unprognostic (1.56e-1)" "unprognostic (2.15e-2)" 39.8 46.8 49.0 20.3 43.6 23.0 32.6 30.8 46.6 25.9 48.6 26.1 22.4 43.0 24.0 57.4 45.2 21.6 19.2 148.9 41.1 37.1 72.8 111.0 18.7 22.2 47.0 27.0 23.9 37.4 31.2 37.5 33.9 45.7 32.6 47.9 33.9 47.1 37.5 164.7 18.7 57.9 46.9 32.8 25.0 37.6 21.0 25.8 31.4 32.1 69.9 29.9 42.0 23.1 87.8 102.4 80.9 91.5 69.1 95.2 112.2 41.8 30.1 38.4 43.1 41.4 38.1 47.7 37.0 43.1 36.2 35.4 69.1 33.0 51.5 24.5 36.5 57.9 22.9 51.4 44.4 39.9 45.0 54.6 107.4 61.2 68.6 46.8 78.4 35.2 37.2 54.8 34.6 31.1 49.3 42.0 49.8 67.0 63.4 52.8 46.7 54.3 79.4 69.0 94.8 54.7 42.5 74.7 97.3 77.2 57.2 43.9 48.8 62.2 62.9 57.0 56.8 45.5 70.7 31.7 27.7 33.2 25.8 31.8 63.3 103.5 65.2 42.5 82.1 34.7 69.2 88.8 80.9 60.3 91.5 64.0 87.8 80.2 74.6 102.4 71.6 79.6 78.0 56.9 69.1 89.7 96.4 95.2 112.2 49.0 43.6 30.8 46.6 41.1 37.1 47.0 27.0 45.7 25.8 157.8 157.2 0.0 0.0 0.0 0.0 0.0 0.0 261.0 194.5 397.8 0.0 553.9 2012.7 380.3 0.0 0.0 0.0 0.0 410.7 419.1 0.0 0.0 101.1 0.0 458.5 0.0 0.0 0.0 0.0 0.0 0.0 101.3 0.0 395.0 0.0 0.0 402.6 0.0 0.0 1143.7 0.0 0.0 0.0 0.0 0.0 0.0 592.2 0.0 0.0 0.0 ATP5PO "ATP5O, ATPO, OSCP" ENSG00000241837 "ATP synthase peripheral stalk subunit OSCP" P48047 21 33903453-33915980 "Plasma proteins, Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Distal tubular cells: 1520.3;Proximal tubular cells: 981.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB016209, HPA041394" Enhanced Approved Mitochondria NA NA 4000000 Mitochondria "CAB016209: AB_631361, HPA041394: AB_2677450" "unprognostic (2.08e-1)" "unprognostic (4.77e-3)" "unprognostic (3.30e-1)" "unprognostic (6.12e-3)" "unprognostic (1.51e-1)" "unprognostic (1.46e-1)" "unprognostic (1.48e-1)" "unprognostic (2.34e-1)" "unprognostic (8.47e-2)" "unprognostic (1.42e-1)" "unprognostic (3.27e-1)" "unprognostic (1.81e-1)" "prognostic favorable (9.34e-4)" "unprognostic (1.03e-1)" "unprognostic (1.37e-2)" "unprognostic (3.26e-2)" "unprognostic (7.89e-3)" 32.6 26.8 49.3 27.7 43.5 34.9 37.8 35.0 44.8 28.7 45.0 21.6 24.2 48.2 25.1 34.3 44.2 28.9 30.3 139.4 40.8 36.7 61.3 57.5 20.6 31.5 45.6 38.4 38.0 40.1 29.5 19.2 25.1 46.4 32.5 52.4 27.2 38.8 28.6 130.6 28.7 57.5 34.8 29.3 27.3 43.2 25.4 20.1 42.7 37.4 98.0 36.2 39.4 26.5 71.9 94.0 48.5 71.5 46.8 73.3 112.2 41.5 19.5 54.4 53.3 37.4 48.0 60.6 23.8 41.8 40.1 39.3 57.2 40.4 55.8 20.5 36.1 39.9 23.6 58.6 81.3 47.5 41.5 58.5 83.6 31.2 56.8 43.1 63.3 29.0 48.8 49.8 38.8 63.7 45.2 55.1 46.1 67.1 72.4 51.5 42.8 48.2 62.2 62.1 105.6 57.8 49.8 53.8 105.2 109.8 37.0 44.0 25.5 40.9 61.2 54.1 49.3 61.7 70.0 31.1 26.4 31.5 47.0 26.9 47.8 52.2 58.4 48.6 108.7 38.0 33.4 69.9 48.5 44.5 71.5 53.0 71.9 58.8 52.9 94.0 59.0 73.3 61.5 17.2 46.8 62.6 55.9 70.1 112.2 49.3 43.5 35.0 44.8 40.8 36.7 45.6 38.4 46.4 20.1 226.3 164.6 0.0 0.0 0.0 0.0 0.0 0.0 187.4 223.0 211.1 0.0 511.4 1520.3 335.0 0.0 0.0 0.0 0.0 367.3 532.1 0.0 0.0 105.8 0.0 543.7 0.0 0.0 0.0 0.0 0.0 0.0 80.4 0.0 380.5 0.0 0.0 302.9 0.0 0.0 981.3 0.0 0.0 0.0 0.0 0.0 0.0 453.3 0.0 0.0 0.0 COX4I1 "COX4, COX4-1" ENSG00000131143 "Cytochrome c oxidase subunit 4I1" P13073 16 85798633-85807044 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002485, CAB004080" Supported Supported Mitochondria NA NA 970000 Mitochondria "CAB004080: AB_2085427, HPA002485: AB_1078559" "unprognostic (4.73e-2)" "unprognostic (9.14e-3)" "unprognostic (2.65e-1)" "unprognostic (6.18e-3)" "unprognostic (2.47e-1)" "unprognostic (4.52e-2)" "unprognostic (2.65e-1)" "unprognostic (1.46e-1)" "unprognostic (5.97e-2)" "unprognostic (7.82e-3)" "unprognostic (3.32e-2)" "unprognostic (2.29e-1)" "prognostic favorable (2.56e-8)" "unprognostic (4.23e-2)" "unprognostic (4.06e-1)" "unprognostic (1.01e-1)" "unprognostic (2.38e-2)" 41.6 38.6 101.1 54.0 100.2 66.5 60.6 51.6 86.9 38.1 87.1 38.9 43.9 77.6 33.9 69.3 54.7 50.4 59.8 218.6 82.3 73.0 59.7 69.5 29.6 49.1 100.1 65.9 45.4 71.2 55.7 36.3 36.8 57.0 37.6 98.4 40.6 65.9 53.1 172.3 48.0 76.5 51.2 58.4 40.1 56.5 21.8 38.7 46.6 49.1 112.6 70.2 47.1 52.4 123.0 144.1 74.8 130.8 74.7 121.9 222.6 44.7 73.0 49.7 66.3 92.0 86.3 85.7 40.9 83.7 77.5 38.8 123.5 67.9 73.5 50.3 65.1 42.4 90.2 70.6 82.2 69.1 24.9 73.0 41.0 61.8 119.9 83.0 37.2 30.6 100.0 127.6 63.4 86.6 81.2 80.9 60.5 68.9 30.2 65.7 161.5 74.4 115.3 66.6 99.8 86.1 84.6 31.2 64.3 114.9 88.9 59.1 48.0 86.6 55.1 66.2 55.7 80.8 103.9 56.8 38.9 45.1 35.7 43.7 60.9 57.8 168.9 59.4 73.8 43.6 50.9 130.8 74.8 72.5 112.8 88.4 123.0 96.3 85.0 144.1 116.1 121.9 100.0 50.7 74.7 98.6 107.7 102.7 222.6 101.1 100.2 51.6 86.9 82.3 73.0 100.1 65.9 57.0 38.7 256.1 363.9 981.6 971.7 1003.2 230.7 3140.6 1197.4 362.7 382.2 600.2 123.7 1081.3 2332.7 965.7 464.1 701.9 2320.1 280.4 1145.7 924.4 671.8 956.9 507.1 1060.0 1395.9 200.2 970.5 596.0 1378.7 820.3 462.0 1118.7 1086.5 1424.7 1513.6 283.9 1228.5 1740.3 336.3 1959.5 260.3 349.3 760.4 345.7 304.0 1190.3 1239.3 852.8 1984.7 1551.2 COX4I2 "COX4-2, COX4B, COX4L2, COXIV-2, dJ857M17.2" ENSG00000131055 "Cytochrome c oxidase subunit 4I2" Q96KJ9 20 31637888-31645006 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 60.7" "Group enriched" "Detected in some" 34 "Sertoli cells: 407.4;Smooth muscle cells: 177.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 11 "naive B-cell: 2.6" "Lineage enriched" "Detected in single" 11 "B-cells: 2.6" "Cell line enriched" "Detected in some" 4 "SH-SY5Y: 6.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (2.64e-1)" "unprognostic (2.09e-2)" "unprognostic (2.76e-3)" "unprognostic (2.18e-2)" "unprognostic (4.51e-2)" "prognostic favorable (6.04e-5)" "unprognostic (5.60e-2)" "unprognostic (1.13e-1)" "unprognostic (2.51e-1)" "unprognostic (7.45e-2)" "unprognostic (1.04e-2)" "unprognostic (5.35e-2)" "prognostic unfavorable (9.78e-4)" "unprognostic (1.11e-1)" "unprognostic (3.30e-3)" "unprognostic (1.43e-1)" "unprognostic (5.59e-2)" 9.9 0.7 1.6 1.7 1.9 0.1 7.9 0.7 2.5 4.7 2.2 1.5 0.9 1.1 5.9 3.5 7.1 2.6 5.4 15.5 1.7 1.4 2.0 0.5 24.6 4.9 2.4 1.0 1.9 1.9 2.1 1.1 60.7 2.7 5.2 1.6 4.1 2.4 2.8 12.8 2.5 2.7 3.9 1.2 0.8 2.0 1.5 2.1 0.5 8.0 7.5 2.3 3.7 3.7 2.6 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 6.3 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.6 1.9 0.7 2.5 1.7 1.4 2.4 1.0 2.7 2.1 0.0 0.0 0.0 0.2 5.7 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 5.7 0.0 0.0 0.0 0.2 4.3 0.2 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.2 3.4 1.1 8.5 0.0 0.0 1.1 0.1 0.0 0.7 0.0 0.4 407.4 177.5 0.0 0.1 5.8 2.1 0.0 0.0 0.3 COX5A ENSG00000178741 "Cytochrome c oxidase subunit 5A" P20674 15 74919791-74938168 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 209.7;skeletal muscle: 222.8" "Cell type enhanced" "Detected in all" 5 "Cardiomyocytes: 1647.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027526 Supported NA NA 5400000 "HPA027526: AB_10602802" "unprognostic (7.32e-2)" "prognostic favorable (2.15e-4)" "unprognostic (4.06e-2)" "unprognostic (9.85e-2)" "unprognostic (1.22e-1)" "unprognostic (1.03e-1)" "unprognostic (2.78e-1)" "unprognostic (3.79e-2)" "unprognostic (9.63e-2)" "unprognostic (2.77e-1)" "unprognostic (1.77e-1)" "unprognostic (8.62e-2)" "prognostic favorable (6.06e-7)" "unprognostic (9.78e-2)" "unprognostic (2.22e-1)" "unprognostic (1.30e-1)" "unprognostic (3.81e-3)" 22.4 20.1 30.4 25.9 29.1 20.6 36.1 22.4 57.9 15.0 70.8 12.1 21.6 51.5 11.6 19.3 31.6 14.6 22.7 209.7 26.7 25.4 42.6 49.4 17.7 29.0 32.7 27.3 8.7 41.1 27.7 16.4 15.0 26.7 15.6 65.7 13.7 32.2 23.1 222.8 17.2 49.4 15.9 20.9 17.3 31.7 26.2 12.2 21.9 19.9 86.5 30.6 17.9 15.1 52.2 81.2 47.3 80.6 58.8 64.1 65.7 35.1 39.1 48.5 42.3 29.9 34.6 53.4 32.0 28.3 41.1 38.4 43.6 44.6 80.7 39.5 27.6 50.0 69.6 114.5 46.5 34.4 45.6 106.8 66.9 40.8 54.0 37.5 76.4 42.1 35.0 50.6 25.6 58.1 28.2 48.0 55.9 61.4 54.9 41.0 27.7 63.7 58.8 51.5 71.5 58.0 59.4 46.5 93.7 60.0 59.5 71.1 30.5 48.5 72.9 100.2 55.3 36.5 62.4 32.4 31.1 29.4 38.8 50.8 62.9 115.4 89.4 33.4 101.4 28.3 47.3 65.5 36.1 37.6 80.6 44.9 52.2 46.7 44.2 81.2 37.8 33.2 38.5 15.8 58.8 72.1 64.7 64.1 65.7 30.4 29.1 22.4 57.9 26.7 25.4 32.7 27.3 26.7 12.2 92.3 98.3 157.9 175.6 140.6 98.6 1647.0 242.0 117.8 108.1 162.3 37.3 430.9 1250.1 355.7 826.5 138.1 1074.0 93.5 379.0 409.1 121.0 226.5 102.6 381.0 504.7 87.4 443.2 110.5 242.1 581.7 92.9 227.7 237.8 426.6 815.4 91.5 365.2 768.6 80.6 703.8 110.5 90.5 143.5 367.8 236.9 139.0 427.4 165.8 1016.3 341.5 COX5B ENSG00000135940 "Cytochrome c oxidase subunit 5B" P10606 2 97646040-97648383 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 336.2" "Cell type enhanced" "Detected in all" 5 "Cardiomyocytes: 3263.7;Distal tubular cells: 3068.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034517 Supported Enhanced Mitochondria NA NA 2200000 Mitochondria "HPA034517: AB_10603561" "unprognostic (4.61e-2)" "unprognostic (4.33e-2)" "unprognostic (1.71e-1)" "unprognostic (1.26e-1)" "unprognostic (1.39e-1)" "unprognostic (1.92e-2)" "unprognostic (2.48e-1)" "unprognostic (1.01e-1)" "unprognostic (1.86e-1)" "unprognostic (2.72e-2)" "unprognostic (1.79e-2)" "unprognostic (4.20e-2)" "unprognostic (4.02e-2)" "unprognostic (3.32e-1)" "unprognostic (1.01e-1)" "unprognostic (1.34e-1)" "prognostic favorable (2.73e-4)" 39.8 25.3 54.5 20.8 46.1 27.6 23.9 22.6 46.4 19.5 58.6 16.0 27.6 44.5 13.1 22.3 31.9 19.4 24.0 160.6 39.9 36.0 44.8 52.5 13.8 16.1 48.1 32.5 17.7 24.6 19.9 17.5 18.1 39.0 21.5 31.5 14.3 36.5 29.2 336.2 18.9 38.6 19.9 30.8 17.9 40.4 13.4 23.0 14.2 25.8 65.4 15.3 19.4 16.7 85.1 111.2 115.8 122.5 48.1 83.6 145.2 19.9 23.3 14.4 23.9 17.0 15.5 62.3 25.7 14.4 17.1 19.1 64.4 20.9 33.7 55.3 16.4 27.0 30.5 16.6 25.8 7.8 26.2 70.6 45.4 25.8 76.9 32.7 43.0 33.3 28.7 22.9 16.4 12.8 17.5 14.6 27.0 33.3 14.9 13.2 49.4 27.1 62.4 28.4 34.1 122.6 26.7 24.8 50.4 23.0 30.7 28.6 30.6 25.0 30.2 48.2 20.0 16.1 45.1 26.5 15.6 26.6 25.0 16.5 38.9 36.8 25.7 28.3 37.0 16.1 96.9 122.5 99.8 54.7 114.1 52.6 85.1 66.3 57.1 111.2 68.8 64.5 57.5 115.8 48.1 95.9 75.8 83.6 145.2 54.5 46.1 22.6 46.4 39.9 36.0 48.1 32.5 39.0 23.0 205.4 224.6 375.1 495.2 343.3 204.5 3263.7 647.1 369.4 268.4 759.0 214.0 640.2 3068.8 479.5 156.4 370.1 2132.4 140.2 527.3 778.4 340.5 424.2 320.2 1125.6 767.8 133.5 711.5 338.8 489.5 270.1 325.7 488.5 865.4 798.1 1204.0 259.4 460.5 1508.0 286.4 1849.4 303.9 439.8 473.4 213.2 290.0 419.6 512.8 265.9 1320.1 744.1 COX6A1 COX6A ENSG00000111775 "Cytochrome c oxidase subunit 6A1" P12074 12 120438090-120440742 "Disease related genes, Predicted membrane proteins" Oxidoreductase "Charcot-Marie-Tooth disease, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062394 Approved Supported Mitochondria NA NA Mitochondria "HPA062394: AB_2684749" "unprognostic (1.18e-1)" "unprognostic (1.03e-2)" "unprognostic (5.10e-2)" "unprognostic (6.16e-2)" "unprognostic (1.47e-1)" "unprognostic (8.78e-2)" "unprognostic (3.33e-1)" "unprognostic (1.34e-1)" "unprognostic (1.09e-1)" "unprognostic (1.13e-2)" "unprognostic (3.22e-2)" "unprognostic (2.82e-1)" "prognostic favorable (6.50e-7)" "unprognostic (2.53e-1)" "unprognostic (1.31e-1)" "unprognostic (5.48e-2)" "unprognostic (2.63e-2)" 49.2 48.0 171.0 32.1 103.0 52.6 43.8 44.4 107.5 37.3 96.8 38.5 32.4 102.8 28.0 47.0 59.3 41.8 37.6 41.5 121.5 92.0 85.8 102.6 32.4 39.6 140.0 57.9 27.7 62.7 43.8 38.3 44.4 86.9 43.1 74.3 31.3 63.8 44.2 10.6 37.7 85.7 38.1 67.2 32.1 60.8 28.1 61.2 33.7 48.2 36.0 40.1 42.1 35.0 74.5 102.2 60.5 69.8 47.8 87.4 83.0 47.2 101.2 57.6 60.1 44.4 37.9 70.6 30.1 40.3 53.5 45.7 122.3 48.3 99.6 90.1 42.5 41.4 79.1 56.1 66.1 34.7 59.7 121.0 53.4 57.9 89.5 41.1 58.5 38.4 45.5 81.6 48.8 57.9 44.2 45.0 72.6 52.3 31.2 44.4 132.3 84.4 148.2 52.5 92.1 148.4 57.7 38.6 93.3 84.4 114.0 76.0 66.1 55.2 54.2 70.7 33.5 97.2 66.9 33.9 33.4 41.3 34.4 41.8 48.5 66.6 77.1 52.4 57.4 44.4 38.5 65.5 58.3 54.4 69.5 58.5 74.5 64.3 59.5 95.1 59.2 59.1 59.3 60.5 47.8 69.8 102.2 87.4 83.0 171.0 103.0 44.4 107.5 121.5 92.0 140.0 57.9 86.9 61.2 369.2 267.5 329.6 423.0 340.5 204.2 104.8 682.8 548.7 311.7 734.5 543.9 662.2 1255.0 574.2 113.2 290.2 1336.6 93.5 578.7 601.6 281.6 433.2 262.5 840.8 680.4 138.2 495.4 264.6 384.0 100.3 279.6 388.0 497.7 739.4 694.0 232.4 574.7 1129.3 249.6 1194.5 252.8 336.3 428.1 355.7 331.5 339.1 775.3 316.6 860.7 644.8 COX6A2 ENSG00000156885 "Cytochrome c oxidase subunit 6A2" Q02221 16 31427731-31428428 "Predicted intracellular proteins, Transporters" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 28 "heart muscle: 398.6;skeletal muscle: 421.1;tongue: 230.8" "Cell type enriched" "Detected in some" 64 "Cardiomyocytes: 3924.5" "Group enriched" "Detected in many" 5 "head and neck cancer: 9.3;liver cancer: 2.9;prostate cancer: 3.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 125 "NK-cell: 12.5" "Lineage enriched" "Detected in single" 125 "NK-cells: 12.5" "Cell line enriched" "Detected in some" 4 "U-266/84: 14.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.66e-1)" "unprognostic (1.73e-3)" "unprognostic (2.09e-2)" "unprognostic (1.25e-2)" "unprognostic (1.68e-2)" "unprognostic (3.88e-1)" "unprognostic (5.61e-2)" "unprognostic (7.20e-2)" "unprognostic (8.71e-2)" "unprognostic (6.20e-2)" "unprognostic (1.68e-1)" "unprognostic (2.65e-1)" 3.0 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.1 9.3 5.6 0.1 0.1 398.6 0.1 0.3 0.2 0.9 0.1 0.1 0.2 0.0 0.1 0.2 0.2 0.8 0.1 0.0 2.3 0.1 0.9 8.4 0.1 421.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.0 5.5 230.8 11.4 0.1 0.1 0.0 0.0 0.0 0.0 12.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 14.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 3924.5 0.0 0.0 0.0 3.5 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 61.4 2.1 3.2 0.0 0.6 2.1 0.8 0.3 0.0 0.0 0.0 0.0 0.8 0.5 0.0 0.7 20.3 3.9 19.4 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 COX6B1 "COX6B, COXG" ENSG00000126267 "Cytochrome c oxidase subunit 6B1" P14854 19 35648223-35658861 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Cardiomyocytes: 2503.3;Distal tubular cells: 2530.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004192 Supported Supported Mitochondria NA NA 1200000 Mitochondria "HPA004192: AB_1847180" "unprognostic (5.12e-2)" "unprognostic (1.86e-2)" "unprognostic (3.81e-2)" "unprognostic (1.22e-1)" "unprognostic (1.62e-2)" "unprognostic (1.32e-1)" "unprognostic (2.18e-1)" "unprognostic (6.16e-2)" "unprognostic (3.52e-1)" "unprognostic (4.80e-2)" "unprognostic (1.64e-1)" "unprognostic (1.88e-1)" "prognostic favorable (5.42e-4)" "unprognostic (2.10e-2)" "unprognostic (6.98e-2)" "unprognostic (5.74e-2)" "unprognostic (5.48e-3)" 37.2 32.2 62.1 32.1 58.7 46.2 42.8 31.1 57.6 34.1 65.0 25.2 41.2 52.7 27.1 70.2 52.4 36.3 39.8 132.5 51.5 52.2 61.1 68.9 24.7 40.4 57.4 60.2 29.2 41.1 41.4 28.8 30.2 39.2 30.2 77.1 31.8 54.9 44.2 168.4 35.1 63.2 37.6 38.7 30.7 42.0 21.0 29.0 42.7 37.6 110.6 52.7 33.8 31.6 110.6 115.5 111.1 116.1 61.2 107.9 167.5 36.4 87.1 37.8 50.4 49.7 50.9 35.1 29.7 45.1 49.1 49.7 71.1 36.7 41.1 52.6 46.7 32.9 26.8 60.7 50.4 48.3 47.8 41.5 70.4 46.6 69.6 39.3 63.2 36.7 59.8 63.3 45.8 26.6 47.1 47.6 44.7 43.9 61.6 49.3 70.5 44.4 46.6 28.1 184.2 58.8 38.5 41.6 68.0 111.9 72.9 33.2 38.0 47.8 82.4 29.3 46.1 32.7 68.7 28.4 28.4 32.5 30.1 46.2 37.0 44.4 55.8 37.5 49.0 36.5 87.7 108.6 94.7 65.5 116.1 62.4 110.6 90.5 76.1 111.8 92.7 89.6 79.4 111.1 61.2 107.8 115.5 107.9 167.5 62.1 58.7 31.1 57.6 51.5 52.2 57.4 60.2 39.2 29.0 226.3 220.0 458.4 406.9 379.4 129.5 2503.3 772.0 354.7 217.2 663.0 60.9 533.3 2530.0 637.7 277.5 330.3 1579.1 210.2 701.4 649.3 430.6 454.9 274.7 1065.5 910.2 84.2 601.2 320.4 754.1 587.8 303.5 609.7 710.3 822.4 1028.9 175.1 735.8 1153.8 256.7 1262.3 137.8 258.7 388.3 116.9 177.2 494.3 560.9 394.4 1027.2 623.0 COX6B2 "COXVIB2, CT59, FLJ32865" ENSG00000160471 "Cytochrome c oxidase subunit 6B2" Q6YFQ2 19 55349306-55354814 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 66.5" "Cell type enhanced" "Detected in some" 24 "Early spermatids: 23.6;Late spermatids: 19.1;Spermatocytes: 77.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "neutrophil: 5.7" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "CAPAN-2: 22.6;SCLC-21H: 9.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA035014 Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA035014: AB_10601261" "unprognostic (7.43e-3)" "unprognostic (8.72e-2)" "unprognostic (1.42e-1)" "unprognostic (5.75e-2)" "unprognostic (2.59e-2)" "unprognostic (9.23e-3)" "unprognostic (1.88e-2)" "unprognostic (6.45e-3)" "unprognostic (1.02e-1)" "unprognostic (6.82e-2)" "prognostic unfavorable (9.70e-5)" "unprognostic (8.11e-2)" "unprognostic (1.81e-6)" "unprognostic (9.91e-2)" "unprognostic (1.47e-1)" "unprognostic (1.02e-2)" "unprognostic (2.02e-1)" 0.3 0.0 0.4 0.6 0.6 0.7 0.5 0.3 0.6 0.2 3.3 0.2 0.2 0.0 0.2 0.8 0.5 0.4 0.2 0.2 0.2 0.5 0.5 0.2 0.2 0.6 0.4 0.2 0.4 0.2 0.0 0.4 0.2 0.6 0.2 3.5 0.7 0.6 0.2 0.2 1.8 0.2 0.2 0.7 0.2 0.0 66.5 0.3 0.2 0.2 0.2 1.2 0.2 0.4 1.3 1.4 5.7 1.0 1.6 0.9 0.8 2.7 0.4 0.1 0.1 0.0 0.0 0.2 0.4 0.1 0.3 0.5 0.1 22.6 0.1 0.2 0.2 0.3 1.8 0.7 0.2 0.2 0.8 0.7 0.0 1.7 0.1 0.3 0.2 1.8 0.2 2.5 0.4 0.5 1.7 0.0 0.1 0.4 0.2 0.0 0.5 0.1 0.2 0.6 2.3 0.5 0.1 0.0 0.2 0.0 0.4 9.7 0.3 0.3 0.1 0.0 0.6 0.4 0.0 0.4 0.3 0.5 0.1 0.2 1.5 1.2 0.1 0.1 0.3 0.2 1.9 1.0 1.0 0.8 0.5 0.5 0.7 0.7 0.6 0.3 1.3 0.7 0.9 5.7 1.6 0.7 1.4 0.6 0.8 0.4 0.6 0.3 0.6 0.2 0.5 0.4 0.2 0.6 0.3 0.0 0.3 0.0 0.6 0.5 2.1 0.4 0.0 0.0 0.0 0.0 3.9 0.5 0.0 0.6 23.6 0.0 3.2 0.0 0.6 0.2 0.4 0.2 0.0 0.0 0.1 3.2 1.2 0.0 0.0 19.1 0.6 0.0 0.0 0.0 1.3 0.9 5.6 3.5 0.0 0.0 4.1 0.0 0.0 77.8 1.3 0.4 0.3 0.0 4.4 2.5 COX6C ENSG00000164919 "Cytochrome c oxidase subunit 6C" P09669 8 99873200-99894062 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 232.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014295, CAB016244" Enhanced Supported Mitochondria NA NA 53000 Mitochondria "CAB016244: AB_2085703, HPA014295: AB_2668966" "unprognostic (4.91e-2)" "unprognostic (2.90e-2)" "unprognostic (6.90e-2)" "unprognostic (3.37e-2)" "unprognostic (1.58e-2)" "unprognostic (1.26e-1)" "unprognostic (1.63e-1)" "unprognostic (2.07e-2)" "unprognostic (1.29e-1)" "unprognostic (3.51e-1)" "unprognostic (3.70e-1)" "unprognostic (8.86e-2)" "unprognostic (3.47e-3)" "unprognostic (1.10e-1)" "unprognostic (5.31e-2)" "unprognostic (1.07e-1)" "unprognostic (6.99e-3)" 20.5 43.1 66.1 21.6 56.2 44.4 23.3 28.5 63.8 18.7 46.0 14.3 29.4 113.7 38.8 64.1 31.6 27.4 23.5 113.0 54.8 46.9 38.7 66.8 18.2 23.2 58.8 36.7 32.7 26.5 12.1 24.0 30.7 38.8 23.3 38.1 20.6 32.4 30.1 232.1 31.2 55.8 38.7 40.4 23.7 35.1 29.6 23.5 17.9 19.5 80.6 17.8 31.0 21.3 45.9 62.3 55.7 50.6 37.2 73.5 48.0 17.0 6.9 8.0 32.8 18.3 13.3 13.4 5.6 5.3 3.8 4.3 6.9 36.5 41.4 42.4 8.7 6.1 22.7 4.5 46.4 6.4 7.5 11.6 85.9 8.2 20.1 11.9 39.6 26.6 12.3 61.8 3.2 7.1 17.0 5.7 13.0 6.0 74.4 6.4 16.3 41.1 36.5 15.4 25.7 15.9 47.8 2.6 40.5 58.2 90.8 24.9 15.2 3.9 85.1 41.6 8.6 60.0 25.4 4.9 29.1 37.9 30.7 7.9 18.5 14.9 24.6 40.9 16.1 25.7 55.7 29.3 22.1 40.1 42.3 41.8 45.9 61.0 42.5 43.8 41.7 73.5 65.7 3.5 37.2 50.6 62.3 56.9 48.0 66.1 56.2 28.5 63.8 54.8 46.9 58.8 36.7 38.8 23.5 375.2 414.8 374.3 402.8 435.9 194.1 2063.7 626.8 575.5 377.6 574.0 96.2 831.0 1886.7 571.0 645.5 416.6 1532.5 303.7 739.7 730.3 697.7 423.0 347.2 1528.6 904.1 147.8 776.1 376.3 443.5 180.9 615.6 499.6 695.0 943.2 982.6 392.7 687.3 1094.2 552.3 1121.0 205.6 485.0 628.5 756.0 487.0 560.0 1492.7 393.7 1121.0 582.7 COX7A1 "COX7A, COX7AH" ENSG00000161281 "Cytochrome c oxidase subunit 7A1" P24310 19 36150922-36152869 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "heart muscle: 114.9;skeletal muscle: 404.3" "Cell type enriched" "Detected in many" 28 "Cardiomyocytes: 19391.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 1.9" "Group enriched" "Detected in many" 8 "dendritic cells: 1.3;granulocytes: 1.4;monocytes: 1.9" "Cell line enhanced" "Detected in some" "ASC diff: 24.5;ASC TERT1: 18.0;BJ: 16.5;BJ hTERT+: 13.7;fHDF/TERT166: 25.1;HHSteC: 16.3;HSkMC: 16.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (5.48e-2)" "unprognostic (1.19e-1)" "unprognostic (6.13e-3)" "unprognostic (6.46e-3)" "unprognostic (5.33e-2)" "unprognostic (3.87e-2)" "unprognostic (3.77e-2)" "unprognostic (9.93e-2)" "unprognostic (1.92e-1)" "unprognostic (1.41e-1)" "unprognostic (9.49e-2)" "unprognostic (1.46e-1)" "unprognostic (7.84e-3)" "unprognostic (7.27e-3)" "unprognostic (9.44e-2)" "unprognostic (6.23e-2)" "unprognostic (1.54e-2)" 15.7 8.1 5.3 2.5 3.6 1.2 8.8 2.1 13.1 4.1 8.0 0.8 2.6 2.0 3.9 6.1 6.6 3.1 5.0 114.9 3.3 2.4 5.0 1.6 4.0 2.7 2.6 4.6 4.2 3.5 6.0 7.9 2.6 1.7 5.9 2.3 5.9 6.2 7.1 404.3 2.0 2.2 12.3 1.4 3.1 3.6 1.6 1.5 1.6 5.1 59.7 2.6 7.0 4.7 0.0 1.3 1.4 1.9 0.0 0.1 0.3 0.1 2.6 0.2 0.0 24.5 18.0 0.1 16.5 13.7 0.5 0.0 0.0 0.8 0.6 6.9 25.1 0.0 0.3 0.0 0.0 0.1 0.1 0.9 0.1 0.9 0.1 16.3 0.0 0.2 16.9 0.0 0.0 0.0 0.0 1.9 0.0 0.2 0.2 0.0 0.3 0.0 0.1 0.4 0.3 0.6 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 3.7 0.0 0.6 0.2 0.1 0.4 0.4 0.3 0.1 0.3 0.5 0.0 1.9 0.0 0.0 1.6 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.0 1.4 0.0 0.5 0.4 0.1 0.3 5.3 3.6 2.1 13.1 3.3 2.4 2.6 4.6 1.7 1.5 0.0 9.0 5.9 1.3 23.5 71.7 19391.7 25.5 1.4 3.4 21.0 43.2 1.0 693.0 10.8 13.4 160.8 0.0 0.0 12.2 0.9 86.2 2.4 43.9 4.4 18.4 63.5 0.0 239.4 11.6 76.0 207.9 6.0 269.9 0.0 0.0 16.2 9.2 0.0 264.5 128.7 56.3 181.1 233.8 1.5 3.2 16.7 1.6 2.5 0.0 0.6 COX7A2 "COX7AL, COXVIIa-L" ENSG00000112695 "Cytochrome c oxidase subunit 7A2" 6 75237675-75250323 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "blood: 157.6" "Cell type enhanced" "Detected in all" 5 "Early spermatids: 3729.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (8.49e-2)" "unprognostic (2.56e-1)" "unprognostic (1.98e-2)" "unprognostic (2.15e-2)" "unprognostic (1.34e-1)" "unprognostic (5.67e-3)" "unprognostic (1.00e-1)" "unprognostic (1.65e-1)" "unprognostic (7.70e-2)" "unprognostic (2.73e-3)" "unprognostic (7.44e-2)" "unprognostic (1.74e-1)" "prognostic favorable (3.43e-5)" "unprognostic (1.80e-1)" "unprognostic (1.26e-1)" "unprognostic (1.71e-1)" "unprognostic (1.26e-1)" 26.9 25.3 49.7 18.8 55.3 26.5 30.2 27.0 54.9 19.5 55.9 12.3 37.0 35.3 16.9 41.5 29.7 20.3 23.4 76.3 38.0 32.9 44.8 51.7 17.8 23.9 48.9 34.6 12.6 46.9 19.4 27.2 18.3 36.8 24.0 61.5 18.3 35.7 27.1 38.2 19.1 35.6 29.0 39.4 18.1 36.4 62.8 27.5 17.4 22.4 47.1 27.1 23.4 16.7 109.1 130.5 94.1 108.8 76.9 110.3 157.6 15.3 35.2 46.2 37.9 27.6 31.4 33.5 37.5 34.5 37.5 40.7 63.3 23.5 25.1 33.3 33.8 50.5 33.4 32.1 40.5 47.0 45.8 65.9 37.6 110.1 83.1 28.4 40.0 44.4 33.9 54.3 34.6 22.7 39.5 43.4 57.2 33.2 36.5 50.6 71.4 17.0 43.6 29.0 75.8 64.5 27.8 23.3 66.0 59.7 100.2 31.6 38.3 23.3 42.8 37.6 39.6 26.1 113.0 21.1 16.6 30.3 13.2 42.5 51.7 56.3 27.8 18.9 45.8 32.3 92.9 100.0 94.1 78.3 107.7 83.0 109.1 102.4 93.5 103.6 90.2 101.1 93.4 74.7 76.9 108.8 130.5 110.3 157.6 49.7 55.3 27.0 54.9 38.0 32.9 48.9 34.6 36.8 27.5 282.9 318.7 403.4 476.4 491.8 218.2 2259.4 751.6 480.5 353.8 478.1 113.9 585.5 2205.0 700.7 3729.3 440.0 1510.8 210.2 878.7 682.4 432.2 710.6 290.2 1241.2 769.2 146.2 637.2 364.0 458.4 2761.1 329.4 416.4 803.1 743.0 1103.4 253.8 951.9 1195.4 318.9 1303.8 241.1 401.0 739.2 2380.3 194.6 547.7 684.3 381.3 1038.8 776.7 COX7B ENSG00000131174 "Cytochrome c oxidase subunit 7B" P24311 X 77899438-77907373 "Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 81.4" "Cell type enhanced" "Detected in all" 5 "Cardiomyocytes: 2170.2;Distal tubular cells: 1934.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058041 Uncertain NA NA "HPA058041: AB_2683587" "unprognostic (1.24e-2)" "unprognostic (1.76e-3)" "unprognostic (8.37e-2)" "unprognostic (1.39e-1)" "unprognostic (1.53e-1)" "unprognostic (1.13e-1)" "unprognostic (3.22e-1)" "unprognostic (1.65e-1)" "unprognostic (2.11e-2)" "unprognostic (1.06e-1)" "unprognostic (2.26e-1)" "unprognostic (8.10e-2)" "prognostic favorable (6.80e-6)" "unprognostic (8.58e-2)" "unprognostic (4.62e-1)" "unprognostic (6.38e-2)" "prognostic favorable (2.43e-4)" 9.4 11.5 23.7 9.2 26.8 18.0 18.2 15.4 32.3 13.1 22.5 4.1 19.8 18.0 8.1 16.4 17.1 10.4 10.7 81.4 21.9 20.6 34.6 28.8 9.7 9.9 24.0 22.9 7.2 15.1 11.1 11.7 8.6 21.3 9.6 22.9 6.9 14.5 18.1 69.4 9.2 19.7 15.9 19.0 8.1 14.5 3.0 12.9 4.8 12.2 62.7 10.8 11.3 9.7 16.5 23.0 19.4 25.9 17.2 22.2 19.1 8.0 20.5 11.8 12.0 13.3 11.3 8.0 6.6 10.3 13.1 15.3 23.9 13.7 12.5 10.1 10.9 12.6 13.2 31.7 18.3 15.5 5.6 31.1 13.6 29.1 22.7 11.1 21.2 8.6 14.4 15.5 15.7 13.9 8.4 13.9 8.2 15.6 22.6 14.0 23.8 12.7 20.5 12.0 38.5 55.9 11.5 17.4 34.5 35.6 26.1 11.4 7.4 17.2 22.3 10.5 10.0 8.6 11.5 9.2 5.9 8.7 12.9 5.8 5.0 13.0 15.6 13.8 28.3 7.6 19.4 20.8 14.0 15.6 25.9 21.1 16.5 20.1 19.0 23.0 13.4 20.7 22.2 15.5 17.2 24.5 17.1 18.4 19.1 23.7 26.8 15.4 32.3 21.9 20.6 24.0 22.9 21.3 12.9 125.0 164.5 253.2 284.4 264.2 96.9 2170.2 624.2 230.2 216.1 350.7 33.4 385.6 1934.8 387.0 16.0 214.7 1219.2 420.4 345.1 332.3 226.1 262.9 221.6 970.7 631.3 44.5 495.8 200.1 437.7 23.1 184.6 371.7 511.2 421.2 729.5 113.4 365.0 764.5 165.9 1221.3 122.9 207.0 327.3 45.0 113.1 302.1 494.9 208.8 796.8 406.4 COX7B2 ENSG00000170516 "Cytochrome c oxidase subunit 7B2" Q8TF08 4 46734827-46909235 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 13 "testis: 43.9" "Group enriched" "Detected in some" 7 "Early spermatids: 328.3;Late spermatids: 134.7;Spermatocytes: 292.2" "Cancer enhanced" "Detected in many" "liver cancer: 7.3" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "neutrophil: 3.4" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.4" "Cell line enriched" "Detected in some" 15 "Karpas-707: 28.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" NA NA "unprognostic (2.82e-1)" "unprognostic (2.42e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 3.4 0.2 0.6 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 28.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.2 0.4 0.1 0.1 0.0 0.4 0.1 0.0 3.4 0.6 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 328.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 134.7 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 292.2 34.5 0.0 0.0 0.0 0.0 0.0 COX7C ENSG00000127184 "Cytochrome c oxidase subunit 7C" P15954 5 86617904-86620962 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 298.4" "Cell type enhanced" "Detected in all" 4 "Cardiomyocytes: 4397.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046647 Approved NA NA "HPA046647: AB_2679736" "unprognostic (1.45e-1)" "unprognostic (1.74e-2)" "unprognostic (9.10e-2)" "unprognostic (2.86e-1)" "unprognostic (2.85e-1)" "unprognostic (8.08e-2)" "unprognostic (1.04e-1)" "unprognostic (3.70e-1)" "unprognostic (4.35e-1)" "unprognostic (1.08e-1)" "unprognostic (1.90e-2)" "unprognostic (1.21e-1)" "prognostic favorable (1.23e-5)" "unprognostic (4.56e-2)" "unprognostic (2.06e-1)" "unprognostic (1.46e-1)" "unprognostic (4.46e-2)" 43.3 60.4 76.4 35.7 68.1 36.8 49.6 41.1 65.0 35.0 74.8 22.7 44.0 76.0 50.7 55.5 53.7 32.6 44.4 150.2 61.8 57.6 91.6 83.1 36.0 66.1 72.0 44.2 51.9 88.8 39.3 47.3 26.5 51.5 42.7 53.9 36.2 127.6 46.1 298.4 28.0 73.3 71.5 39.7 35.5 54.2 31.2 32.1 39.7 56.3 84.9 40.1 53.9 58.0 92.8 91.6 54.1 73.4 51.2 96.5 113.9 55.5 64.2 57.7 107.6 53.9 54.3 64.7 43.2 34.7 28.7 40.6 74.5 101.3 75.7 47.3 31.9 78.1 60.6 51.0 82.1 47.1 56.1 78.3 60.5 99.2 76.9 45.1 71.9 72.2 63.5 70.8 36.5 50.2 82.4 45.8 66.0 36.6 89.1 41.9 110.9 74.5 90.7 61.3 55.5 185.9 72.5 67.3 139.2 85.7 106.5 72.0 52.6 41.5 97.8 91.1 65.6 99.3 98.1 45.3 26.7 49.0 45.7 82.5 86.4 99.9 87.4 68.5 84.2 50.4 38.0 72.1 54.1 58.1 73.4 72.5 92.8 91.1 71.8 91.6 79.4 96.5 84.2 7.3 51.2 68.2 85.2 80.2 113.9 76.4 68.1 41.1 65.0 61.8 57.6 72.0 44.2 51.5 32.1 476.4 561.1 1097.3 719.7 642.7 245.3 4397.0 1722.3 686.6 645.0 1151.5 147.3 1042.4 4003.9 1050.4 765.0 580.9 1905.7 373.8 1318.7 727.2 613.8 874.5 590.4 2267.2 1206.0 217.7 881.2 710.8 1215.4 325.7 912.7 888.1 1057.8 1208.3 1577.3 394.4 1159.8 1813.1 677.5 3328.8 216.7 588.6 707.6 958.9 346.1 817.7 1104.6 792.5 1997.9 1118.8 COX8A "COX, COX8, COX8-2, COX8L, VIII, VIII-L" ENSG00000176340 "Cytochrome c oxidase subunit 8A" P10176 11 63974607-63976543 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 275.5" "Cell type enhanced" "Detected in all" 5 "Distal tubular cells: 1984.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA055942 Supported NA NA "HPA055942: AB_2682979" "unprognostic (6.93e-2)" "unprognostic (1.01e-3)" "unprognostic (2.96e-2)" "unprognostic (1.02e-2)" "unprognostic (2.24e-1)" "unprognostic (7.70e-3)" "unprognostic (2.01e-2)" "unprognostic (2.12e-1)" "unprognostic (3.46e-1)" "unprognostic (6.49e-3)" "unprognostic (1.00e-1)" "unprognostic (1.24e-1)" "prognostic favorable (2.51e-6)" "unprognostic (2.70e-2)" "unprognostic (5.41e-2)" "unprognostic (1.13e-1)" "unprognostic (8.44e-2)" 41.4 42.8 54.0 32.8 53.4 50.4 47.4 40.9 60.3 30.2 76.6 18.2 35.5 69.0 23.3 31.2 63.3 35.9 43.9 154.9 41.5 41.0 78.8 61.1 38.1 50.8 54.5 34.0 24.7 43.0 38.7 37.6 32.2 35.7 37.9 51.6 35.9 54.4 50.2 275.5 31.2 66.7 29.9 37.0 31.0 50.8 18.7 24.3 44.6 42.4 121.7 34.8 38.8 29.8 52.7 114.8 87.8 108.6 51.0 75.7 80.3 60.3 80.6 52.0 51.6 22.3 27.3 37.7 32.0 35.9 63.6 49.5 53.8 49.6 28.8 70.9 44.5 60.2 60.3 40.0 55.1 21.8 42.3 69.5 41.9 65.4 63.1 35.8 42.2 54.6 35.2 41.9 50.9 41.1 28.4 39.4 68.6 48.7 62.8 39.9 157.1 59.7 143.7 47.3 72.0 141.6 46.8 41.8 121.1 51.4 51.0 47.2 66.8 38.1 55.4 78.5 23.2 81.4 45.9 24.2 37.0 50.2 79.2 37.3 78.9 61.8 44.4 48.1 41.7 44.3 78.3 101.8 87.8 57.5 108.6 42.4 52.7 63.2 56.4 114.8 46.4 49.0 53.4 71.3 51.0 97.9 113.0 75.7 80.3 54.0 53.4 40.9 60.3 41.5 41.0 54.5 34.0 35.7 24.3 208.4 199.1 288.8 299.8 261.7 169.3 1162.0 458.6 376.1 244.5 415.2 68.7 392.2 1984.5 389.4 7.0 198.9 1123.7 140.2 421.4 448.5 223.4 381.0 221.4 677.3 801.9 101.7 693.6 209.3 461.0 13.2 221.8 429.5 595.5 445.4 846.8 231.3 439.3 874.7 207.9 1094.8 128.1 155.2 347.5 51.9 59.0 324.2 306.9 320.7 910.0 526.5 COX8C COX8-3 ENSG00000187581 "Cytochrome c oxidase subunit 8C" Q7Z4L0 14 93347191-93348356 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 72 "testis: 72.8" "Group enriched" "Detected in some" 11 "Early spermatids: 811.2;Late spermatids: 1407.4;Spermatocytes: 393.6" "Group enriched" "Detected in some" 8 "ovarian cancer: 2.9;testis cancer: 6.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "myeloid DC: 1.0" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 9 "U-937: 18.0" "Not detected" "Not detected" HPA003127 Approved NA NA "HPA003127: AB_1078560" "unprognostic (1.29e-1)" "unprognostic (1.19e-1)" "unprognostic (1.47e-1)" "unprognostic (3.76e-3)" "unprognostic (2.11e-1)" "unprognostic (2.77e-2)" "unprognostic (7.71e-2)" "unprognostic (3.83e-1)" "unprognostic (1.99e-2)" "unprognostic (8.28e-2)" "unprognostic (6.33e-2)" "unprognostic (2.64e-2)" "unprognostic (9.15e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.1 0.0 0.0 0.1 0.0 0.0 72.8 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 1.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 2.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 811.2 0.0 0.0 0.0 0.0 10.6 0.2 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1407.4 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.2 0.0 19.4 0.0 393.6 80.8 0.1 2.9 0.0 0.0 0.1 CYC1 UQCR4 ENSG00000179091 "Cytochrome c1" P08574 8 144095027-144097525 "Disease related genes, Plasma proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" Translocase "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 145.2" "Cell type enhanced" "Detected in all" 4 "Distal tubular cells: 693.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 151.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001247 Supported Approved "Nucleoplasm,Nuclear bodies,Mitochondria,Cytosol" NA NA 110000 Mitochondria "Nucleoplasm, Nuclear bodies, Cytosol" "HPA001247: AB_1078602" "unprognostic (3.07e-2)" "unprognostic (1.79e-1)" "unprognostic (1.65e-1)" "unprognostic (3.66e-2)" "unprognostic (1.25e-1)" "unprognostic (6.52e-2)" "unprognostic (1.39e-1)" "unprognostic (3.92e-3)" "unprognostic (6.23e-2)" "unprognostic (1.98e-1)" "unprognostic (2.26e-1)" "unprognostic (2.15e-1)" "prognostic favorable (5.89e-6)" "unprognostic (6.03e-2)" "unprognostic (1.83e-1)" "unprognostic (2.13e-1)" "unprognostic (3.13e-2)" 16.0 31.3 16.2 13.2 20.1 19.5 12.1 19.1 32.1 13.0 33.3 13.4 14.4 38.1 13.9 10.1 36.2 15.5 13.1 92.1 16.6 14.1 44.8 55.9 11.2 16.5 18.0 18.6 15.0 21.4 17.9 10.6 16.0 17.7 16.5 25.3 13.3 23.3 17.2 145.2 17.7 42.6 16.3 11.8 18.3 22.4 13.9 11.5 21.5 21.7 43.8 18.5 19.9 14.4 34.9 76.7 22.1 60.0 30.2 26.1 58.5 22.2 50.5 13.4 28.0 11.1 12.4 25.9 12.8 15.7 32.7 21.5 35.3 27.9 31.6 29.0 17.1 15.9 33.0 29.3 25.4 12.3 19.3 38.8 33.9 42.7 32.3 20.0 20.0 22.1 18.0 31.9 20.8 41.4 11.0 19.0 21.9 30.8 28.2 17.1 80.0 37.4 18.5 15.6 62.7 151.5 33.0 18.0 55.3 26.9 35.9 36.1 15.9 35.8 49.5 26.3 7.7 40.7 30.7 14.4 20.9 44.6 23.0 39.0 31.4 22.8 23.4 26.6 34.1 26.6 22.1 59.7 15.9 24.1 60.0 25.4 34.9 20.1 25.8 76.7 29.4 19.7 25.4 5.8 30.2 44.8 42.9 26.1 58.5 16.2 20.1 19.1 32.1 16.6 14.1 18.0 18.6 17.7 11.5 17.9 24.8 104.2 137.8 138.6 109.2 340.1 175.8 33.5 25.0 75.0 76.6 235.5 693.0 191.2 55.0 98.8 477.2 70.0 250.0 197.5 112.8 124.7 59.9 203.6 217.6 82.6 140.6 55.3 91.9 71.2 82.3 127.4 170.4 267.9 288.6 98.9 227.1 319.6 85.2 391.4 75.4 71.1 158.3 73.6 93.6 143.2 198.1 79.6 481.1 207.2 ETFA "EMA, GA2, MADD" ENSG00000140374 "Electron transfer flavoprotein alpha subunit" P13804 15 76215355-76311472 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Electron transport, Transport" "Disease mutation, Glutaricaciduria" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018990, HPA018993, HPA018996, HPA024089" Enhanced Enhanced Mitochondria NA NA 6300000 Mitochondria "HPA018990: AB_1848277, HPA018993: AB_1848275, HPA018996: AB_1848276, HPA024089: AB_1848278" "unprognostic (3.44e-3)" "unprognostic (1.50e-1)" "unprognostic (2.29e-1)" "unprognostic (2.26e-1)" "unprognostic (3.71e-3)" "unprognostic (5.99e-2)" "unprognostic (6.81e-3)" "unprognostic (3.02e-1)" "unprognostic (5.01e-2)" "unprognostic (6.01e-2)" "unprognostic (3.38e-3)" "unprognostic (1.99e-1)" "prognostic favorable (5.04e-8)" "unprognostic (2.87e-1)" "unprognostic (4.90e-2)" "unprognostic (9.22e-2)" "unprognostic (2.90e-2)" 18.8 39.9 12.8 16.4 13.6 10.7 26.1 7.6 13.4 8.6 26.4 7.3 9.6 27.5 10.1 11.1 18.9 7.7 12.6 84.4 13.3 8.5 36.4 78.3 9.8 15.7 11.9 12.9 7.8 28.1 7.6 11.0 24.0 11.8 11.2 26.0 9.4 15.8 10.8 84.0 12.3 29.2 17.3 11.8 11.7 18.5 9.7 10.8 10.8 11.9 37.9 12.8 14.8 11.5 24.6 50.7 25.2 38.8 36.0 29.3 39.4 21.7 35.9 23.8 24.9 26.9 28.7 37.5 26.4 30.5 34.2 30.7 31.8 40.7 36.6 26.5 26.2 25.9 55.9 92.3 36.6 39.9 43.8 18.0 39.8 26.1 36.7 21.9 37.9 29.7 21.4 34.7 17.3 28.9 18.8 34.5 11.8 37.6 38.0 35.0 34.3 7.8 31.7 18.5 40.5 10.8 34.4 29.6 48.9 37.7 70.2 24.9 12.6 39.9 91.2 36.1 57.7 46.9 40.2 20.2 33.4 22.7 29.2 31.8 18.6 38.1 45.1 24.1 50.5 23.6 11.2 38.8 25.2 22.1 34.5 20.8 24.6 20.8 22.7 50.7 20.2 17.0 21.1 9.9 36.0 28.4 20.3 29.3 39.4 12.8 13.6 7.6 13.4 13.3 8.5 11.9 12.9 11.8 10.8 53.6 38.2 49.8 84.3 47.5 12.6 330.7 79.0 33.5 34.2 34.9 21.6 240.1 177.4 96.7 9.4 51.7 207.6 70.0 73.2 147.6 65.4 64.8 37.0 330.0 115.9 50.9 62.8 52.2 76.6 5.4 55.0 77.4 54.0 158.7 117.7 20.6 89.9 152.0 54.8 301.8 18.1 45.3 63.7 39.6 31.3 49.9 251.0 56.8 156.2 138.0 ETFB ENSG00000105379 "Electron transfer flavoprotein beta subunit" P38117 19 51345169-51366418 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Electron transport, Transport" "Disease mutation, Glutaricaciduria" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 108.6;liver: 106.6" "Cell type enhanced" "Detected in all" 6 "Hepatocytes: 1022.8;Proximal tubular cells: 1001.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 183.6;OE19: 84.6" "Low region specificity" "Detected in all" "HPA018910, HPA018921, HPA018923" Supported Enhanced Mitochondria NA NA 640000 Mitochondria "HPA018910: AB_1848280, HPA018921: AB_1848281, HPA018923: AB_1848282" "unprognostic (1.44e-1)" "prognostic favorable (6.45e-4)" "unprognostic (8.66e-2)" "unprognostic (3.08e-1)" "unprognostic (1.77e-1)" "unprognostic (3.94e-2)" "unprognostic (3.20e-1)" "unprognostic (6.93e-3)" "unprognostic (2.63e-2)" "unprognostic (7.79e-2)" "unprognostic (1.23e-1)" "unprognostic (4.75e-1)" "prognostic favorable (6.45e-5)" "unprognostic (2.19e-1)" "unprognostic (2.54e-1)" "unprognostic (4.83e-1)" "unprognostic (1.99e-1)" 35.8 28.7 26.1 12.0 30.7 14.3 16.7 9.4 19.5 9.1 27.2 17.7 11.3 33.2 9.8 10.1 24.2 13.2 31.5 108.6 22.2 19.2 32.1 106.6 10.2 12.3 27.9 17.1 11.1 23.0 12.8 11.7 10.5 18.1 12.9 10.1 18.4 46.7 10.2 72.9 13.6 30.6 16.6 22.2 10.6 19.1 7.7 15.9 17.7 14.2 47.7 14.6 11.4 9.9 66.0 62.5 27.0 49.3 46.2 50.7 31.9 13.0 33.8 4.7 12.9 15.0 17.6 7.5 8.9 6.9 7.2 7.2 28.4 21.5 13.1 9.1 14.3 3.8 11.6 9.3 19.0 2.2 19.5 36.2 10.3 20.7 183.6 16.5 9.8 7.7 27.3 5.7 9.8 10.1 9.1 6.1 12.9 15.4 14.7 9.3 26.5 10.2 9.3 3.0 84.6 41.9 11.4 12.6 24.5 9.9 15.0 10.5 5.1 19.7 5.6 10.1 3.5 14.7 9.5 8.6 7.6 7.9 8.1 8.1 22.6 13.7 11.6 38.5 14.6 19.4 26.7 46.9 27.0 26.4 49.3 34.4 63.9 39.6 33.7 53.5 66.0 42.2 35.0 23.6 46.2 36.6 62.5 50.7 31.9 26.1 30.7 9.4 19.5 22.2 19.2 27.9 17.1 18.1 15.9 74.5 84.5 90.8 84.9 57.8 71.3 216.3 254.8 84.3 67.1 115.1 29.5 201.1 484.1 142.6 109.5 67.1 494.9 140.2 122.3 163.1 89.1 73.5 87.6 1022.8 188.0 41.3 161.8 136.9 151.1 228.9 99.5 69.4 271.7 69.5 259.6 93.2 146.4 263.1 107.5 1001.5 53.3 97.0 80.2 54.2 48.9 55.7 133.9 91.6 302.4 92.8 ETFDH ETFQO ENSG00000171503 "Electron transfer flavoprotein dehydrogenase" Q16134 4 158672125-158709623 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Transport" Oxidoreductase "Disease mutation, Glutaricaciduria" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 72.8" "Cell type enhanced" "Detected in all" 6 "Cardiomyocytes: 138.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041978 Enhanced NA NA "HPA041978: AB_10795605" "unprognostic (7.19e-2)" "unprognostic (2.28e-1)" "unprognostic (2.90e-2)" "unprognostic (5.92e-3)" "unprognostic (1.91e-1)" "unprognostic (8.45e-2)" "unprognostic (1.23e-3)" "unprognostic (7.17e-2)" "unprognostic (2.01e-1)" "unprognostic (4.55e-2)" "unprognostic (1.71e-2)" "unprognostic (5.76e-2)" "prognostic favorable (5.76e-10)" "unprognostic (2.51e-1)" "unprognostic (2.07e-1)" "unprognostic (8.85e-3)" "unprognostic (1.74e-1)" 11.3 20.1 7.0 3.9 8.6 2.8 12.9 10.3 8.2 5.1 12.5 6.5 6.1 23.0 5.7 6.4 10.9 4.3 5.2 47.8 7.2 5.0 17.3 72.8 4.3 2.9 8.0 5.3 5.0 8.9 11.4 8.8 9.0 8.5 5.2 10.5 7.4 7.2 5.6 33.7 7.7 20.4 8.5 4.8 4.8 9.2 4.1 8.4 4.9 6.0 17.5 5.4 5.8 6.1 5.8 11.0 24.5 13.5 6.2 9.2 5.4 5.7 3.6 6.0 10.8 25.9 15.5 2.9 10.1 10.2 7.5 7.3 2.0 12.7 14.0 2.2 12.2 7.8 6.7 11.5 10.1 10.6 22.2 8.4 12.8 8.2 3.4 11.3 11.0 12.3 14.3 12.7 8.1 6.9 11.5 14.6 9.5 7.1 26.5 12.0 5.9 10.7 5.5 2.3 16.9 8.8 8.6 2.0 9.8 11.2 5.0 9.1 3.5 10.1 20.2 9.6 5.7 13.7 8.5 6.5 6.1 3.1 8.9 5.2 14.9 18.5 9.5 12.6 9.3 6.5 2.5 13.5 24.5 6.7 13.3 8.1 5.8 6.3 6.8 11.0 5.4 7.8 6.6 4.6 6.2 11.7 8.4 9.2 5.4 7.0 8.6 10.3 8.2 7.2 5.0 8.0 5.3 8.5 8.4 11.9 9.3 20.1 42.9 29.3 26.0 138.5 12.7 10.7 12.5 17.4 60.9 18.8 24.9 11.1 2.6 18.0 45.5 46.7 10.2 7.3 20.8 16.4 4.7 70.6 11.7 23.8 17.2 12.3 7.8 3.6 21.3 13.7 8.5 7.2 18.2 11.7 10.7 23.7 22.3 23.7 43.8 32.3 23.1 37.2 33.4 32.2 35.9 18.3 21.5 33.8 LHPP HDHD2B ENSG00000107902 "Phospholysine phosphohistidine inorganic pyrophosphate phosphatase" Q9H008 10 124461834-124617888 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 106.0" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 103.7;Late spermatids: 124.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009163, HPA009269" Enhanced Supported "Nuclear speckles,Cytosol" NA NA 880000 "Nuclear speckles, Cytosol" "HPA009163: AB_1079250, HPA009269: AB_1079249" "unprognostic (3.46e-2)" "unprognostic (1.23e-2)" "unprognostic (4.78e-2)" "unprognostic (3.89e-1)" "unprognostic (2.14e-1)" "unprognostic (1.96e-1)" "unprognostic (5.77e-3)" "unprognostic (2.02e-2)" "unprognostic (3.58e-1)" "unprognostic (1.93e-1)" "unprognostic (6.42e-2)" "unprognostic (5.55e-2)" "unprognostic (1.79e-3)" "unprognostic (2.52e-1)" "unprognostic (2.10e-1)" "unprognostic (1.98e-1)" "unprognostic (1.64e-1)" 9.6 14.2 37.3 6.0 34.0 6.9 7.9 11.9 34.2 12.3 13.6 29.7 8.2 17.9 7.5 11.0 12.7 8.1 8.3 9.8 43.0 31.5 18.6 33.8 6.6 8.2 62.7 19.3 5.5 12.2 6.6 5.6 7.2 20.5 6.9 6.7 6.7 13.3 10.6 6.5 8.9 15.7 8.1 106.0 8.2 12.4 14.2 19.5 7.1 20.5 3.6 11.2 8.7 5.7 24.7 20.0 13.3 16.1 3.9 17.2 12.9 14.8 7.4 3.0 7.6 11.7 9.6 8.0 5.5 11.2 3.5 6.4 1.3 13.8 14.7 12.8 8.2 3.8 16.2 0.9 2.9 3.6 3.3 10.6 10.8 2.4 6.8 12.0 2.1 17.5 7.1 12.6 3.4 8.3 10.2 5.5 13.3 5.3 5.9 4.3 14.7 7.1 6.9 5.3 6.3 4.2 7.6 3.3 18.8 7.5 1.9 1.7 9.1 3.8 14.1 5.0 4.3 10.7 0.3 2.6 5.4 8.0 4.5 1.4 4.9 1.5 4.7 4.9 4.2 1.2 4.6 16.1 13.3 9.5 13.5 12.4 23.7 11.1 10.1 20.0 24.7 13.7 9.6 2.7 3.9 14.9 7.5 17.2 12.9 37.3 34.0 11.9 25.0 43.0 31.5 62.7 19.3 20.5 19.5 3.0 15.0 15.6 9.1 6.5 6.2 12.0 15.3 18.7 12.5 7.0 0.0 44.1 28.2 4.0 103.7 1.6 23.3 0.0 2.1 20.7 9.3 7.6 10.4 53.3 22.8 11.1 9.1 7.4 13.2 124.0 5.5 9.2 16.9 14.4 17.3 6.9 3.5 25.9 9.9 58.6 6.4 12.9 5.1 28.8 10.2 4.6 20.3 7.2 19.6 11.1 MT-ATP6 "ATP6, ATPase-6, MTATP6, RP, Su6m" ENSG00000198899 "Mitochondrially encoded ATP synthase membrane subunit 6" P00846 MT 8527-9207 "Disease related genes, Predicted membrane proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Cardiomyopathy, Disease mutation, Leber hereditary optic neuropathy, Leigh syndrome, Neuropathy, Primary mitochondrial disease, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 419.0;skeletal muscle: 475.3" "Cell type enriched" "Detected in many" 5 "Cardiomyocytes: 108059.0" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 419.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 1186.6" "Low region specificity" "Detected in all" NA NA "unprognostic (2.97e-1)" "unprognostic (4.16e-1)" "unprognostic (1.86e-2)" "unprognostic (4.55e-2)" "unprognostic (8.45e-3)" "unprognostic (1.66e-1)" "prognostic favorable (3.79e-4)" "unprognostic (6.47e-2)" "unprognostic (2.39e-1)" "unprognostic (1.44e-2)" "prognostic favorable (7.64e-4)" "unprognostic (6.01e-2)" "unprognostic (4.64e-2)" "unprognostic (1.46e-1)" "unprognostic (1.37e-1)" "unprognostic (3.56e-1)" "unprognostic (2.52e-3)" 85.2 89.2 126.0 25.1 159.3 20.1 29.6 45.2 81.2 20.1 60.3 75.6 23.5 30.9 42.8 19.8 24.6 309.5 122.3 90.2 154.4 166.8 18.0 19.3 102.8 26.5 54.7 36.2 22.0 34.1 37.6 59.4 66.8 35.6 475.3 62.5 52.6 27.9 61.3 20.7 58.4 27.7 22.4 18.6 23.0 15.7 110.2 58.9 419.0 88.2 72.3 90.5 35.3 100.8 166.4 116.2 182.2 221.8 50.9 75.9 148.7 27.1 20.1 34.0 195.6 110.9 179.7 63.2 80.2 31.2 219.8 12.1 116.0 37.3 128.3 105.3 157.3 1186.6 338.6 37.7 93.1 203.9 83.0 102.9 36.1 34.9 141.5 35.7 100.8 103.4 131.1 78.3 284.0 57.3 247.9 30.5 77.4 68.9 72.2 49.5 110.7 208.9 256.0 66.4 85.2 53.3 113.7 107.5 199.3 121.6 319.6 188.2 82.0 121.2 135.4 106.1 58.0 76.5 124.6 71.6 198.7 45.8 419.0 88.2 156.1 56.6 66.3 71.6 106.0 64.7 71.1 47.5 110.2 76.5 90.5 100.1 72.3 67.8 58.9 47.6 35.3 1381.7 1526.0 11633.9 5315.5 2578.7 0.0 108059.0 10741.3 2731.6 2651.3 6092.6 0.0 0.0 1593.2 1756.2 808.5 1505.8 13591.3 14997.7 2949.2 0.0 1371.6 3985.7 1952.8 21340.2 0.0 0.0 3847.9 7623.7 10387.2 3622.6 7103.8 2816.3 2404.1 3082.2 11928.5 0.0 2519.5 9780.9 4668.2 10316.3 0.0 6202.4 2943.8 6022.8 4841.7 2653.0 0.0 6498.2 11027.9 6485.3 MT-ATP8 "A6L, ATP8, MTATP8" ENSG00000228253 "Mitochondrially encoded ATP synthase membrane subunit 8" P03928 MT 8366-8572 "Disease related genes, Predicted membrane proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Cardiomyopathy, Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 959.7" "Cell type enriched" "Detected in many" 31 "Cardiomyocytes: 20663.1" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 352.9" "Lineage enriched" "Detected in all" 4 "granulocytes: 352.9" "Cell line enhanced" "Detected in all" "HeLa: 805.0" NA NA "unprognostic (1.54e-1)" "unprognostic (4.12e-2)" "unprognostic (3.95e-2)" "unprognostic (2.56e-1)" "unprognostic (3.07e-2)" "unprognostic (1.17e-1)" "prognostic favorable (7.56e-5)" "unprognostic (5.17e-2)" "unprognostic (6.61e-2)" "unprognostic (2.52e-3)" "unprognostic (8.26e-2)" "unprognostic (1.30e-2)" "unprognostic (1.10e-1)" "unprognostic (1.31e-1)" "unprognostic (2.76e-1)" "unprognostic (2.62e-1)" "unprognostic (1.63e-2)" 257.8 128.5 111.1 33.5 124.1 20.5 31.2 42.1 82.1 14.9 78.9 115.5 23.9 11.6 31.6 14.4 19.9 203.6 108.7 78.8 151.5 165.2 16.9 18.5 88.8 24.3 56.4 22.8 21.1 27.7 44.2 38.7 65.2 25.7 959.7 33.1 91.5 14.2 52.0 19.3 67.4 26.1 23.2 11.8 19.6 15.4 87.7 58.0 352.9 78.1 75.9 79.1 24.2 189.4 69.9 228.3 43.4 248.7 39.8 112.1 398.9 23.6 18.1 31.7 81.2 127.3 485.5 99.6 85.8 69.2 326.0 14.0 131.5 28.5 214.5 91.1 367.2 805.0 183.1 45.4 213.8 314.4 85.5 69.8 40.2 34.6 254.6 25.8 193.9 194.4 154.0 55.5 101.3 125.2 315.4 50.2 106.8 50.5 103.4 111.0 102.1 133.6 189.5 71.8 129.8 151.3 140.3 147.4 378.1 136.9 449.1 377.2 88.4 195.8 194.6 182.8 104.4 174.8 277.5 87.1 380.3 53.6 352.9 78.1 97.9 49.4 68.6 73.5 87.7 55.9 58.5 47.2 87.3 68.9 79.1 49.0 75.9 68.0 58.0 44.0 24.2 175.7 127.6 194.5 6.6 10.3 0.0 20663.1 265.0 662.5 619.9 12.2 0.0 0.0 3.3 11.5 6.0 7.1 98.6 420.4 26.4 0.0 6.7 3.9 274.2 625.8 0.0 0.0 28.0 241.2 345.1 31.7 37.7 12.6 11.8 11.8 48.6 0.0 16.1 47.0 23.7 20.3 0.0 38.8 11.3 24.7 22.2 8.0 0.0 192.9 46.4 6.2 MT-CO1 "COI, COX1, MTCO1" ENSG00000198804 "Mitochondrially encoded cytochrome c oxidase I" P00395 MT 5904-7445 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters" "Electron transport, Respiratory chain, Transport" Translocase "Deafness, Disease mutation, Leber hereditary optic neuropathy, Non-syndromic deafness, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 396.5;heart muscle: 345.0;skeletal muscle: 380.7" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 81405.0;Enterocytes: 59874.1" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 872.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016241, HPA069328" Enhanced Supported Mitochondria NA NA Mitochondria "CAB016241: AB_2229888, HPA069328: AB_2686122" "unprognostic (4.39e-1)" "unprognostic (2.45e-1)" "unprognostic (1.39e-1)" "unprognostic (2.21e-1)" "unprognostic (1.59e-1)" "unprognostic (3.31e-1)" "prognostic favorable (2.29e-4)" "unprognostic (8.28e-2)" "unprognostic (1.01e-1)" "unprognostic (5.56e-3)" "unprognostic (1.20e-2)" "unprognostic (6.60e-2)" "unprognostic (2.83e-2)" "unprognostic (5.06e-3)" "unprognostic (4.50e-2)" "unprognostic (2.15e-2)" "unprognostic (2.44e-2)" 57.6 82.5 184.1 22.2 164.2 26.4 37.4 40.6 117.1 31.5 80.8 78.1 25.7 42.7 43.5 24.8 32.4 345.0 161.8 111.7 151.0 150.5 20.9 22.6 126.3 23.7 42.5 62.3 10.1 29.0 35.8 84.4 65.6 54.2 380.7 68.9 60.0 38.2 61.2 28.1 65.5 27.8 23.8 21.9 31.6 15.3 292.2 232.9 177.4 396.5 182.8 192.4 130.5 114.5 173.2 235.7 256.3 540.3 247.5 249.9 261.4 87.1 66.0 110.6 208.4 373.6 302.7 125.7 198.6 65.0 435.2 26.9 231.6 94.6 143.0 165.0 181.7 872.7 389.9 74.8 104.9 230.2 288.6 241.1 65.3 145.0 306.7 79.4 172.7 115.3 217.3 195.5 277.4 85.7 469.5 59.9 156.0 141.8 112.3 70.4 181.6 334.7 303.0 112.7 150.2 90.6 351.3 163.0 296.6 201.5 352.9 316.5 264.7 180.2 259.8 131.1 103.0 98.6 68.6 130.7 276.7 128.6 177.4 396.5 169.3 156.6 236.0 176.4 255.6 154.9 171.8 163.0 292.2 159.7 192.4 93.5 182.8 260.1 232.9 138.6 130.5 2694.8 3022.9 23660.6 9171.4 8678.3 0.0 81405.0 28094.1 4463.5 5243.5 18590.0 0.0 0.0 3606.0 6482.3 1224.4 4243.1 59874.1 34807.7 4485.9 0.0 3116.3 8181.6 3594.1 45857.2 0.0 0.0 7240.0 18002.1 27410.8 6497.0 10830.0 8032.7 6539.1 13021.9 32338.6 0.0 5722.6 29051.7 7980.9 24852.9 0.0 13394.3 6634.5 9840.4 12887.5 10030.7 0.0 18830.6 25753.2 17251.8 MT-CO2 "CO2, COX2, MTCO2" ENSG00000198712 "Mitochondrially encoded cytochrome c oxidase II" P00403 MT 7586-8269 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Electron transport, Respiratory chain, Transport" Translocase "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 489.9;skeletal muscle: 343.4" "Cell type enriched" "Detected in many" 10 "Cardiomyocytes: 412590.4" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 1073.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016243, HPA051505, HPA054758" Enhanced NA NA 1300000 "CAB016243: AB_2066366, HPA051505: AB_2681511, HPA054758: AB_2682595" "unprognostic (2.67e-1)" "unprognostic (5.72e-2)" "unprognostic (4.57e-2)" "unprognostic (5.31e-2)" "unprognostic (2.77e-2)" "unprognostic (1.96e-2)" "prognostic favorable (2.89e-4)" "unprognostic (1.06e-1)" "unprognostic (3.39e-1)" "unprognostic (2.72e-3)" "prognostic favorable (7.10e-4)" "unprognostic (1.25e-1)" "unprognostic (9.30e-2)" "unprognostic (3.05e-1)" "unprognostic (1.70e-1)" "unprognostic (9.50e-2)" "unprognostic (3.72e-3)" 54.6 64.8 149.7 21.7 194.8 30.2 45.5 48.9 99.5 27.0 106.9 73.6 23.8 46.3 35.8 25.1 23.7 252.1 151.9 112.4 158.4 173.8 22.7 22.8 154.6 21.2 46.4 50.4 22.5 41.4 38.2 106.4 61.7 56.0 343.4 56.4 51.1 40.0 77.8 25.9 68.5 28.2 23.3 29.5 29.9 16.2 379.8 278.1 489.9 409.1 220.4 273.9 181.4 111.2 179.1 238.3 230.3 487.6 188.0 175.6 145.1 117.7 82.5 124.6 192.6 251.5 232.6 121.5 213.4 84.9 422.7 31.5 298.5 111.8 180.1 161.5 166.8 1073.7 370.2 106.1 140.2 187.4 275.7 441.7 42.5 152.4 270.3 91.3 232.4 155.7 226.9 226.0 240.8 102.5 404.1 62.3 220.6 114.0 107.2 72.6 194.8 336.5 310.9 89.2 147.6 119.5 294.8 209.6 367.9 205.2 568.6 225.1 200.0 173.5 188.5 102.0 115.3 114.6 131.1 106.4 283.3 131.3 489.9 409.1 476.0 194.9 292.9 236.6 379.8 217.1 218.8 205.5 378.1 227.9 273.9 180.3 220.4 308.7 278.1 170.3 181.4 1343.0 1746.9 18282.0 6995.6 5999.6 0.0 412590.4 19500.5 2813.3 2462.5 17642.7 0.0 0.0 3143.4 3272.8 866.0 2789.7 27604.7 22029.3 4281.1 0.0 1817.5 4991.0 2029.2 43011.4 0.0 0.0 6162.7 12438.4 17929.8 4401.0 7095.7 4687.5 4875.7 4595.3 21499.4 0.0 3881.8 14501.3 4815.7 15512.8 0.0 6946.2 3920.2 6682.3 8100.4 5859.1 0.0 11198.1 21247.6 11593.6 MT-CO3 "CO3, COIII, COX3, MTCO3" ENSG00000198938 "Mitochondrially encoded cytochrome c oxidase III" P00414 MT 9207-9990 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Translocase "Disease mutation, Leber hereditary optic neuropathy, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 319.5" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 76804.5" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 810.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042788 Approved NA NA "HPA042788: AB_10793985" "unprognostic (2.38e-1)" "unprognostic (5.24e-2)" "unprognostic (1.71e-1)" "unprognostic (1.88e-1)" "unprognostic (3.04e-1)" "unprognostic (2.93e-1)" "prognostic favorable (2.01e-4)" "unprognostic (1.18e-1)" "unprognostic (1.45e-2)" "unprognostic (1.05e-2)" "prognostic favorable (1.04e-4)" "unprognostic (1.05e-1)" "unprognostic (8.80e-3)" "unprognostic (2.75e-2)" "unprognostic (1.20e-1)" "unprognostic (9.29e-2)" "unprognostic (1.33e-2)" 56.5 83.7 174.1 20.5 149.4 34.8 55.5 47.4 106.2 30.5 90.9 76.1 27.5 46.0 40.4 26.3 28.7 290.4 159.6 111.4 190.3 143.1 21.0 22.8 120.2 27.9 38.9 60.5 26.7 32.5 37.3 95.5 79.0 64.3 319.5 70.0 55.3 39.0 61.9 21.7 60.5 36.5 31.0 31.0 26.9 18.7 247.1 126.7 244.3 245.3 141.7 181.1 106.8 130.8 155.4 238.8 339.1 475.8 196.3 130.7 170.6 101.1 67.4 104.1 208.0 195.6 292.9 73.9 141.6 73.7 359.5 37.6 204.9 119.5 99.3 164.3 155.7 810.6 345.5 96.2 92.6 205.1 188.5 291.4 74.1 110.5 238.7 124.6 168.0 123.3 296.8 222.5 267.4 94.0 540.0 53.0 208.4 112.2 100.6 75.3 211.0 420.2 231.5 107.0 148.6 79.5 87.1 164.8 347.1 182.0 408.6 199.6 113.0 193.8 211.0 111.3 122.2 78.6 163.5 112.8 302.0 74.2 132.0 245.3 121.5 110.0 128.3 137.4 198.7 119.5 127.0 126.7 247.1 153.2 181.1 244.3 141.7 122.3 107.8 79.5 106.8 1774.7 2343.8 18268.7 8249.8 7411.8 0.0 76804.5 19304.4 3075.6 3885.5 15697.2 0.0 0.0 3702.1 4549.9 1673.9 3293.3 31596.9 21118.2 5876.9 0.0 3002.6 5473.3 1979.3 30765.6 0.0 0.0 6556.1 11050.6 17592.2 7669.6 10722.1 5677.4 5267.0 6541.2 23740.6 0.0 4985.0 16907.1 7340.6 25199.2 0.0 11945.6 6322.1 9983.2 10814.8 7412.6 0.0 11568.9 24590.7 11079.5 MT-CYB "COB, CYTB, MTCYB, UQCR3" ENSG00000198727 "Mitochondrially encoded cytochrome b" P00156 MT 14747-15887 "Disease related genes, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Cardiomyopathy, Cataract, Deafness, Disease mutation, Leber hereditary optic neuropathy, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 324.2;skeletal muscle: 302.1" "Cell type enriched" "Detected in many" 4 "Cardiomyocytes: 61379.6" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 490.3;HeLa: 493.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032215, HPA068400, HPA074796" Approved Supported Mitochondria NA NA Mitochondria "CAB032215: AB_2261378, HPA068400: AB_2685982, HPA074796: " "unprognostic (4.50e-1)" "unprognostic (2.56e-1)" "unprognostic (9.12e-2)" "unprognostic (3.88e-2)" "unprognostic (9.22e-2)" "unprognostic (3.50e-1)" "prognostic favorable (5.96e-4)" "unprognostic (1.63e-2)" "unprognostic (8.53e-2)" "unprognostic (1.49e-2)" "unprognostic (1.01e-3)" "unprognostic (6.09e-2)" "unprognostic (1.40e-1)" "unprognostic (7.90e-3)" "unprognostic (3.07e-1)" "unprognostic (4.09e-2)" "unprognostic (1.54e-2)" 78.0 52.4 98.5 14.7 143.5 14.4 32.3 38.4 59.6 30.9 54.0 55.6 25.0 43.6 28.0 25.0 21.2 222.5 93.9 68.0 128.7 144.7 19.6 13.7 83.6 25.3 51.4 33.6 23.7 32.6 32.9 57.7 59.2 49.5 302.1 63.5 37.2 37.4 44.3 15.7 55.2 20.2 20.9 20.6 23.6 14.7 183.7 78.7 324.2 155.7 90.0 146.7 57.6 73.4 99.2 123.0 131.3 490.3 78.9 99.1 84.7 35.1 22.2 38.5 97.6 162.5 188.2 41.5 100.3 26.6 231.5 18.2 104.1 54.5 91.9 81.5 105.1 493.3 174.0 92.4 59.0 128.5 170.3 155.3 42.0 90.5 150.2 56.2 76.8 53.7 118.5 113.1 202.8 54.8 121.7 27.3 71.8 67.4 64.8 48.4 117.8 176.2 171.6 43.9 77.6 59.0 111.5 83.4 192.8 162.6 203.7 176.1 77.9 101.9 141.8 65.0 32.5 43.6 80.6 46.8 92.0 48.9 324.2 155.7 235.1 102.8 94.4 135.3 150.5 118.7 132.0 78.0 183.7 128.3 146.7 148.0 90.0 96.8 78.7 79.8 57.6 1101.8 1182.9 10535.1 6605.8 2949.0 0.0 61379.6 10280.2 2941.7 2205.5 7087.1 0.0 0.0 1833.6 2297.4 679.0 1928.7 15168.1 14904.3 3076.0 0.0 1463.9 4337.7 1777.7 14746.0 0.0 0.0 2756.0 7288.5 8580.4 3048.7 7355.0 2431.1 2478.3 3811.6 11241.0 0.0 2672.3 10113.2 5078.0 11513.5 0.0 5704.4 3210.7 4468.4 3767.8 2992.1 0.0 6827.7 9828.0 8723.5 MT-ND1 "MTND1, NAD1, ND1" ENSG00000198888 "Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1" P03886 MT 3307-4262 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" Translocase "Alzheimer disease, Amyloidosis, Diabetes mellitus, Disease mutation, Epilepsy, Leber hereditary optic neuropathy, MELAS syndrome, Neurodegeneration, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 314.4;skeletal muscle: 398.2" "Cell type enriched" "Detected in many" 5 "Cardiomyocytes: 72531.4" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 314.4" "Lineage enriched" "Detected in all" 5 "granulocytes: 314.4" "Cell line enhanced" "Detected in all" "HeLa: 673.1" "Low region specificity" "Detected in all" "CAB033779, HPA066847" Approved NA NA "CAB033779: AB_2149736, HPA066847: " "prognostic favorable (3.63e-4)" "unprognostic (3.55e-1)" "unprognostic (3.77e-2)" "unprognostic (3.65e-1)" "unprognostic (3.50e-1)" "unprognostic (1.28e-1)" "unprognostic (1.95e-3)" "unprognostic (5.84e-2)" "unprognostic (1.06e-1)" "unprognostic (5.05e-2)" "prognostic favorable (3.26e-4)" "unprognostic (8.67e-2)" "unprognostic (8.66e-2)" "unprognostic (3.24e-2)" "unprognostic (1.42e-2)" "unprognostic (3.99e-2)" "unprognostic (2.85e-2)" 83.5 48.0 118.0 15.2 136.1 17.7 31.8 45.0 85.9 19.6 58.3 40.2 16.3 43.4 30.7 16.7 17.6 223.1 106.1 74.3 96.0 104.7 20.5 12.1 101.8 14.2 48.2 35.1 14.3 32.2 26.6 58.6 71.2 48.4 398.2 75.4 33.3 24.6 55.2 16.7 45.0 29.8 13.8 17.1 19.9 9.4 60.8 32.2 314.4 54.4 35.8 46.4 19.5 101.9 104.3 85.6 77.9 325.0 59.2 110.1 88.0 26.0 24.4 25.8 181.3 111.3 125.2 56.0 66.3 24.8 68.2 9.4 53.0 49.0 89.2 73.5 139.3 673.1 257.0 69.8 65.9 137.7 140.2 144.8 37.8 54.6 99.7 26.2 36.7 64.0 78.3 72.4 140.2 53.0 273.1 22.9 64.3 78.6 55.9 38.9 67.2 135.5 165.5 35.6 56.7 48.8 78.1 85.3 108.9 69.7 228.7 137.9 81.8 73.9 104.2 73.1 86.9 53.5 58.0 55.0 116.9 22.3 314.4 54.4 103.0 25.7 31.4 37.3 54.3 30.8 34.0 20.6 60.8 41.1 46.4 157.8 35.8 32.0 32.2 22.0 19.5 1256.6 1138.7 6703.3 2831.5 2012.7 0.0 72531.4 10000.0 1801.4 2082.6 4374.0 0.0 0.0 875.4 1190.4 925.4 1519.1 10706.5 9881.7 3135.3 0.0 1058.8 2565.3 1330.0 13675.3 0.0 0.0 3018.7 7368.9 9328.1 4287.1 6527.3 2029.2 1420.6 1887.4 12938.3 0.0 1718.0 6638.7 3334.2 5210.0 0.0 6305.8 2437.5 5090.3 4626.8 1812.2 0.0 3284.5 11055.0 4223.0 MT-ND2 "MTND2, NAD2, ND2" ENSG00000198763 "Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2" P03891 MT 4470-5511 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" Translocase "Alzheimer disease, Amyloidosis, Disease mutation, Leber hereditary optic neuropathy, Neurodegeneration, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 432.3" "Cell type enhanced" "Detected in many" 9 "Cardiomyocytes: 49093.4" "Low cancer specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "basophil: 432.3" "Lineage enriched" "Detected in all" 7 "granulocytes: 432.3" "Cell line enhanced" "Detected in all" "HeLa: 612.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (5.82e-3)" "unprognostic (1.58e-2)" "unprognostic (1.53e-2)" "unprognostic (1.36e-1)" "unprognostic (4.77e-1)" "unprognostic (4.79e-2)" "unprognostic (9.56e-3)" "unprognostic (3.74e-2)" "unprognostic (2.18e-1)" "unprognostic (3.38e-3)" "unprognostic (4.55e-3)" "unprognostic (3.79e-2)" "unprognostic (4.35e-2)" "unprognostic (3.94e-2)" "unprognostic (2.11e-1)" "unprognostic (5.92e-2)" "unprognostic (4.35e-2)" 93.0 57.2 116.0 16.9 169.9 15.6 33.9 40.1 73.5 22.6 53.7 50.1 21.5 59.8 29.0 22.1 19.3 262.4 112.2 85.2 125.9 128.9 20.9 14.7 113.0 25.1 62.0 24.3 20.3 37.0 28.1 59.0 85.3 41.0 263.4 72.7 39.2 24.6 72.4 15.2 49.2 27.3 18.2 17.7 23.8 13.1 66.1 43.5 432.3 54.8 43.0 57.9 21.8 94.6 104.2 93.3 157.4 337.2 60.2 88.3 88.4 22.1 23.6 29.9 131.2 128.0 135.9 84.1 63.4 38.9 170.0 14.6 110.5 51.2 118.3 75.9 156.8 612.6 211.5 69.1 152.0 182.5 99.4 202.0 58.1 57.6 84.5 34.7 75.0 114.3 133.2 56.7 111.9 86.3 246.1 46.8 99.5 68.3 75.8 52.3 113.9 175.1 146.5 58.4 70.0 38.2 117.4 140.8 155.7 180.7 175.9 109.6 88.9 110.1 125.0 111.9 87.1 74.6 114.4 57.7 131.3 39.7 432.3 54.8 93.1 34.1 39.7 54.7 58.6 39.5 42.5 23.0 66.1 48.5 57.9 88.6 43.0 45.7 43.5 25.9 21.8 854.6 571.9 9056.6 6978.7 2368.7 0.0 49093.4 9352.8 2568.3 1610.6 5912.8 0.0 0.0 1531.9 1483.8 1182.4 1676.0 12590.8 16329.3 3187.2 0.0 1222.0 4063.7 1766.1 15003.8 0.0 0.0 3057.2 8326.4 10199.3 4945.8 8393.1 2380.5 1572.4 3231.9 13237.7 0.0 2288.2 10285.9 4266.6 9047.2 0.0 7166.1 2550.6 5515.5 4332.8 2146.6 0.0 6221.6 10985.9 6668.6 MT-ND3 "MTND3, NAD3, ND3" ENSG00000198840 "Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 3" P03897 MT 10059-10404 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" Translocase "Disease mutation, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 357.8" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 33020.6;Erythroid cells: 20674.5" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 644.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063296 Enhanced Uncertain Cytosol NA NA Cytosol "HPA063296: AB_2684978" "unprognostic (1.71e-2)" "unprognostic (1.05e-1)" "unprognostic (8.10e-2)" "unprognostic (3.07e-1)" "unprognostic (2.48e-1)" "unprognostic (1.36e-1)" "prognostic favorable (4.63e-5)" "unprognostic (2.45e-2)" "unprognostic (7.13e-2)" "unprognostic (8.85e-2)" "unprognostic (1.76e-3)" "unprognostic (1.74e-1)" "unprognostic (7.63e-2)" "unprognostic (2.51e-2)" "unprognostic (1.19e-1)" "unprognostic (2.07e-1)" "unprognostic (5.65e-3)" 102.1 73.9 117.3 17.6 137.2 17.9 59.3 33.7 70.5 31.2 76.3 64.0 25.9 49.2 21.7 24.7 19.7 256.8 110.3 81.7 138.1 145.8 19.7 17.4 92.0 27.5 77.8 14.6 22.2 34.6 39.1 59.1 67.6 50.7 357.8 42.2 48.9 28.4 66.8 19.1 60.6 21.0 25.0 20.3 24.2 15.9 84.8 32.6 159.6 48.5 48.6 75.3 24.4 85.5 139.7 93.3 91.5 644.7 129.2 77.7 72.1 42.4 39.1 44.3 210.2 133.3 89.1 111.9 92.5 70.8 178.3 40.1 157.5 67.3 127.7 192.1 87.6 465.1 346.0 100.6 129.0 132.7 223.4 292.0 65.5 73.9 233.9 60.8 102.4 69.0 104.2 73.7 279.5 67.7 172.2 47.9 245.4 129.3 58.7 91.7 82.0 237.9 236.2 38.5 83.7 34.8 69.8 142.5 254.3 161.5 208.4 103.2 60.5 91.9 105.1 77.0 40.5 53.1 192.1 49.1 78.4 34.2 159.6 48.5 36.6 36.7 36.4 49.8 73.1 42.6 44.8 32.6 84.8 63.1 75.3 100.7 48.6 32.7 32.3 27.6 24.4 652.1 738.1 6543.7 1904.3 1765.5 0.0 33020.6 8848.3 2785.1 1856.3 4782.3 0.0 0.0 986.5 1173.3 880.9 872.1 11850.5 20674.5 2500.6 0.0 790.1 1401.0 1375.6 14769.6 0.0 0.0 2746.0 8921.3 11655.5 4356.4 8457.2 1642.1 1763.0 2463.5 12873.7 0.0 1918.1 9893.1 4573.5 7467.5 0.0 6887.9 1962.1 6063.0 3539.9 1651.0 0.0 4305.8 10869.3 1952.0 MT-ND4 "LHON, MTND4, NAD4, ND4" ENSG00000198886 "Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4" P03905 MT 10760-12137 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" Translocase "Disease mutation, Dystonia, Leber hereditary optic neuropathy, MELAS syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 392.9" "Cell type enriched" "Detected in many" 4 "Cardiomyocytes: 130137.0" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 821.0" "Low region specificity" "Detected in all" HPA053928 Approved Supported Mitochondria NA NA Mitochondria "HPA053928: AB_2682313" "unprognostic (8.39e-2)" "unprognostic (1.83e-1)" "unprognostic (7.29e-2)" "unprognostic (9.54e-2)" "unprognostic (5.41e-2)" "unprognostic (3.78e-2)" "unprognostic (2.50e-3)" "unprognostic (8.16e-2)" "unprognostic (1.45e-1)" "prognostic favorable (1.76e-4)" "unprognostic (1.01e-2)" "unprognostic (7.23e-2)" "unprognostic (2.79e-2)" "unprognostic (1.53e-1)" "unprognostic (1.43e-1)" "unprognostic (3.14e-2)" "unprognostic (4.24e-2)" 82.5 72.4 124.2 19.8 138.2 14.9 34.5 43.8 78.5 34.1 68.7 56.5 27.8 37.1 32.9 25.2 23.7 292.7 122.4 90.3 129.8 178.5 20.8 17.4 101.6 25.5 58.3 37.8 19.7 39.1 37.3 82.1 61.7 65.6 288.4 61.1 41.0 37.8 63.6 21.7 67.7 29.6 24.3 23.4 26.0 15.3 164.7 87.6 392.9 119.5 87.1 129.7 53.0 102.6 106.9 138.9 205.1 326.5 82.3 97.3 104.6 40.0 24.3 47.5 162.1 117.7 182.9 92.3 89.1 35.8 192.5 12.4 169.4 43.6 105.5 67.2 112.6 821.0 271.8 49.3 113.1 134.0 139.2 179.5 35.8 128.4 229.8 58.7 92.3 93.8 226.5 87.5 231.7 44.5 257.0 39.3 89.7 72.7 60.6 43.6 110.2 177.8 222.1 51.2 69.3 60.8 202.4 104.6 257.3 141.7 267.4 162.8 99.5 96.8 133.1 81.0 135.9 55.1 81.4 64.9 196.6 52.9 392.9 119.5 268.8 82.9 91.3 115.5 148.0 93.0 98.9 65.9 164.7 109.6 129.7 105.7 87.1 89.0 87.6 67.6 53.0 1179.2 1324.7 15760.8 7514.4 3912.5 0.0 130137.0 15452.1 2295.3 2103.1 12148.5 0.0 0.0 2064.1 2636.7 917.0 2449.9 17720.8 23127.3 3538.6 0.0 2017.3 5309.0 2067.8 31565.1 0.0 0.0 4902.7 11944.3 15339.0 4282.8 8180.5 3605.2 3603.6 4879.3 17860.7 0.0 3353.9 12846.0 5441.2 13683.6 0.0 6208.8 3859.5 7259.5 5529.7 4316.1 0.0 9799.9 18174.2 10097.1 MT-ND4L "MTND4L, NAD4L, ND4L" ENSG00000212907 "Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4L" P03901 MT 10470-10766 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" Translocase "Disease mutation, Leber hereditary optic neuropathy, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 434.4;skeletal muscle: 294.4" "Group enriched" "Detected in many" 4 "Cardiomyocytes: 16050.3;Hepatocytes: 4100.6" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 885.9" "Low region specificity" "Detected in all" HPA075648 Approved Centrosome,Mitochondria NA NA Mitochondria Centrosome "HPA075648: AB_2686760" "unprognostic (5.81e-2)" "unprognostic (3.46e-2)" "unprognostic (2.76e-2)" "unprognostic (7.91e-2)" "unprognostic (5.64e-2)" "unprognostic (1.05e-1)" "prognostic favorable (4.47e-4)" "unprognostic (1.97e-1)" "unprognostic (4.04e-2)" "unprognostic (4.63e-3)" "unprognostic (6.61e-2)" "unprognostic (7.38e-3)" "unprognostic (1.39e-1)" "unprognostic (3.09e-1)" "unprognostic (3.73e-1)" "unprognostic (2.97e-2)" "unprognostic (5.68e-2)" 101.1 71.9 102.4 20.3 114.5 13.2 39.4 41.5 73.3 39.4 83.8 48.0 26.1 34.1 30.7 23.9 23.4 187.5 102.7 79.1 123.5 185.7 20.2 13.1 88.6 26.2 43.4 29.7 18.5 30.9 34.2 80.0 43.2 75.4 294.4 31.8 38.4 38.6 59.2 16.1 62.5 27.5 24.6 24.4 25.8 14.3 200.8 111.2 434.4 139.9 112.1 153.0 66.8 97.1 90.4 163.1 166.1 571.6 120.3 71.9 208.6 52.3 32.7 59.8 150.2 89.8 241.1 85.5 140.9 53.6 185.3 25.3 223.3 65.2 94.9 104.4 173.3 885.9 279.0 83.9 178.2 155.8 210.6 228.8 62.4 218.5 246.4 65.5 125.0 95.5 172.9 119.9 173.6 67.7 228.6 41.1 103.4 109.2 39.3 70.3 107.2 174.1 205.2 49.5 67.0 102.3 162.1 69.9 366.4 115.3 224.3 209.4 86.0 107.1 125.8 79.8 156.5 73.2 128.4 61.7 242.4 40.1 434.4 139.9 290.0 102.4 110.6 140.6 166.9 110.0 117.5 86.1 200.8 132.4 153.0 78.4 112.1 99.4 111.2 79.0 66.8 208.4 153.9 1221.6 193.7 203.1 0.0 16050.3 1630.6 940.9 684.7 307.1 0.0 0.0 76.3 127.4 46.0 141.8 949.6 2499.6 297.1 0.0 116.0 126.2 448.0 4100.6 0.0 0.0 246.6 1665.3 1966.8 217.5 386.3 249.3 243.0 242.5 657.8 0.0 237.0 573.3 217.1 415.7 0.0 342.8 211.1 226.8 167.2 211.8 0.0 631.2 458.3 137.0 MT-ND5 "MTND5, NAD5, ND5" ENSG00000198786 "Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5" P03915 MT 12337-14148 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" Translocase "Disease mutation, Leber hereditary optic neuropathy, Leigh syndrome, MELAS syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 193.9;heart muscle: 190.3;skeletal muscle: 223.2" "Cell type enhanced" "Detected in many" 14 "Cardiomyocytes: 21708.1;Hepatocytes: 6052.2" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 367.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.87e-1)" "unprognostic (3.18e-2)" "unprognostic (3.00e-1)" "unprognostic (1.53e-1)" "unprognostic (2.99e-1)" "unprognostic (1.30e-1)" "unprognostic (1.07e-3)" "unprognostic (5.09e-3)" "unprognostic (1.06e-2)" "unprognostic (3.01e-1)" "unprognostic (3.29e-3)" "unprognostic (4.78e-2)" "prognostic favorable (7.31e-5)" "unprognostic (9.93e-3)" "unprognostic (8.75e-2)" "unprognostic (1.26e-2)" "unprognostic (3.68e-2)" 47.2 30.4 71.2 14.8 94.5 11.3 16.5 23.2 45.8 13.6 30.3 38.9 16.6 24.9 26.2 21.4 19.1 190.3 65.0 52.8 56.3 66.6 19.3 9.4 56.1 18.6 22.9 23.1 7.9 15.1 27.5 28.0 25.7 21.5 223.2 63.9 29.5 25.3 37.9 12.6 41.4 14.6 12.8 13.2 24.9 8.0 124.1 89.3 193.9 123.4 79.6 99.3 33.7 70.0 74.7 91.4 88.3 276.3 72.4 49.3 144.0 22.1 16.2 27.1 109.7 92.4 170.5 73.1 67.2 18.2 150.6 8.5 75.6 27.0 95.4 58.2 124.9 367.2 185.3 31.9 87.3 130.0 108.0 60.5 18.3 44.0 89.3 32.6 55.4 45.4 81.7 55.2 132.9 32.7 107.8 18.0 40.1 41.0 62.8 42.9 73.1 98.0 139.7 27.3 41.8 67.1 120.3 40.1 144.3 87.4 131.2 227.9 93.3 65.1 109.9 55.7 31.2 53.9 47.5 49.9 79.8 40.5 193.9 123.4 79.9 81.3 100.2 99.3 99.4 79.3 87.3 73.4 124.1 78.5 86.6 45.3 79.6 95.9 89.3 62.1 33.7 583.6 431.9 2723.9 906.1 795.2 0.0 21708.1 2619.1 1640.9 1064.6 1097.4 0.0 0.0 240.4 680.7 99.3 666.5 2590.2 4134.9 811.9 0.0 364.3 748.8 814.8 6052.2 0.0 0.0 752.3 2617.9 3186.6 403.9 979.2 872.2 577.0 1484.2 1582.7 0.0 1038.2 1813.1 797.6 2081.7 0.0 685.6 570.5 650.3 492.1 851.0 0.0 1584.2 1461.9 1233.6 MT-ND6 "MTND6, NAD6, ND6" ENSG00000198695 "Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6" P03923 MT 14149-14673 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" Translocase "Disease mutation, Dystonia, Leber hereditary optic neuropathy, Leigh syndrome, MELAS syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 395.3;skeletal muscle: 593.2" "Cell type enriched" "Detected in many" 16 "Cardiomyocytes: 10763.4" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 524.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.96e-1)" "unprognostic (3.27e-1)" "unprognostic (2.28e-1)" "unprognostic (1.13e-1)" "unprognostic (2.21e-1)" "unprognostic (1.22e-2)" "unprognostic (1.03e-3)" "unprognostic (6.02e-3)" "unprognostic (1.68e-2)" "unprognostic (1.48e-1)" "unprognostic (6.06e-3)" "unprognostic (2.91e-1)" "prognostic favorable (8.91e-6)" "unprognostic (3.64e-2)" "unprognostic (1.42e-2)" "unprognostic (1.15e-2)" "unprognostic (2.92e-2)" 79.2 43.1 55.5 34.4 78.5 30.7 9.6 14.7 76.1 5.9 30.2 90.3 19.2 0.0 69.5 23.2 40.2 395.3 50.7 41.2 65.5 42.8 28.5 25.9 41.9 23.2 48.0 0.0 3.5 10.3 28.0 0.3 48.1 0.0 593.2 176.3 63.8 0.0 24.8 19.9 53.2 22.7 17.5 0.0 32.3 5.7 127.3 91.2 164.8 108.2 88.8 104.3 29.7 99.5 80.8 71.5 90.8 12.0 1.1 51.3 134.7 0.2 0.4 0.4 109.8 101.1 214.8 91.6 3.6 13.5 149.0 0.7 2.4 0.7 126.9 62.0 128.7 524.8 313.8 0.9 81.4 121.6 2.0 3.3 3.3 2.7 68.1 0.7 45.0 55.3 84.4 2.9 212.8 25.0 112.4 15.5 57.2 39.8 60.9 45.7 92.3 1.9 293.8 29.5 47.4 70.1 123.5 55.6 118.8 95.7 158.8 273.9 79.6 67.2 112.6 53.9 28.9 77.1 51.5 54.0 83.1 46.2 164.8 108.2 68.3 89.1 103.5 104.3 118.4 94.5 96.1 66.2 127.3 94.7 102.4 53.7 88.8 103.7 91.2 71.8 29.7 77.4 48.1 340.3 38.0 14.9 0.0 10763.4 298.1 156.6 138.8 122.1 0.0 0.0 14.9 22.5 5.1 82.2 98.6 584.0 30.5 0.0 11.3 44.8 92.7 656.7 0.0 0.0 29.0 406.4 492.6 24.4 57.8 31.8 32.1 42.3 60.4 0.0 23.3 63.7 42.5 111.6 0.0 58.2 27.7 25.6 53.0 17.9 0.0 156.7 77.0 76.6 NDUFA1 "CI-MWFE, MWFE" ENSG00000125356 "NADH:ubiquinone oxidoreductase subunit A1" O15239 X 119871487-119876662 "Disease related genes, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 144.8;skeletal muscle: 138.8" "Cell type enhanced" "Detected in all" 7 "Cardiomyocytes: 3052.5;Distal tubular cells: 1856.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029768, HPA054359" Enhanced Approved Mitochondria,Cytosol No No "Mitochondria, Cytosol" "HPA029768: AB_2673192, HPA054359: AB_2682461" "unprognostic (1.72e-1)" "unprognostic (3.00e-3)" "unprognostic (3.12e-2)" "unprognostic (1.17e-1)" "unprognostic (1.74e-1)" "unprognostic (7.34e-3)" "unprognostic (1.56e-1)" "unprognostic (8.20e-3)" "unprognostic (2.13e-1)" "unprognostic (1.02e-1)" "unprognostic (8.11e-3)" "unprognostic (4.77e-2)" "prognostic favorable (3.48e-4)" "unprognostic (1.16e-1)" "unprognostic (3.62e-2)" "unprognostic (2.67e-2)" "unprognostic (2.78e-3)" 24.5 30.1 37.9 20.1 42.5 25.2 23.8 27.9 37.8 19.7 38.4 8.7 27.3 41.0 13.5 25.8 21.6 15.9 24.8 144.8 30.1 28.5 46.0 40.2 21.1 22.2 34.6 32.8 14.6 40.4 22.7 21.7 15.4 29.5 17.9 31.1 15.5 38.4 29.6 138.8 12.1 34.6 19.3 31.5 17.1 28.1 7.7 21.1 9.2 16.2 67.4 16.7 14.0 14.9 66.3 90.5 96.3 85.7 49.8 75.5 73.8 33.6 36.4 26.0 27.7 31.4 19.9 32.6 26.6 24.3 18.7 23.4 20.3 28.2 27.5 41.1 27.8 40.0 32.5 36.5 25.6 21.5 37.9 50.4 28.5 66.4 45.5 24.4 43.5 31.7 32.4 34.8 19.9 15.5 30.6 23.2 28.1 15.5 42.7 25.7 59.6 30.9 41.2 38.4 87.9 65.0 31.3 24.8 82.5 56.4 48.0 19.0 25.1 54.7 67.9 36.5 36.6 17.2 51.3 29.9 16.0 16.2 33.2 51.9 39.4 48.8 35.9 29.0 51.7 19.7 96.3 79.0 91.6 60.2 80.4 57.1 66.3 67.1 62.8 84.0 52.7 56.1 65.7 94.6 49.8 85.7 90.5 75.5 73.8 37.9 42.5 27.9 37.8 30.1 28.5 34.6 32.8 29.5 21.1 148.9 173.3 221.0 195.7 189.9 139.0 3052.5 636.9 330.6 205.9 533.9 74.6 331.6 1856.9 408.0 28.1 249.5 1244.9 256.9 444.8 351.6 251.4 215.4 204.5 881.4 567.3 77.9 441.2 254.8 408.9 27.3 272.7 346.6 541.6 587.1 745.3 168.3 446.0 706.9 268.0 1089.7 161.0 213.4 269.6 46.1 78.8 217.9 318.3 243.7 663.1 282.7 NDUFA10 CI-42k ENSG00000130414 "NADH:ubiquinone oxidoreductase subunit A10" O95299 2 239892450-240025402 "Disease related genes, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059529, HPA067045, CAB070846" Approved Supported Mitochondria "Intracellular and membrane" NA NA 12000 Mitochondria "CAB070846: AB_11152346, HPA059529: AB_2684051, HPA067045: AB_2732756" "unprognostic (2.12e-2)" "unprognostic (8.94e-3)" "unprognostic (8.73e-2)" "unprognostic (2.02e-2)" "unprognostic (8.96e-2)" "unprognostic (2.53e-1)" "unprognostic (8.78e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (2.95e-4)" "unprognostic (5.71e-2)" "unprognostic (2.47e-2)" "unprognostic (1.05e-1)" "prognostic favorable (2.09e-7)" "unprognostic (1.16e-1)" "unprognostic (4.96e-2)" "unprognostic (1.98e-1)" "unprognostic (2.95e-1)" 19.0 37.5 19.7 18.2 30.4 20.3 19.5 26.2 31.5 14.5 31.0 24.5 18.6 30.4 14.8 18.4 28.5 18.8 17.1 66.0 28.6 18.7 36.3 40.6 13.1 13.8 21.4 27.7 19.8 23.5 25.1 15.5 15.9 33.4 13.7 34.7 16.2 20.6 26.7 67.0 26.1 24.3 18.6 27.0 13.8 24.9 15.4 19.8 13.2 16.9 34.1 20.2 19.3 17.7 24.6 35.7 11.0 27.7 21.2 24.6 24.5 16.9 16.6 12.4 20.8 15.0 25.0 20.3 14.4 18.6 20.8 20.9 16.6 21.2 12.6 6.7 16.0 15.5 22.8 27.9 25.8 26.7 16.7 18.5 16.5 15.7 35.5 22.6 22.5 13.4 24.2 21.1 16.6 22.7 18.1 26.3 20.4 25.0 8.9 22.2 25.9 21.3 23.2 14.6 26.3 18.1 21.8 27.6 22.0 29.5 33.3 19.6 12.9 14.2 32.2 22.5 9.4 29.9 22.9 16.4 14.8 15.1 18.8 16.0 15.3 6.8 20.1 16.1 20.6 17.7 6.3 26.1 11.0 18.9 27.7 24.6 24.6 19.1 20.5 35.7 18.3 19.0 19.0 5.8 21.2 23.4 12.7 22.0 24.5 19.7 30.4 26.2 31.5 28.6 18.7 21.4 27.7 33.4 19.8 71.5 71.5 70.9 81.5 93.2 72.1 304.5 79.0 77.6 80.8 73.3 58.9 175.7 263.6 95.5 40.3 66.1 150.4 0.0 68.2 97.5 68.1 53.9 64.6 119.2 111.3 47.7 89.3 62.6 83.6 48.6 46.3 74.1 106.3 115.4 134.7 70.1 74.8 106.6 46.3 181.4 103.3 64.7 75.1 53.2 69.0 104.0 182.4 62.3 201.1 84.3 NDUFA11 B14.7 ENSG00000174886 "NADH:ubiquinone oxidoreductase subunit A11" Q86Y39 19 5891276-5904006 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA072209 Uncertain Mitochondria NA NA Mitochondria "HPA072209: AB_2686495" "unprognostic (2.24e-1)" "prognostic favorable (4.54e-5)" "unprognostic (8.20e-3)" "prognostic favorable (3.38e-5)" "unprognostic (4.54e-2)" "unprognostic (7.73e-2)" "unprognostic (6.30e-2)" "unprognostic (7.26e-3)" "unprognostic (3.95e-1)" "unprognostic (4.20e-2)" "unprognostic (1.67e-3)" "unprognostic (9.02e-2)" "unprognostic (1.12e-2)" "unprognostic (2.91e-1)" "unprognostic (1.16e-1)" "unprognostic (3.40e-2)" "unprognostic (6.16e-3)" 32.3 70.8 50.2 40.9 41.3 43.4 49.3 29.9 75.2 35.3 45.1 25.8 41.2 41.6 35.9 36.9 53.1 38.4 41.4 149.3 41.9 45.8 44.1 59.8 37.9 51.9 48.3 45.8 38.4 70.9 13.5 33.8 32.5 35.9 35.1 19.6 35.9 76.3 41.1 106.0 32.4 39.5 45.2 40.2 31.5 38.8 21.2 27.0 37.3 37.8 72.1 30.5 38.3 37.2 63.3 90.2 54.3 87.4 44.8 73.7 121.4 49.2 38.1 28.4 46.2 23.3 37.9 31.8 34.1 39.4 62.5 57.8 45.5 26.3 48.7 53.8 32.5 26.8 32.6 19.6 39.7 15.1 42.0 73.5 20.0 36.6 72.7 61.0 29.7 29.8 51.8 36.1 35.4 16.8 24.1 40.7 44.8 42.2 54.3 31.4 37.5 77.1 53.0 43.0 39.3 95.9 53.5 35.5 69.7 38.6 33.0 41.1 43.7 26.5 43.6 60.0 12.7 33.5 63.4 36.4 34.9 33.5 69.3 55.6 82.6 71.6 63.0 58.8 71.4 44.7 54.3 87.4 47.7 53.5 68.0 54.8 63.3 59.6 54.0 74.9 54.6 56.7 49.5 39.2 44.8 57.7 90.2 73.7 121.4 50.2 41.3 29.9 75.2 41.9 45.8 48.3 45.8 35.9 27.0 134.0 182.8 195.8 195.3 182.6 52.9 357.1 252.3 159.3 142.1 277.4 23.6 487.2 712.9 246.9 126.8 162.6 455.6 140.2 261.1 500.5 250.4 204.0 208.9 654.2 369.3 47.7 337.5 259.7 354.1 271.6 180.4 216.7 271.7 380.5 351.7 119.5 275.3 350.7 157.3 766.8 60.4 116.4 219.2 83.0 80.8 212.9 496.2 182.7 391.9 191.2 NDUFA12 "B17.2, DAP13" ENSG00000184752 "NADH:ubiquinone oxidoreductase subunit A12" Q9UI09 12 94897055-95003770 "Disease related genes, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 129.0" "Group enriched" "Detected in all" 5 "Cardiomyocytes: 2083.1;Distal tubular cells: 525.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039903 Supported Supported Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA039903: AB_10795516" "unprognostic (2.76e-1)" "unprognostic (5.32e-3)" "unprognostic (1.17e-1)" "unprognostic (2.56e-2)" "unprognostic (2.85e-1)" "unprognostic (4.03e-2)" "unprognostic (3.05e-2)" "unprognostic (6.68e-2)" "unprognostic (1.67e-1)" "unprognostic (2.47e-2)" "unprognostic (1.89e-1)" "unprognostic (1.64e-1)" "unprognostic (3.13e-3)" "unprognostic (2.32e-1)" "unprognostic (1.65e-1)" "unprognostic (6.13e-2)" "unprognostic (3.27e-2)" 24.0 24.8 36.0 17.9 36.8 19.7 19.7 27.2 36.5 17.9 35.5 12.5 20.0 27.4 17.0 21.9 23.3 19.4 14.4 82.8 31.2 32.0 33.2 34.6 18.1 20.1 37.0 29.9 17.0 18.4 22.3 22.4 21.1 31.3 19.1 35.7 13.1 18.7 20.7 129.0 17.4 26.7 24.0 24.2 23.9 20.9 14.2 23.5 21.0 27.9 40.0 28.1 21.9 21.4 60.8 78.4 69.7 67.9 59.1 93.8 100.6 41.6 45.3 37.9 26.9 31.1 29.0 28.2 19.9 29.3 43.5 39.5 55.9 21.5 47.9 11.8 30.4 24.1 31.5 38.9 45.9 49.4 41.3 46.7 40.1 37.8 56.3 32.0 56.8 49.0 31.1 58.0 36.4 44.7 45.5 35.6 41.7 37.4 22.3 42.1 60.4 39.3 87.8 28.7 51.2 78.9 30.1 32.8 54.6 42.6 62.6 36.1 21.9 33.7 49.2 25.8 34.2 48.6 37.4 40.6 23.1 23.5 33.5 33.8 36.4 54.0 73.1 13.9 47.6 35.2 69.7 59.5 29.8 52.1 67.9 48.2 60.8 71.6 62.5 78.4 50.7 93.8 68.6 8.6 59.1 63.3 48.0 74.8 100.6 36.0 36.8 27.2 36.5 31.2 32.0 37.0 29.9 31.3 23.5 68.5 58.6 79.6 121.2 96.5 65.8 2083.1 160.5 77.6 45.5 102.9 60.9 215.5 525.6 141.2 192.8 157.8 177.2 46.7 143.2 214.5 94.4 120.9 56.6 123.1 168.7 35.0 81.9 98.8 95.5 70.6 90.3 125.9 151.8 218.2 146.8 79.4 169.8 188.7 125.5 242.6 113.4 103.5 149.9 130.8 119.2 111.7 175.3 96.5 189.4 182.6 NDUFA13 "B16.6, CDA016, CGI-39, GRIM-19, GRIM19" ENSG00000186010 "NADH:ubiquinone oxidoreductase subunit A13" Q9P0J0 19 19515736-19529054 "Disease related genes, Predicted membrane proteins" "Apoptosis, Electron transport, Host-virus interaction, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 116.3;testis: 140.2" "Cell type enhanced" "Detected in all" 8 "Late spermatids: 2344.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041213 Supported Supported Mitochondria NA NA Mitochondria "HPA041213: AB_10794988" "unprognostic (2.87e-1)" "unprognostic (2.88e-3)" "unprognostic (9.98e-2)" "unprognostic (1.11e-1)" "unprognostic (3.36e-2)" "unprognostic (5.78e-2)" "unprognostic (6.00e-2)" "unprognostic (3.30e-2)" "unprognostic (2.81e-1)" "unprognostic (1.83e-3)" "unprognostic (1.26e-2)" "unprognostic (1.13e-1)" "unprognostic (1.45e-2)" "unprognostic (1.33e-1)" "unprognostic (2.37e-1)" "unprognostic (2.15e-2)" "unprognostic (2.15e-2)" 17.9 16.9 20.0 11.7 23.9 15.4 14.4 20.7 25.2 11.0 19.2 8.7 16.5 16.5 9.7 19.6 12.2 11.7 12.9 68.0 16.4 13.9 18.9 20.8 8.4 11.9 19.9 22.3 10.6 17.8 10.6 12.1 12.1 20.0 12.9 11.9 9.8 15.2 15.5 79.7 9.5 14.9 12.1 13.4 10.1 15.0 140.2 16.2 7.6 11.3 28.1 8.4 9.6 10.2 73.7 74.9 61.4 76.8 44.8 72.7 116.3 33.1 24.5 45.3 45.0 46.2 37.5 42.5 39.5 43.8 44.6 43.5 39.7 49.8 44.1 93.0 47.6 27.8 27.0 32.0 42.9 18.4 26.9 72.4 33.7 39.1 48.6 41.3 63.3 47.6 50.3 39.0 31.2 36.0 31.5 32.0 51.6 37.2 63.2 35.4 65.9 75.1 62.9 46.1 85.3 68.2 43.1 29.4 67.4 65.0 47.6 43.0 54.4 40.2 47.4 39.3 26.4 29.3 87.2 33.3 43.7 14.8 50.9 49.0 45.0 35.4 47.5 38.5 49.2 31.9 61.4 76.8 57.8 51.2 72.9 45.5 73.7 58.9 56.0 74.9 60.5 56.9 51.1 26.9 44.8 60.8 61.2 72.7 116.3 20.0 23.9 20.7 25.2 16.4 13.9 19.9 22.3 20.0 16.2 122.1 153.3 217.5 53.6 114.6 57.3 436.5 216.6 210.1 204.8 237.3 23.6 341.6 517.3 485.5 369.3 147.4 952.4 140.2 502.5 299.6 215.0 71.6 253.9 389.3 292.2 39.7 534.5 181.7 314.3 2344.2 142.1 234.7 249.7 531.2 516.2 105.2 438.1 641.8 121.3 667.2 59.7 90.5 183.3 59.7 92.9 111.0 416.8 195.8 508.5 65.7 NDUFA2 B8 ENSG00000131495 "NADH:ubiquinone oxidoreductase subunit A2" O43678 5 140638740-140647785 "Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035933 Approved NA NA 12000 "HPA035933: AB_10669661" "unprognostic (4.48e-1)" "prognostic favorable (6.53e-4)" "unprognostic (3.61e-2)" "unprognostic (1.96e-2)" "unprognostic (6.15e-2)" "unprognostic (5.39e-3)" "unprognostic (4.01e-1)" "unprognostic (2.75e-2)" "unprognostic (1.60e-1)" "unprognostic (4.39e-3)" "unprognostic (1.84e-2)" "unprognostic (1.41e-1)" "unprognostic (3.18e-2)" "unprognostic (3.78e-2)" "unprognostic (9.96e-2)" "unprognostic (4.22e-1)" "unprognostic (1.30e-3)" 25.6 41.5 37.1 19.2 35.1 31.1 23.1 20.8 31.0 18.0 29.1 13.1 33.9 34.2 12.8 28.1 22.8 18.2 29.8 55.8 30.3 30.5 41.4 44.8 19.7 23.5 35.6 22.1 17.6 40.8 9.0 23.1 21.2 24.1 20.2 21.4 18.1 39.6 37.4 90.9 13.5 30.9 18.9 25.5 22.1 24.2 21.4 21.7 22.0 26.9 46.7 17.2 17.5 15.7 47.0 64.1 66.6 66.9 31.3 48.7 63.1 25.1 36.6 18.0 37.1 21.0 15.6 23.7 15.0 12.6 18.3 22.6 56.1 28.5 23.1 36.7 12.0 23.9 19.7 16.3 27.9 10.7 23.1 43.1 15.0 34.9 42.9 12.8 26.4 19.6 18.7 20.8 12.1 8.7 16.0 18.8 24.3 15.5 37.2 16.7 35.5 35.7 52.8 19.0 28.1 36.7 27.9 22.2 39.9 29.9 26.1 23.1 20.4 20.8 53.3 40.0 16.3 50.0 40.8 13.7 21.8 16.9 19.0 23.4 41.9 60.6 34.2 25.8 29.4 12.8 33.8 66.9 66.6 33.3 56.8 34.2 47.0 36.7 36.8 55.9 40.0 34.0 35.5 60.0 31.3 44.8 64.1 48.7 63.1 37.1 35.1 20.8 31.0 30.3 30.5 35.6 22.1 24.1 21.7 101.3 102.6 131.8 103.7 86.8 78.7 263.8 211.5 141.8 108.1 232.1 35.3 258.0 691.4 157.7 418.1 98.7 492.0 186.9 192.0 193.4 113.2 137.5 90.1 429.3 254.8 50.9 185.7 161.4 214.5 291.3 152.8 157.0 180.5 259.7 266.5 118.0 177.0 343.7 144.2 695.9 79.5 116.4 135.9 168.6 261.8 102.3 186.0 119.4 305.6 136.6 NDUFA3 B9 ENSG00000170906 "NADH:ubiquinone oxidoreductase subunit A3" O95167 19 54102728-54109257 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Cardiomyocytes: 1041.5;Late spermatids: 1291.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 38.9" "Low region specificity" "Detected in all" HPA046976 Supported NA NA "HPA046976: AB_10960994" "unprognostic (3.04e-2)" "unprognostic (4.12e-3)" "unprognostic (9.53e-2)" "unprognostic (5.95e-2)" "unprognostic (6.73e-2)" "unprognostic (3.14e-2)" "unprognostic (3.91e-1)" "unprognostic (3.05e-1)" "unprognostic (2.95e-1)" "unprognostic (2.00e-2)" "prognostic favorable (9.65e-4)" "unprognostic (9.91e-2)" "unprognostic (3.24e-3)" "unprognostic (7.79e-2)" "unprognostic (1.33e-1)" "unprognostic (7.24e-2)" "prognostic favorable (4.80e-4)" 17.7 20.8 47.4 15.4 50.9 21.8 22.0 17.3 36.5 12.8 22.6 13.7 21.5 31.8 11.7 25.1 15.8 17.1 20.0 66.1 40.9 33.1 29.7 37.2 20.8 26.9 43.3 31.1 12.9 34.0 22.2 25.5 12.3 29.5 15.9 25.8 13.9 27.0 24.7 95.7 42.4 27.6 15.7 26.8 14.7 23.7 32.6 19.6 16.1 19.5 34.7 16.6 16.3 15.1 20.9 27.3 21.7 16.7 17.1 16.4 18.8 5.4 4.7 4.7 6.4 6.2 5.7 3.7 4.6 5.0 3.7 4.2 5.9 4.0 4.3 3.1 4.1 3.6 3.4 3.7 8.9 1.7 6.5 19.6 4.8 6.3 6.6 4.4 5.3 2.0 3.7 8.8 3.2 4.3 2.5 6.7 4.2 2.6 3.1 3.7 17.4 4.9 6.2 3.9 38.9 9.0 2.2 2.5 9.0 2.7 13.6 7.8 4.1 4.3 10.3 2.5 5.8 12.0 5.2 5.9 4.9 2.4 2.1 7.5 4.7 3.5 2.5 5.4 5.0 2.3 17.2 16.3 21.7 15.0 16.7 15.0 20.9 15.5 15.6 15.8 19.8 16.3 16.4 15.9 17.1 13.7 27.3 15.4 18.8 47.4 50.9 17.3 36.5 40.9 33.1 43.3 31.1 29.5 19.6 89.3 115.3 159.2 44.9 35.3 34.7 1041.5 244.5 190.1 113.7 373.4 9.8 147.2 691.4 171.8 409.1 107.4 555.4 163.5 167.0 149.5 119.0 58.2 112.2 459.8 264.7 22.3 288.8 206.2 255.7 1291.0 151.0 163.3 207.5 272.3 310.4 63.8 191.8 343.7 133.0 664.3 46.3 84.1 82.1 132.9 71.5 54.6 124.1 142.2 317.6 56.7 NDUFA4 "CI-9k, MLRQ" ENSG00000189043 "NDUFA4, mitochondrial complex associated" O00483 7 10931951-10940256 "Disease related genes, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 149.9;skeletal muscle: 151.6" "Cell type enhanced" "Detected in all" 6 "Cardiomyocytes: 3966.4;Distal tubular cells: 3355.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055323, HPA078265" Approved Approved Mitochondria NA NA 18000 Mitochondria "HPA055323: , HPA078265: " "unprognostic (1.83e-1)" "unprognostic (6.64e-2)" "unprognostic (1.65e-1)" "unprognostic (1.51e-1)" "unprognostic (2.16e-1)" "unprognostic (4.97e-3)" "unprognostic (3.85e-1)" "unprognostic (2.25e-1)" "unprognostic (1.69e-1)" "unprognostic (3.90e-2)" "unprognostic (8.65e-3)" "unprognostic (1.74e-1)" "prognostic favorable (4.61e-8)" "unprognostic (1.24e-1)" "unprognostic (1.94e-1)" "unprognostic (1.44e-3)" "unprognostic (2.08e-1)" 21.9 22.0 72.8 13.6 55.3 19.8 27.0 33.1 74.4 20.5 18.3 12.0 16.8 25.1 16.9 29.6 15.8 20.2 16.7 149.9 56.1 32.1 46.2 46.7 15.9 13.5 47.6 48.9 17.1 23.7 18.9 5.6 11.4 33.0 23.1 20.4 14.1 36.0 31.1 151.6 12.1 17.3 21.4 26.3 13.6 23.6 7.4 23.2 6.8 20.4 60.1 15.6 15.8 11.6 29.0 41.1 52.8 39.6 21.7 37.5 48.0 11.4 19.7 33.6 38.7 19.1 18.0 15.5 14.5 13.8 13.7 12.1 24.7 31.5 22.4 13.9 20.9 37.5 20.3 22.3 17.3 15.0 11.0 16.3 18.7 23.2 23.0 16.7 25.8 18.5 19.3 17.4 16.7 14.8 26.1 19.0 20.2 27.8 30.5 28.5 22.1 11.5 22.7 36.8 78.1 40.0 15.6 24.0 25.1 34.7 24.9 21.1 21.9 23.1 66.5 13.1 49.0 42.0 31.7 16.6 16.3 22.6 23.4 24.0 18.5 23.6 25.7 22.6 27.9 50.7 52.8 32.5 44.4 23.4 38.6 27.4 29.0 32.7 29.3 41.1 22.0 34.1 29.7 7.4 21.7 39.6 38.5 37.5 48.0 72.8 55.3 33.1 74.4 56.1 32.1 47.6 48.9 33.0 23.2 455.6 386.9 389.1 472.6 361.6 472.0 3966.4 996.2 704.0 533.5 903.7 251.3 756.7 3355.6 748.9 115.7 549.6 532.5 186.9 833.3 599.3 543.2 716.7 552.0 1498.2 844.7 149.4 201.3 748.3 552.8 81.7 457.0 587.9 868.9 625.8 610.1 384.0 636.5 584.4 737.2 2069.7 472.4 329.8 932.8 105.9 274.8 422.2 550.9 350.3 618.2 678.3 NDUFA5 "B13, CI-13kB, CI-13KD-B, NUFM, UQOR13" ENSG00000128609 "NADH:ubiquinone oxidoreductase subunit A5" Q16718 7 123536997-123558255 "Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Cardiomyocytes: 621.7;Distal tubular cells: 906.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043175 Supported NA NA 69000 "HPA043175: AB_10793992" "prognostic favorable (8.47e-5)" "unprognostic (4.00e-2)" "unprognostic (1.82e-1)" "unprognostic (2.04e-1)" "unprognostic (4.90e-2)" "unprognostic (3.26e-1)" "unprognostic (2.23e-1)" "unprognostic (3.46e-2)" "unprognostic (1.81e-1)" "unprognostic (2.14e-2)" "unprognostic (1.37e-1)" "unprognostic (9.20e-2)" "prognostic favorable (3.99e-9)" "unprognostic (3.39e-1)" "unprognostic (1.59e-1)" "unprognostic (1.93e-1)" "unprognostic (2.73e-3)" 13.9 39.9 50.4 9.5 47.5 9.5 22.1 30.3 56.3 16.9 22.2 9.9 17.9 22.3 15.7 22.7 16.5 16.5 14.7 64.9 53.9 41.5 53.6 33.6 13.4 10.7 42.6 37.8 14.3 12.2 32.5 31.0 12.7 42.1 23.4 23.7 13.4 22.3 20.6 67.2 9.1 20.7 18.4 29.3 10.6 21.6 13.2 16.0 9.7 43.1 30.4 12.7 16.8 10.8 22.9 18.2 21.3 22.3 24.2 27.0 26.4 12.1 7.0 15.8 20.1 15.7 16.5 8.2 10.4 15.2 11.8 15.8 7.1 16.5 22.2 10.9 12.8 17.9 14.3 18.4 16.3 18.4 16.1 12.6 12.5 14.0 14.6 15.8 28.8 14.2 13.5 17.0 10.1 11.0 18.1 17.1 15.0 43.6 27.8 21.0 7.2 28.0 40.0 24.1 30.0 17.8 15.5 16.7 36.2 31.3 11.2 36.1 20.4 15.0 76.3 19.4 22.2 17.6 24.5 9.9 16.0 6.2 69.5 17.5 23.5 18.0 22.8 32.6 24.3 20.4 21.3 11.7 12.8 18.7 20.0 27.0 22.9 23.8 20.7 15.2 17.7 26.0 26.2 4.0 24.2 22.3 18.2 23.7 26.4 50.4 47.5 30.3 56.3 53.9 41.5 42.6 37.8 42.1 16.0 95.3 84.9 88.1 116.9 99.9 176.7 621.7 101.9 151.3 88.7 157.1 78.5 138.8 906.9 106.8 269.2 99.3 135.7 23.3 78.8 126.5 106.9 130.3 86.6 142.1 96.9 120.8 132.4 49.1 59.6 48.7 83.4 82.4 192.3 59.5 113.6 182.8 78.5 127.9 105.4 520.3 174.3 116.4 138.7 134.2 94.5 96.4 132.5 99.2 140.2 118.0 NDUFA6 "B14, CI-B14, LYRM6, NADHB14" ENSG00000184983 "NADH:ubiquinone oxidoreductase subunit A6" P56556 22 42085525-42090955 "Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Cardiomyocytes: 1434.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.48e-2)" "prognostic favorable (3.87e-4)" "unprognostic (7.00e-3)" "prognostic favorable (4.96e-4)" "unprognostic (1.65e-1)" "unprognostic (1.13e-1)" "unprognostic (1.55e-2)" "unprognostic (4.02e-2)" "unprognostic (2.71e-2)" "unprognostic (1.47e-2)" "unprognostic (8.28e-2)" "unprognostic (3.61e-1)" "prognostic favorable (1.05e-6)" "unprognostic (2.15e-1)" "unprognostic (1.63e-1)" "unprognostic (9.49e-2)" "unprognostic (4.84e-2)" 11.1 18.3 18.4 11.6 18.9 16.9 17.3 16.4 17.7 7.8 21.8 8.7 15.7 11.4 10.2 12.7 20.0 8.0 13.3 68.5 14.7 15.3 30.8 39.1 11.5 13.0 18.8 15.0 8.5 17.3 35.1 13.3 22.0 16.2 15.4 30.8 13.2 16.0 15.1 55.8 11.2 25.8 13.8 11.4 11.4 18.9 8.7 9.3 14.0 15.0 34.2 12.9 19.4 10.2 22.6 34.9 26.9 28.3 19.5 25.7 34.8 7.1 0.8 1.9 7.6 15.5 11.5 4.1 0.1 0.1 0.3 0.4 7.4 13.8 0.2 0.7 11.8 1.0 8.3 0.5 0.5 1.8 0.1 0.3 0.4 3.8 25.9 0.3 12.8 12.6 6.9 8.3 9.9 15.4 0.7 6.3 0.8 11.4 13.8 0.6 13.9 7.2 1.5 6.8 20.8 21.7 11.6 7.1 0.1 0.6 2.7 0.4 4.9 13.7 9.4 23.4 2.7 15.8 0.2 0.0 1.0 17.8 7.7 12.1 8.2 11.1 1.6 5.5 14.7 15.8 19.3 27.2 26.9 19.5 26.6 19.6 22.6 25.7 17.3 34.9 20.3 20.5 22.6 9.4 19.5 28.3 23.0 25.6 34.8 18.4 18.9 16.4 17.7 14.7 15.3 18.8 15.0 16.2 9.3 56.6 80.3 104.2 178.3 165.0 55.0 1434.3 198.7 101.7 64.8 171.0 43.2 382.8 809.1 225.5 144.1 130.4 388.3 93.5 220.7 352.4 189.5 145.7 102.7 481.4 312.1 33.4 164.0 92.1 111.7 34.7 93.5 166.9 273.3 270.5 197.2 82.8 223.5 252.6 104.0 407.8 67.6 103.5 197.5 102.4 159.0 162.6 639.0 103.6 249.2 201.5 NDUFA8 "MGC793, PGIV" ENSG00000119421 "NADH:ubiquinone oxidoreductase subunit A8" P51970 9 122144058-122159819 "Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 105.4" "Cell type enhanced" "Detected in all" 6 "Cardiomyocytes: 528.1;Distal tubular cells: 520.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041510, HPA041600" Enhanced Supported Mitochondria NA NA 14000 Mitochondria "HPA041510: AB_10794379, HPA041600: AB_10796778" "unprognostic (2.90e-1)" "unprognostic (2.27e-3)" "unprognostic (3.58e-1)" "unprognostic (3.42e-2)" "unprognostic (2.32e-1)" "unprognostic (2.20e-2)" "unprognostic (1.07e-2)" "unprognostic (1.98e-2)" "unprognostic (2.33e-2)" "unprognostic (6.98e-2)" "unprognostic (1.46e-2)" "unprognostic (4.12e-2)" "prognostic favorable (4.17e-6)" "unprognostic (1.80e-1)" "unprognostic (1.96e-1)" "unprognostic (1.04e-1)" "unprognostic (4.62e-2)" 15.4 20.0 35.9 9.5 40.5 7.3 16.5 18.8 36.8 14.2 23.4 12.4 19.6 19.4 12.6 26.9 17.0 18.9 16.9 105.4 32.3 27.5 29.0 23.6 10.9 11.2 31.3 30.3 11.3 16.8 21.8 15.3 14.1 22.4 17.9 26.6 14.6 25.1 19.7 68.3 11.1 17.4 22.0 19.1 10.9 18.0 25.1 16.8 10.0 18.5 30.9 15.8 15.6 15.3 29.7 39.7 22.2 34.3 25.5 30.8 24.3 17.9 33.3 22.1 29.1 23.9 22.0 27.4 21.0 24.9 28.8 24.3 42.2 17.9 26.3 20.8 24.5 52.6 45.3 41.8 45.3 28.4 25.8 28.9 20.7 55.9 36.4 25.8 36.5 21.4 24.0 44.3 28.8 18.5 26.5 41.2 29.5 31.5 19.8 32.8 45.7 22.6 23.8 20.2 81.0 64.2 18.2 34.9 38.3 41.4 25.0 38.3 15.1 32.9 39.1 26.0 23.6 41.4 17.6 26.7 16.0 16.1 30.0 23.4 22.4 36.1 26.0 33.3 23.7 26.4 5.1 29.4 22.2 29.1 34.3 27.8 29.7 27.0 28.4 38.1 29.3 29.0 30.5 4.8 25.5 28.8 39.7 30.8 24.3 35.9 40.5 18.8 36.8 32.3 27.5 31.3 30.3 22.4 16.8 26.8 30.2 50.6 59.9 42.8 43.3 528.1 56.0 69.6 48.9 78.5 27.5 106.7 520.6 91.1 282.6 89.5 102.7 46.7 88.4 95.7 43.5 75.0 19.7 93.1 108.4 42.9 74.3 58.3 41.0 68.2 52.3 46.0 89.4 88.4 92.7 52.1 87.8 87.7 70.7 161.2 38.8 25.8 56.7 227.6 125.0 49.7 105.8 45.0 118.7 71.0 NDUFA9 "CI-39k, NDUFS2L, SDR22E1" ENSG00000139180 "NADH:ubiquinone oxidoreductase subunit A9" Q16795 12 4649095-4694317 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 66.6" "Cell type enhanced" "Detected in all" 7 "Late spermatids: 461.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA042268, HPA073212" Supported Supported Nucleoplasm,Mitochondria No No Mitochondria Nucleoplasm "HPA042268: AB_2677922, HPA073212: AB_2686581" "unprognostic (2.26e-1)" "unprognostic (7.85e-3)" "unprognostic (3.67e-2)" "unprognostic (1.84e-1)" "unprognostic (2.41e-2)" "unprognostic (7.58e-2)" "unprognostic (9.64e-3)" "unprognostic (3.02e-1)" "unprognostic (2.06e-1)" "unprognostic (1.25e-1)" "unprognostic (3.45e-2)" "unprognostic (1.16e-1)" "prognostic favorable (2.57e-7)" "unprognostic (7.80e-2)" "unprognostic (1.71e-1)" "unprognostic (1.93e-2)" "prognostic favorable (5.75e-4)" 10.7 13.2 11.0 10.1 17.8 21.2 11.7 15.3 20.7 9.2 22.1 12.0 8.6 20.9 10.1 11.0 13.4 8.4 8.5 41.3 11.6 11.0 23.7 22.1 8.5 11.8 12.7 9.9 8.4 10.4 10.4 12.2 9.5 16.2 9.9 22.7 12.1 13.3 10.1 66.6 10.6 18.9 11.7 8.3 11.5 13.6 5.8 9.3 14.4 10.2 30.7 12.8 8.2 8.8 36.8 43.5 14.6 41.5 25.8 35.9 59.6 10.9 19.8 9.8 13.0 7.2 7.2 28.3 8.4 8.5 16.3 12.4 42.9 22.1 12.4 4.5 9.1 18.4 18.5 14.1 12.4 10.6 24.0 24.8 12.1 21.1 32.4 15.8 17.6 13.1 9.2 12.1 11.1 15.1 10.1 12.2 17.8 8.4 23.5 12.0 21.3 17.6 20.3 25.2 20.7 16.5 24.9 14.4 12.9 22.4 25.1 7.1 8.0 10.6 28.5 14.7 22.2 5.9 16.9 8.5 12.4 25.2 11.3 19.4 4.6 5.4 20.5 13.0 11.0 13.6 14.6 35.8 13.3 27.7 41.5 28.0 36.8 29.0 30.2 42.3 26.2 25.3 26.2 3.1 25.8 32.2 43.5 35.9 59.6 11.0 17.8 15.3 20.7 11.6 11.0 12.7 9.9 16.2 9.3 26.8 28.0 46.2 52.9 43.0 46.1 165.0 50.9 41.5 36.4 61.1 55.0 100.9 140.9 108.0 102.8 42.7 83.0 23.3 114.3 98.5 39.0 37.2 56.6 65.2 101.8 31.8 45.5 34.4 33.6 461.4 26.2 46.0 52.3 57.7 92.6 40.4 94.0 94.8 34.6 133.6 48.3 19.4 42.6 28.8 28.1 41.3 83.5 45.7 120.3 64.7 NDUFAB1 "ACP, ACP1, FASN2A, SDAP" ENSG00000004779 "NADH:ubiquinone oxidoreductase subunit AB1" O14561 16 23581002-23596356 "Predicted intracellular proteins" "Electron transport, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 118.2;skeletal muscle: 112.0" "Cell type enhanced" "Detected in all" 7 "Cardiomyocytes: 1253.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054364, HPA076020" Approved Supported Nucleoplasm,Mitochondria No No Mitochondria Nucleoplasm "HPA054364: AB_2682463, HPA076020: " "unprognostic (3.33e-3)" "unprognostic (9.38e-2)" "unprognostic (1.14e-2)" "unprognostic (9.10e-2)" "unprognostic (2.33e-1)" "unprognostic (5.71e-2)" "unprognostic (1.22e-1)" "unprognostic (5.97e-2)" "unprognostic (1.97e-1)" "unprognostic (7.57e-2)" "unprognostic (3.89e-1)" "unprognostic (5.60e-2)" "prognostic favorable (1.94e-7)" "unprognostic (1.77e-1)" "unprognostic (1.07e-1)" "unprognostic (4.83e-2)" "unprognostic (3.16e-1)" 21.6 25.5 29.4 14.8 28.0 15.1 20.4 21.2 37.7 13.4 31.2 11.4 16.2 30.2 13.7 15.5 19.4 16.2 17.4 118.2 24.1 25.6 32.5 38.8 12.0 15.2 27.0 21.6 10.9 29.1 21.9 18.6 15.2 23.3 16.0 26.5 15.3 24.3 19.2 112.0 12.4 25.7 18.1 15.5 14.0 20.1 11.4 11.5 14.5 15.8 54.3 16.7 13.4 12.7 39.3 61.8 17.4 49.3 25.0 39.5 43.1 28.2 20.9 26.2 23.3 18.7 20.2 36.4 21.8 16.2 22.0 18.1 18.1 23.0 46.8 35.8 15.7 27.4 23.4 45.5 25.9 17.5 26.5 52.6 25.1 37.5 88.9 19.6 46.6 20.9 18.8 36.0 16.2 17.5 20.7 27.9 42.3 52.6 23.8 23.8 42.8 36.0 70.9 68.0 42.2 48.6 49.6 29.5 63.7 20.2 25.4 36.0 28.1 24.4 44.7 40.7 30.1 36.1 39.0 21.9 20.2 21.2 19.5 29.9 30.4 44.2 52.5 22.6 37.7 22.8 15.1 43.1 17.4 31.7 49.3 34.6 39.3 37.7 35.0 55.2 34.6 35.2 36.5 8.9 25.0 38.0 61.8 39.5 43.1 29.4 28.0 21.2 37.7 24.1 25.6 27.0 21.6 23.3 11.5 92.3 83.8 96.1 105.6 108.4 80.0 1253.7 109.5 175.3 81.9 106.4 43.2 246.2 600.2 140.5 81.4 113.0 204.9 70.0 182.7 251.9 115.6 117.8 83.1 281.9 233.1 49.3 194.3 96.3 110.6 24.0 89.8 100.2 148.5 155.9 210.6 118.9 192.1 168.4 114.2 541.1 90.3 90.5 123.0 114.6 115.3 124.3 187.8 90.6 317.0 150.7 NDUFB1 "CI-MNLL, MNLL" ENSG00000183648 "NADH:ubiquinone oxidoreductase subunit B1" O75438 14 92116122-92121917 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 161.6" "Cell type enhanced" "Detected in all" 6 "Cardiomyocytes: 2033.2;Hepatocytes: 1436.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA063737 Supported Supported "Nuclear speckles,Mitochondria" NA NA Mitochondria "Nuclear speckles" "HPA063737: AB_2685109" "unprognostic (1.12e-2)" "unprognostic (1.31e-3)" "unprognostic (6.70e-2)" "unprognostic (2.67e-2)" "unprognostic (1.28e-1)" "unprognostic (2.54e-2)" "unprognostic (6.91e-2)" "unprognostic (3.74e-3)" "unprognostic (5.35e-3)" "unprognostic (4.55e-3)" "unprognostic (1.18e-2)" "unprognostic (4.15e-2)" "prognostic favorable (1.31e-5)" "unprognostic (7.35e-2)" "unprognostic (1.19e-1)" "unprognostic (2.16e-1)" "unprognostic (5.05e-3)" 38.3 48.3 47.8 22.4 43.1 30.2 22.1 30.9 53.6 12.4 39.7 13.4 28.1 36.4 14.8 39.2 23.2 15.9 20.0 142.2 38.4 35.7 51.2 64.6 28.1 24.9 40.6 36.0 16.5 48.5 9.9 30.6 13.2 41.8 19.3 26.9 22.9 54.1 35.9 161.6 12.6 32.9 25.9 31.3 19.3 29.4 10.0 26.4 11.9 21.6 48.9 21.3 17.1 16.3 61.7 98.6 116.1 93.9 45.1 70.1 95.0 27.1 55.1 44.7 28.8 29.3 21.9 20.5 33.5 18.9 19.9 18.4 33.2 46.3 24.5 31.2 18.7 29.1 34.0 25.6 27.2 18.0 38.6 58.5 47.5 86.5 39.5 23.3 37.5 27.2 27.0 16.5 20.8 18.4 47.1 17.7 47.1 25.8 50.5 27.2 102.8 37.0 33.6 22.6 103.1 67.5 33.1 42.5 36.4 49.6 67.3 29.9 21.7 65.6 40.0 42.6 39.3 59.8 58.6 39.5 12.7 24.1 25.3 22.3 40.0 62.3 54.5 38.2 27.8 26.2 58.1 93.9 67.8 43.7 63.5 50.2 61.7 64.7 49.8 82.6 52.0 65.4 60.4 116.1 45.1 58.1 98.6 70.1 95.0 47.8 43.1 30.9 53.6 38.4 35.7 40.6 36.0 41.8 26.4 154.9 246.4 237.3 88.1 114.4 72.8 2033.2 565.6 282.4 178.6 369.9 37.3 225.4 988.2 197.4 98.7 145.0 655.0 280.4 371.9 86.0 164.5 117.3 207.1 1436.2 359.0 52.4 305.2 426.6 707.7 29.0 243.1 282.3 315.5 296.6 433.5 108.9 268.5 512.0 226.7 864.5 130.9 219.9 185.4 133.6 144.5 153.9 172.1 204.2 467.2 90.1 NDUFB10 PDSW ENSG00000140990 "NADH:ubiquinone oxidoreductase subunit B10" O96000 16 1959508-1961975 "Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 280.4" "Cell type enhanced" "Detected in all" 4 "Cardiomyocytes: 1107.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073189 Supported NA NA "HPA073189: AB_2686579" "unprognostic (3.56e-1)" "prognostic favorable (7.38e-4)" "unprognostic (1.08e-1)" "unprognostic (5.22e-2)" "unprognostic (1.73e-1)" "unprognostic (1.44e-1)" "unprognostic (5.58e-2)" "unprognostic (1.75e-1)" "unprognostic (7.84e-2)" "unprognostic (1.22e-2)" "unprognostic (2.20e-1)" "unprognostic (1.44e-1)" "prognostic favorable (9.43e-6)" "unprognostic (1.24e-1)" "unprognostic (5.21e-2)" "unprognostic (4.43e-1)" "unprognostic (8.76e-2)" 21.6 20.3 29.0 18.3 30.9 15.6 23.5 21.0 32.2 18.2 31.3 17.0 22.2 32.3 18.8 22.9 22.1 18.9 22.0 97.1 26.9 20.1 28.8 33.9 13.0 22.3 27.7 28.7 15.4 29.8 26.3 13.3 15.1 20.1 18.9 28.2 17.9 32.0 24.2 280.4 16.8 27.8 27.5 18.9 15.7 25.2 19.2 15.6 16.6 20.0 73.7 17.3 20.1 17.7 64.6 84.7 66.6 75.5 51.8 84.8 80.2 17.4 51.4 24.7 29.6 24.9 23.7 25.6 21.8 26.4 25.3 17.4 37.8 23.7 35.6 37.3 27.9 13.5 37.3 27.2 33.3 19.1 32.6 101.2 27.5 40.7 42.8 32.0 44.3 26.6 26.6 30.2 24.4 27.4 27.3 29.3 31.9 25.6 35.0 32.1 72.9 52.2 46.2 31.7 46.6 58.6 61.7 26.4 76.3 36.8 18.1 56.1 36.0 41.0 66.7 28.7 15.2 40.5 30.1 25.1 23.6 22.3 33.5 23.7 58.0 44.5 46.6 16.6 22.2 24.7 54.8 75.5 66.6 57.7 63.2 55.8 64.6 71.2 72.1 79.0 58.0 56.9 59.5 41.3 51.8 53.2 84.7 84.8 80.2 29.0 30.9 21.0 32.2 26.9 20.1 27.7 28.7 20.1 15.6 107.2 71.6 131.7 132.1 151.5 82.2 1107.2 300.7 160.6 76.2 207.6 17.7 313.5 832.3 248.3 262.3 175.5 627.2 163.5 362.2 264.7 185.2 120.1 110.6 343.0 279.7 74.7 195.8 149.8 199.0 686.6 146.4 164.2 263.2 256.9 319.4 135.9 259.6 427.8 146.7 623.8 82.2 187.5 259.7 198.1 121.6 159.6 167.3 149.5 388.8 110.0 NDUFB11 "ESSS, Np15, NP17.3" ENSG00000147123 "NADH:ubiquinone oxidoreductase subunit B11" Q9NX14 X 47142216-47145504 "Disease related genes, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Cardiomyopathy, Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 164.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030367 Supported Approved Mitochondria NA NA Mitochondria "HPA030367: AB_10603882" "unprognostic (2.20e-1)" "unprognostic (6.77e-3)" "unprognostic (1.39e-1)" "unprognostic (1.33e-1)" "unprognostic (9.80e-2)" "unprognostic (8.84e-2)" "unprognostic (3.31e-2)" "unprognostic (2.05e-1)" "unprognostic (5.18e-2)" "unprognostic (1.24e-2)" "unprognostic (1.69e-2)" "unprognostic (2.19e-1)" "unprognostic (6.58e-2)" "unprognostic (3.27e-1)" "unprognostic (2.34e-1)" "unprognostic (1.69e-1)" "unprognostic (8.46e-3)" 16.9 33.4 26.1 21.2 24.8 25.2 29.2 18.9 29.7 17.6 23.3 10.5 24.7 24.2 14.3 25.1 23.3 18.8 24.0 64.4 22.4 20.6 24.4 48.8 18.1 36.5 22.5 22.0 14.9 50.9 15.6 24.5 14.2 24.4 18.1 21.2 13.0 37.0 30.2 164.0 17.3 22.8 16.0 18.3 19.2 22.8 9.7 12.3 30.4 38.5 53.6 21.2 14.3 20.5 58.9 69.0 22.2 44.7 27.7 54.6 59.5 19.9 29.7 23.5 27.1 20.3 17.5 25.0 14.5 16.9 23.8 23.1 31.6 24.5 24.6 12.6 15.8 25.1 25.6 26.4 15.4 16.0 23.7 70.6 14.1 40.6 26.1 20.4 23.6 21.7 19.1 14.1 20.6 13.7 15.3 17.7 32.1 16.8 32.4 13.3 45.1 27.8 65.3 36.7 23.8 54.6 30.3 23.2 55.8 24.1 21.3 43.3 32.0 27.6 31.8 22.0 31.3 45.6 30.9 13.5 16.7 22.8 31.0 17.0 32.0 27.9 27.5 18.2 14.8 22.2 22.2 44.7 19.8 34.0 32.0 42.2 58.9 48.4 39.0 52.8 52.8 54.6 43.6 9.5 27.7 23.7 69.0 51.0 59.5 26.1 24.8 18.9 29.7 22.4 20.6 22.5 22.0 24.4 12.3 98.3 106.3 255.4 204.6 230.6 88.2 209.9 272.6 84.3 121.7 275.7 35.3 385.7 494.0 274.0 3.3 148.1 318.7 303.7 319.8 368.1 203.9 216.1 191.4 557.4 340.7 52.4 317.3 186.6 292.7 7.4 168.2 251.5 251.4 301.2 382.3 151.0 288.4 321.1 165.9 606.1 75.5 161.7 184.4 17.2 37.7 253.9 377.1 200.3 398.2 277.3 NDUFB2 "AGGG, CI-AGGG" ENSG00000090266 "NADH:ubiquinone oxidoreductase subunit B2" O95178 7 140690777-140722790 "Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 153.5" "Cell type enhanced" "Detected in all" 7 "Cardiomyocytes: 3102.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051377 Approved Uncertain Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA051377: AB_2681460" "unprognostic (1.17e-2)" "unprognostic (4.63e-2)" "unprognostic (2.25e-1)" "unprognostic (4.83e-2)" "unprognostic (2.29e-2)" "unprognostic (2.07e-1)" "unprognostic (3.20e-2)" "unprognostic (3.30e-2)" "unprognostic (8.30e-2)" "unprognostic (1.95e-3)" "unprognostic (4.35e-3)" "unprognostic (1.23e-1)" "prognostic favorable (7.60e-7)" "unprognostic (2.05e-1)" "unprognostic (1.07e-1)" "unprognostic (8.28e-2)" "unprognostic (1.55e-1)" 25.1 31.2 45.1 19.9 52.5 20.2 27.3 29.1 43.3 21.5 39.0 26.0 25.1 28.3 20.1 29.5 27.7 22.0 25.7 105.5 37.0 36.0 46.6 41.2 18.4 23.8 46.0 35.6 14.5 47.0 26.5 23.9 17.7 33.3 20.7 30.8 28.1 37.6 27.4 127.2 17.2 28.1 38.1 37.7 19.7 26.9 14.3 25.2 15.6 57.6 48.1 21.1 25.5 17.5 94.7 116.5 55.2 108.5 75.9 87.8 153.5 41.1 67.0 24.0 52.4 38.6 39.2 34.9 29.9 26.2 31.0 29.6 51.7 41.1 31.3 44.8 36.2 58.7 20.4 21.4 42.1 24.7 52.2 73.6 22.9 57.3 58.1 30.6 35.3 30.9 43.6 36.5 29.4 18.1 26.6 46.1 44.5 38.7 37.9 42.9 122.0 55.3 91.1 55.6 84.7 76.6 31.9 23.4 72.2 62.1 81.8 48.9 48.3 41.0 67.2 35.9 28.6 29.2 40.5 38.4 41.0 24.1 48.4 51.5 36.2 67.2 54.9 62.4 56.8 51.3 55.2 108.5 48.1 83.5 107.8 71.3 94.7 82.1 81.4 116.5 72.9 87.8 87.7 9.0 75.9 97.1 92.8 73.9 153.5 45.1 52.5 29.1 43.3 37.0 36.0 46.0 35.6 33.3 25.2 175.7 232.0 217.4 229.1 201.1 175.8 3102.3 435.7 235.5 197.9 638.6 92.3 489.8 1692.7 343.0 795.3 237.8 727.9 70.0 273.3 377.8 291.6 360.2 272.6 944.1 632.0 131.9 411.8 215.5 261.6 154.7 206.2 385.8 411.7 381.5 493.4 197.7 268.8 531.3 229.1 1640.6 200.8 194.1 278.2 77.7 190.5 245.3 430.7 214.4 506.9 369.0 NDUFB3 B12 ENSG00000119013 "NADH:ubiquinone oxidoreductase subunit B3" O43676 2 201071433-201085750 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 113.9" "Cell type enhanced" "Detected in all" 10 "Cardiomyocytes: 1805.8;Distal tubular cells: 901.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034596 Enhanced NA NA "HPA034596: AB_10602712" "unprognostic (5.38e-2)" "unprognostic (2.90e-1)" "unprognostic (4.46e-2)" "unprognostic (6.85e-2)" "unprognostic (1.85e-1)" "prognostic unfavorable (7.24e-4)" "unprognostic (1.41e-3)" "unprognostic (6.29e-2)" "unprognostic (8.81e-3)" "unprognostic (2.55e-2)" "unprognostic (1.53e-1)" "unprognostic (1.20e-1)" "unprognostic (1.37e-2)" "unprognostic (9.40e-3)" "unprognostic (9.20e-2)" "unprognostic (1.94e-1)" "unprognostic (7.27e-2)" 16.9 19.9 23.4 13.9 23.6 10.1 14.7 13.5 33.3 10.4 27.1 8.2 16.8 23.8 8.4 18.9 21.1 8.6 13.0 57.5 24.2 19.9 35.2 25.8 10.4 12.6 25.6 29.7 6.8 13.0 15.3 13.2 10.9 20.8 11.7 23.8 8.8 21.8 11.7 113.9 8.6 21.2 10.8 19.2 13.4 17.5 17.2 17.8 10.8 11.6 39.1 16.9 9.4 12.0 40.5 55.8 66.2 52.9 36.4 47.3 27.2 25.1 20.6 31.1 17.6 26.6 22.9 26.7 29.4 18.6 21.7 23.8 46.1 31.2 18.1 36.5 24.1 34.8 23.9 25.4 35.8 33.2 37.3 59.5 42.1 49.9 54.3 17.2 60.6 24.7 22.3 27.1 25.4 15.1 25.9 27.9 33.3 38.3 35.8 34.3 29.3 43.4 67.3 20.7 48.1 68.3 31.8 25.9 55.9 46.2 38.4 31.1 22.7 22.5 23.7 36.8 47.5 22.1 54.0 27.9 20.8 27.8 22.0 31.6 27.3 54.2 61.4 37.7 35.5 24.1 43.5 37.7 40.0 32.7 51.7 36.3 40.5 38.5 37.8 45.8 31.4 33.8 41.2 66.2 36.4 52.9 55.8 47.3 27.2 23.4 23.6 13.5 33.3 24.2 19.9 25.6 29.7 20.8 17.8 74.5 43.1 110.7 86.1 69.4 45.6 1805.8 155.4 131.2 79.6 177.9 11.8 229.3 901.9 200.3 116.7 76.5 387.2 23.3 176.3 165.0 71.9 72.2 76.2 207.9 250.1 30.2 140.6 86.5 115.2 32.2 88.3 118.4 160.3 347.2 205.2 105.4 170.7 284.0 95.5 609.5 64.6 90.5 95.2 200.4 91.8 80.4 131.8 87.3 261.2 108.6 NDUFB4 B15 ENSG00000065518 "NADH:ubiquinone oxidoreductase subunit B4" O95168 3 120596309-120602500 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 195.7" "Cell type enhanced" "Detected in all" 4 "Cardiomyocytes: 1416.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051739, HPA064441" Enhanced Supported "Nucleoplasm,Nuclear membrane,Mitochondria" No No Mitochondria "Nucleoplasm, Nuclear membrane" "HPA051739: AB_2681585, HPA064441: " "unprognostic (1.75e-1)" "unprognostic (2.57e-3)" "unprognostic (6.95e-2)" "unprognostic (4.69e-2)" "unprognostic (1.59e-1)" "unprognostic (1.31e-1)" "unprognostic (1.72e-2)" "unprognostic (1.62e-2)" "unprognostic (1.47e-1)" "unprognostic (4.35e-3)" "unprognostic (9.66e-3)" "unprognostic (7.97e-2)" "unprognostic (2.84e-1)" "unprognostic (3.69e-2)" "unprognostic (1.01e-1)" "unprognostic (1.12e-1)" "prognostic favorable (1.79e-4)" 25.5 68.2 37.6 20.1 37.7 22.4 59.4 40.7 51.6 25.6 37.2 19.1 25.6 33.6 23.2 32.2 30.2 24.3 27.8 130.2 32.5 30.8 53.3 46.9 25.4 42.0 37.3 29.4 25.8 36.5 34.1 32.8 18.5 36.7 26.8 34.8 24.6 33.9 29.5 195.7 27.3 30.6 37.6 32.4 22.6 28.7 26.6 25.6 31.1 25.9 64.8 25.4 32.3 29.1 64.5 73.4 52.1 60.5 39.1 79.7 49.0 51.3 37.5 44.9 44.9 28.3 33.8 36.5 28.9 38.4 37.6 41.6 36.4 39.5 26.1 58.7 32.3 47.2 49.8 34.6 36.8 28.4 40.0 39.8 40.3 39.4 36.6 17.2 35.4 47.8 30.5 49.1 18.3 24.1 45.6 46.9 49.7 23.8 40.2 40.3 40.3 70.0 51.3 35.7 84.6 102.8 40.6 25.6 57.4 60.9 32.1 50.6 51.8 33.9 38.0 61.5 31.3 64.0 56.5 36.0 33.3 43.9 14.1 40.2 49.6 44.7 78.9 52.6 49.9 45.1 46.2 46.2 52.1 45.5 60.5 47.4 64.5 63.5 51.3 58.4 47.2 54.8 53.4 28.1 39.1 60.5 73.4 79.7 49.0 37.6 37.7 40.7 51.6 32.5 30.8 37.3 29.4 36.7 25.6 151.8 116.9 147.4 227.4 197.5 114.3 1416.5 333.7 208.8 175.1 303.6 55.0 310.4 1039.5 474.7 797.6 248.2 436.8 93.5 541.7 349.0 180.0 247.2 169.9 411.5 288.6 79.4 286.7 153.4 221.7 73.1 254.9 235.4 411.7 399.5 378.0 175.1 503.3 436.8 260.6 758.9 123.5 252.2 270.2 329.1 90.3 219.8 294.7 162.0 391.3 307.0 NDUFB5 "CI-SGDH, MGC12314, SGDH" ENSG00000136521 "NADH:ubiquinone oxidoreductase subunit B5" O43674 3 179604690-179627647 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005640 Enhanced Supported Nucleoplasm,Mitochondria "Intracellular and membrane" NA NA Mitochondria Nucleoplasm "HPA005640: AB_1079461" "unprognostic (6.76e-2)" "unprognostic (1.09e-2)" "unprognostic (6.33e-2)" "unprognostic (3.51e-3)" "unprognostic (1.38e-1)" "unprognostic (7.35e-3)" "unprognostic (1.33e-2)" "unprognostic (1.63e-1)" "unprognostic (4.46e-2)" "unprognostic (5.96e-3)" "unprognostic (4.83e-2)" "unprognostic (7.11e-2)" "prognostic favorable (3.32e-5)" "unprognostic (3.05e-1)" "unprognostic (1.36e-1)" "unprognostic (6.50e-2)" "unprognostic (1.95e-1)" 32.2 39.6 41.3 16.0 44.6 12.1 27.2 20.0 45.7 23.7 32.3 22.0 21.2 43.7 16.2 15.4 26.4 20.0 20.5 86.9 34.1 31.7 48.1 42.3 17.8 21.7 39.4 33.6 22.1 23.2 31.1 18.7 21.3 37.6 19.6 29.9 24.8 35.8 21.3 96.3 17.5 38.5 21.3 30.9 20.4 24.9 21.8 18.4 22.7 27.7 47.3 18.5 26.5 17.3 27.7 41.4 19.5 44.9 14.6 25.0 26.7 23.4 6.6 16.4 19.9 21.7 29.2 22.2 14.9 18.8 21.3 21.6 19.7 17.1 20.5 45.2 12.6 36.6 26.0 17.7 19.7 21.5 42.4 14.8 22.0 12.0 16.4 19.9 26.3 17.5 26.9 25.5 12.0 20.0 22.1 24.4 20.0 18.6 29.9 22.8 16.7 15.1 20.4 23.7 45.5 26.7 16.8 19.0 63.6 38.6 18.1 11.7 19.6 9.0 50.9 35.1 15.4 77.6 42.9 15.7 14.1 13.4 19.2 35.4 39.8 41.2 30.3 22.8 28.2 20.0 19.5 29.9 14.4 13.9 37.6 22.1 27.7 20.0 17.0 41.4 19.5 20.8 21.0 6.7 14.6 44.9 24.0 25.0 26.7 41.3 44.6 20.0 45.7 34.1 31.7 39.4 33.6 37.6 18.4 44.7 44.0 87.9 92.8 75.7 45.3 340.1 112.1 52.2 53.4 83.7 31.4 192.8 431.0 110.3 85.8 85.1 125.2 0.0 92.5 115.9 83.1 75.7 92.3 108.0 222.8 38.1 112.9 97.6 229.9 13.7 75.1 156.2 128.2 124.4 173.7 74.4 86.7 189.4 65.7 379.0 54.1 71.1 81.4 233.1 125.2 77.5 192.3 81.2 242.9 137.2 NDUFB6 "B17, CI" ENSG00000165264 "NADH:ubiquinone oxidoreductase subunit B6" O95139 9 32552999-32573184 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Early spermatids: 591.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044001, HPA053334" Supported Enhanced Mitochondria No No Mitochondria "HPA044001: AB_10959448, HPA053334: AB_2682116" "unprognostic (4.09e-1)" "prognostic favorable (3.18e-4)" "unprognostic (1.81e-2)" "unprognostic (1.53e-2)" "unprognostic (1.50e-1)" "unprognostic (1.49e-1)" "unprognostic (1.14e-1)" "unprognostic (6.10e-2)" "unprognostic (1.18e-1)" "unprognostic (1.35e-3)" "unprognostic (1.22e-1)" "unprognostic (1.49e-1)" "prognostic favorable (7.47e-10)" "unprognostic (2.70e-1)" "unprognostic (1.82e-1)" "unprognostic (1.26e-1)" "unprognostic (1.83e-1)" 21.9 26.8 33.9 17.7 31.8 16.0 18.7 22.6 28.3 13.7 21.9 15.5 17.3 26.5 16.8 17.4 18.6 15.4 15.9 58.6 27.6 27.9 32.8 36.6 13.9 15.4 28.4 27.2 14.1 19.5 15.4 17.8 15.5 22.9 15.1 18.2 14.6 22.7 16.1 87.2 14.6 25.5 16.4 25.9 13.5 20.0 28.9 17.1 19.2 22.2 34.4 14.5 14.1 13.5 26.0 38.8 77.4 27.3 22.2 27.5 26.5 30.2 18.6 20.7 23.7 14.1 13.2 13.3 20.3 16.6 18.8 20.8 18.2 13.7 22.6 21.2 13.9 19.5 17.2 19.5 22.4 14.1 31.0 31.3 53.7 28.6 18.8 13.8 26.7 13.9 13.6 10.9 16.9 12.9 14.2 16.9 34.7 17.1 25.5 20.9 17.5 36.0 63.1 21.9 26.0 41.4 24.8 17.4 20.9 21.0 11.4 20.9 23.6 23.5 27.0 13.6 16.2 25.5 20.8 15.0 20.5 31.1 22.6 29.7 11.4 21.2 36.6 34.3 18.9 9.6 25.0 25.8 33.3 21.0 23.1 20.2 26.0 22.4 21.6 27.6 21.8 23.0 24.3 77.4 22.2 27.3 38.8 27.5 26.5 33.9 31.8 22.6 28.3 27.6 27.9 28.4 27.2 22.9 17.1 116.1 94.0 77.4 80.5 83.7 39.2 514.3 107.0 155.2 108.1 102.9 5.9 175.9 452.6 143.9 591.4 96.3 138.7 93.5 145.0 113.2 93.0 79.2 86.8 170.4 141.7 17.5 62.0 71.8 59.8 88.6 84.8 89.6 151.8 111.8 116.6 72.0 133.2 118.5 84.5 440.9 40.8 103.5 124.6 143.8 114.3 84.6 87.1 65.4 146.3 88.4 NDUFB7 "B18, CI-B18, MGC2480" ENSG00000099795 "NADH:ubiquinone oxidoreductase subunit B7" P17568 19 14566078-14572062 "Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 182.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002817 Enhanced NA NA "HPA002817: AB_1079462" "unprognostic (2.80e-2)" "prognostic favorable (3.54e-4)" "unprognostic (2.03e-1)" "unprognostic (4.09e-2)" "unprognostic (4.36e-2)" "unprognostic (2.03e-1)" "unprognostic (1.95e-1)" "unprognostic (1.45e-3)" "unprognostic (2.07e-1)" "unprognostic (1.87e-2)" "unprognostic (2.02e-2)" "unprognostic (4.14e-2)" "prognostic favorable (2.41e-4)" "unprognostic (1.40e-1)" "unprognostic (1.69e-1)" "unprognostic (1.59e-1)" "unprognostic (9.25e-3)" 35.5 34.0 42.1 24.1 37.3 26.0 34.6 25.1 50.3 24.7 36.2 19.4 28.5 36.6 22.2 31.6 28.3 27.2 31.9 110.4 32.6 32.3 36.2 44.9 22.6 26.8 40.7 29.6 21.3 55.1 20.4 23.9 21.8 29.3 24.5 17.0 24.9 58.1 30.8 182.0 22.6 32.7 28.7 26.4 18.9 30.3 20.9 20.0 20.4 27.6 65.5 19.7 19.3 23.6 64.2 82.6 48.7 77.5 67.3 83.1 90.6 37.0 37.4 15.2 32.3 13.2 13.3 26.9 17.3 19.4 32.4 30.8 49.7 20.6 16.9 52.1 16.1 14.1 29.1 10.0 37.9 4.3 26.1 50.9 32.7 61.6 51.3 23.4 21.1 22.7 21.6 31.7 17.0 8.0 9.1 25.9 30.8 20.1 31.1 14.9 70.1 34.3 47.2 38.6 35.2 122.9 26.8 18.1 40.9 22.6 39.7 32.9 35.1 18.1 42.3 46.0 4.1 27.8 38.1 19.1 41.2 20.0 52.0 31.8 42.5 43.5 21.1 39.5 41.2 27.6 48.7 77.5 23.8 83.1 68.5 77.1 64.2 56.8 70.0 74.7 56.9 47.6 62.2 21.9 67.3 64.7 82.6 63.8 90.6 42.1 37.3 25.1 50.3 32.6 32.3 40.7 29.6 29.3 20.0 71.5 82.9 160.0 137.4 118.5 101.4 590.7 285.3 140.5 116.0 246.0 53.0 296.5 978.2 260.6 63.3 159.0 823.9 93.5 394.9 276.1 228.8 165.8 101.4 537.7 331.0 68.3 319.0 192.8 231.2 180.8 192.1 159.9 359.4 312.8 436.8 150.4 310.7 547.1 188.1 778.8 103.1 232.8 265.0 103.0 228.5 140.9 188.7 143.4 440.9 144.9 NDUFB8 "ASHI, CI-ASHI" ENSG00000166136 "NADH:ubiquinone oxidoreductase subunit B8" O95169 10 100523740-100530000 "Plasma proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Distal tubular cells: 742.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA003886, HPA065549" Supported Enhanced Mitochondria NA NA Mitochondria "HPA003886: AB_1079463, HPA065549: " "unprognostic (4.07e-2)" "unprognostic (1.95e-3)" "unprognostic (2.28e-1)" "unprognostic (7.33e-2)" "unprognostic (4.88e-2)" "unprognostic (5.78e-2)" "unprognostic (3.02e-1)" "unprognostic (6.46e-2)" "unprognostic (8.33e-2)" "unprognostic (9.09e-2)" "unprognostic (1.25e-2)" "unprognostic (8.23e-2)" "unprognostic (4.62e-2)" "unprognostic (1.10e-1)" "unprognostic (1.21e-1)" "unprognostic (1.15e-1)" "unprognostic (5.10e-2)" 35.2 39.8 86.7 27.0 67.4 35.6 26.1 39.3 81.5 25.4 37.7 23.8 23.1 38.8 24.7 42.3 36.8 28.8 28.2 110.0 70.6 62.8 50.4 50.6 19.8 28.1 63.9 54.1 27.7 36.3 31.5 31.4 19.9 49.9 26.6 36.2 25.7 39.7 34.5 88.5 24.3 33.8 41.5 38.9 22.1 31.5 12.0 41.4 18.3 28.3 49.2 27.8 25.2 21.5 76.6 88.6 62.2 74.4 60.5 105.9 129.7 42.2 71.3 38.5 68.3 29.2 28.4 42.6 28.9 62.8 44.4 48.1 96.6 49.3 44.8 26.1 32.3 32.8 50.7 28.8 46.9 35.4 29.4 73.6 31.5 60.5 78.2 39.6 64.3 54.3 34.9 42.4 44.3 59.8 32.2 48.5 59.6 32.7 28.5 38.2 51.3 62.0 81.0 25.8 54.4 66.6 43.3 42.1 59.1 52.0 48.4 26.7 37.4 21.3 40.5 41.9 27.6 60.3 57.6 32.5 25.4 28.8 27.1 50.5 51.7 46.9 55.6 50.5 68.2 28.3 35.1 74.4 62.2 59.0 72.9 69.5 76.6 73.6 67.8 80.4 64.1 79.8 76.7 17.1 60.5 61.4 88.6 105.9 129.7 86.7 67.4 39.3 81.5 70.6 62.8 63.9 54.1 49.9 41.4 71.5 126.9 126.6 146.5 0.0 174.3 341.7 234.4 156.6 88.7 188.5 55.0 285.1 742.8 226.5 20.4 131.5 123.8 116.8 230.9 258.4 136.0 175.3 101.1 286.9 348.6 144.6 101.8 146.7 171.1 43.8 202.0 160.0 0.0 261.5 229.2 129.5 225.4 259.6 204.4 592.8 122.1 168.1 220.6 53.7 79.5 0.0 257.3 174.0 305.7 185.2 NDUFB9 "B22, LYRM3, UQOR22" ENSG00000147684 "NADH:ubiquinone oxidoreductase subunit B9" Q9Y6M9 8 124539103-124568510 "Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 221.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 254.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042768 Approved Supported Mitochondria NA NA Mitochondria "HPA042768: AB_10797508" "unprognostic (1.18e-2)" "unprognostic (2.00e-2)" "unprognostic (1.30e-1)" "unprognostic (2.03e-3)" "unprognostic (8.32e-2)" "unprognostic (9.71e-2)" "unprognostic (3.25e-1)" "unprognostic (1.14e-1)" "unprognostic (4.16e-2)" "unprognostic (3.80e-2)" "unprognostic (1.51e-1)" "unprognostic (3.64e-1)" "prognostic favorable (3.42e-5)" "unprognostic (9.54e-2)" "unprognostic (9.64e-2)" "unprognostic (4.94e-2)" "unprognostic (2.74e-1)" 26.9 20.8 61.0 19.6 45.1 43.7 33.3 26.9 63.7 20.7 40.4 15.0 25.4 35.5 17.4 30.0 27.9 19.4 23.8 125.1 44.2 39.0 50.1 52.9 23.8 38.2 60.0 49.1 16.8 51.7 20.6 16.3 15.8 46.7 20.6 37.5 13.4 39.9 24.0 221.3 18.0 26.1 31.3 44.8 15.3 28.9 44.1 31.1 13.5 27.7 80.7 19.3 16.7 16.5 53.8 52.7 52.1 54.4 37.5 71.2 64.2 28.8 26.7 20.5 27.7 21.3 18.2 17.2 14.2 16.2 25.9 19.6 35.1 27.9 28.6 36.9 16.3 13.5 32.9 29.7 22.6 24.5 33.2 40.5 69.5 19.0 42.0 28.4 21.6 19.0 21.2 32.9 23.7 51.3 14.1 23.5 20.8 42.9 24.1 20.7 90.1 34.0 43.3 20.6 104.1 59.4 23.0 15.6 39.0 34.0 24.4 28.6 22.4 30.9 254.6 30.4 12.9 35.0 29.3 18.7 15.1 39.4 14.1 33.4 31.1 41.4 32.8 26.3 43.3 19.9 52.1 54.4 27.5 48.3 37.2 47.9 53.8 64.0 53.9 52.7 42.5 63.4 52.2 11.2 37.5 27.2 39.6 71.2 64.2 61.0 45.1 26.9 63.7 44.2 39.0 60.0 49.1 46.7 31.1 116.1 101.5 163.0 206.1 193.5 71.0 877.9 259.9 172.6 153.6 272.2 92.3 413.9 678.1 287.5 321.0 148.3 490.6 46.7 353.1 228.0 195.3 239.3 136.2 450.4 353.4 35.0 224.5 179.2 208.1 585.5 147.0 181.9 234.5 201.0 282.2 86.2 298.7 372.2 143.5 593.2 52.3 168.1 258.4 306.2 277.3 164.6 437.4 148.2 397.6 262.6 NDUFC1 KFYI ENSG00000109390 "NADH:ubiquinone oxidoreductase subunit C1" O43677 4 139266880-139302551 "Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 164.1" "Cell type enhanced" "Detected in all" 8 "Cardiomyocytes: 1810.7;Distal tubular cells: 963.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044556, HPA062427" Enhanced Approved Mitochondria No No Mitochondria "HPA044556: AB_10794402, HPA062427: " "unprognostic (6.07e-2)" "unprognostic (4.61e-3)" "unprognostic (1.76e-2)" "prognostic favorable (8.23e-5)" "unprognostic (7.11e-2)" "unprognostic (1.74e-1)" "unprognostic (1.23e-1)" "unprognostic (1.40e-1)" "unprognostic (7.62e-2)" "unprognostic (3.60e-2)" "unprognostic (3.58e-2)" "unprognostic (1.17e-2)" "prognostic favorable (9.96e-4)" "unprognostic (2.33e-1)" "unprognostic (1.07e-1)" "unprognostic (1.66e-1)" "prognostic favorable (7.25e-4)" 7.4 17.0 15.2 6.4 15.8 5.6 8.3 12.2 15.7 8.5 13.1 11.8 7.0 15.2 6.6 12.0 11.7 8.3 7.7 55.5 12.4 14.6 20.3 17.1 8.4 6.7 13.0 12.1 9.7 13.1 11.4 14.3 8.9 10.0 8.1 12.6 11.3 10.9 10.5 164.1 9.1 16.4 7.2 10.4 10.5 11.9 27.1 8.5 6.1 11.6 57.6 9.4 7.0 7.3 32.7 40.0 40.8 24.4 12.8 31.4 26.1 8.7 3.7 10.7 13.3 7.7 8.4 8.6 10.8 7.2 8.0 6.1 6.5 11.0 3.8 3.9 7.6 7.9 5.2 20.9 7.1 6.3 5.5 6.7 6.1 7.1 10.4 9.7 5.0 3.3 12.1 10.7 7.6 11.2 10.3 7.9 8.8 14.0 16.4 5.5 6.2 7.4 12.4 8.2 16.4 5.0 6.3 6.6 29.1 12.8 5.7 9.1 6.9 7.7 9.5 4.9 9.0 10.4 9.9 3.9 7.9 3.7 5.5 6.1 13.2 23.2 9.6 8.5 13.3 6.3 16.0 24.4 40.8 21.7 17.3 17.3 28.3 24.4 23.2 24.0 32.7 31.4 23.1 15.4 12.8 18.8 40.0 28.3 26.1 15.2 15.8 12.2 15.7 12.4 14.6 13.0 12.1 10.0 8.5 83.4 126.2 85.5 146.6 124.6 118.7 1810.7 239.5 211.5 137.6 417.0 31.4 127.4 963.3 232.9 260.2 150.4 371.3 93.5 293.9 141.6 109.0 170.1 69.5 334.5 190.8 112.8 212.7 108.1 87.2 30.8 156.8 98.4 253.1 220.0 288.1 223.0 228.9 313.4 194.1 826.9 103.1 97.0 148.0 386.4 224.2 156.7 98.7 62.3 275.8 158.3 NDUFC2 "B14.5b, HLC-1" ENSG00000151366 "NADH:ubiquinone oxidoreductase subunit C2" O95298 11 78068304-78080219 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA038873, HPA056195" Approved Supported Mitochondria NA NA Mitochondria "HPA038873: AB_10673480, HPA056195: AB_2683063" "unprognostic (7.32e-2)" "unprognostic (5.91e-3)" "unprognostic (4.00e-2)" "unprognostic (6.14e-2)" "unprognostic (1.94e-1)" "unprognostic (8.97e-2)" "unprognostic (1.60e-1)" "unprognostic (4.23e-3)" "unprognostic (4.75e-3)" "unprognostic (3.32e-3)" "unprognostic (1.34e-1)" "unprognostic (2.11e-1)" "prognostic favorable (5.00e-5)" "unprognostic (6.32e-2)" "unprognostic (3.01e-1)" "unprognostic (4.18e-2)" "unprognostic (3.61e-3)" 55.0 70.8 40.8 23.3 44.4 32.3 46.2 51.4 58.4 22.5 41.1 31.2 68.0 63.4 31.8 32.8 41.8 35.6 31.9 60.4 41.0 44.5 37.5 89.6 30.1 36.4 43.2 47.0 27.3 48.4 25.3 34.7 31.8 40.8 27.3 20.3 29.7 79.5 59.0 122.8 29.0 55.3 23.7 41.1 24.5 36.6 28.6 23.2 26.9 63.5 43.7 23.3 31.9 24.1 50.3 78.2 70.3 73.2 44.5 46.3 81.2 36.0 45.0 24.5 15.4 23.3 14.7 30.2 44.1 26.5 35.1 25.0 120.6 40.5 21.6 80.9 20.8 28.7 38.1 18.4 25.9 13.4 40.9 52.1 23.2 46.7 94.9 39.8 50.7 23.1 20.4 24.1 26.9 10.2 21.6 23.8 23.2 45.7 36.5 19.6 62.1 33.1 91.4 27.6 88.8 56.9 29.0 46.6 73.1 26.5 54.3 34.6 30.7 31.4 64.8 22.7 22.3 51.3 42.1 31.1 34.2 42.2 81.4 37.8 33.6 65.8 49.7 19.5 30.5 32.7 65.8 73.2 70.3 39.4 58.2 36.2 50.3 45.6 41.5 77.2 45.5 39.6 41.3 21.0 44.5 48.0 78.2 46.3 81.2 40.8 44.4 51.4 58.4 41.0 44.5 43.2 47.0 40.8 23.2 154.9 160.2 100.4 139.2 84.8 134.1 213.8 247.1 202.1 144.5 371.6 62.8 347.5 258.6 334.7 231.4 158.7 177.9 70.0 374.9 317.5 154.4 190.2 148.0 738.1 305.1 85.8 161.2 184.1 179.8 53.3 199.6 133.3 232.8 193.8 274.2 214.0 379.3 301.9 189.5 354.7 91.8 232.8 163.6 380.6 170.3 100.0 323.7 113.3 343.3 186.0 NDUFS1 CI-75k ENSG00000023228 "NADH:ubiquinone oxidoreductase core subunit S1" P28331 2 206114817-206159603 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Oxidoreductase, Translocase" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 99.5" "Cell type enriched" "Detected in many" 5 "Cardiomyocytes: 534.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064605, CAB070844" Enhanced Supported Mitochondria NA NA Mitochondria "CAB070844: , HPA064605: AB_2685297" "prognostic unfavorable (3.85e-4)" "unprognostic (1.76e-1)" "unprognostic (9.22e-3)" "unprognostic (5.01e-2)" "unprognostic (8.63e-3)" "unprognostic (3.75e-1)" "unprognostic (3.72e-2)" "unprognostic (6.18e-2)" "unprognostic (2.30e-2)" "unprognostic (3.28e-1)" "unprognostic (2.00e-2)" "unprognostic (1.28e-1)" "prognostic favorable (1.47e-12)" "unprognostic (1.17e-1)" "unprognostic (1.29e-1)" "unprognostic (4.76e-2)" "unprognostic (4.73e-2)" 13.9 29.0 12.1 8.3 22.1 7.6 10.3 11.6 26.4 9.1 17.4 16.4 9.2 18.3 9.1 7.7 15.7 7.7 7.3 62.6 11.3 11.7 29.5 30.7 8.3 7.7 13.3 13.8 8.2 9.3 22.1 11.6 10.8 24.2 10.7 18.9 13.5 12.8 10.9 99.5 11.0 19.9 11.1 10.8 8.4 14.9 8.8 11.1 11.2 10.8 34.7 10.5 11.6 9.4 10.7 15.3 15.7 21.4 12.5 16.1 8.9 12.9 12.9 18.8 13.6 17.6 14.3 21.9 19.1 20.6 31.9 23.2 33.5 15.2 14.7 16.9 23.8 31.7 18.2 25.1 18.5 28.4 6.7 11.8 29.3 32.1 30.0 18.3 21.1 13.3 17.4 10.9 25.0 19.7 14.3 24.8 18.6 31.7 14.9 20.7 16.2 17.4 14.0 17.4 21.9 23.1 17.6 26.3 25.4 26.4 23.7 18.4 14.4 22.0 21.6 31.2 26.9 19.0 20.5 18.9 17.6 15.7 17.2 18.1 14.4 17.3 21.9 17.6 17.5 17.9 12.0 13.3 15.7 13.6 15.4 10.8 10.7 12.2 13.0 15.3 9.5 10.9 12.4 9.6 12.5 21.4 8.2 16.1 8.9 12.1 22.1 11.6 26.4 11.3 11.7 13.3 13.8 24.2 11.1 56.6 24.1 13.7 19.6 14.3 94.7 534.9 63.7 60.2 35.2 36.6 113.9 40.2 79.6 36.7 9.9 33.7 63.8 0.0 24.5 26.7 24.7 17.4 35.9 83.9 29.8 111.2 49.0 33.7 34.6 5.2 31.1 25.2 28.7 27.1 47.3 60.7 29.2 35.1 42.1 80.9 78.2 32.3 27.8 28.6 37.3 14.4 43.8 18.7 52.8 23.9 NDUFS2 CI-49 ENSG00000158864 "NADH:ubiquinone oxidoreductase core subunit S2" O75306 1 161197104-161214395 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Oxidoreductase, Translocase" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 104.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055140, HPA061953" Enhanced Supported Mitochondria NA NA 16000 Mitochondria "HPA055140: AB_2682713, HPA061953: AB_2684646" "unprognostic (2.13e-2)" "unprognostic (2.24e-2)" "unprognostic (8.47e-2)" "unprognostic (7.78e-2)" "unprognostic (9.81e-2)" "unprognostic (2.70e-1)" "unprognostic (1.10e-2)" "unprognostic (1.51e-1)" "unprognostic (3.10e-1)" "unprognostic (1.57e-2)" "unprognostic (3.17e-2)" "unprognostic (1.11e-1)" "prognostic favorable (2.32e-4)" "unprognostic (2.35e-1)" "unprognostic (2.80e-1)" "unprognostic (1.13e-1)" "unprognostic (1.82e-1)" 14.6 30.7 16.6 8.0 25.4 10.2 15.5 23.4 25.4 13.0 25.6 17.9 11.7 23.6 12.3 11.2 16.7 14.5 10.6 75.4 17.6 14.8 37.4 52.6 12.8 9.2 28.0 25.0 14.1 14.3 25.6 10.7 11.5 24.1 12.7 27.2 11.4 14.6 14.5 104.9 14.0 22.1 15.7 16.1 13.0 19.4 8.8 25.3 10.4 12.3 37.1 15.1 13.2 10.5 18.9 47.3 26.6 42.2 20.3 29.2 32.4 17.2 27.8 17.6 20.4 25.9 23.0 15.2 15.7 23.1 31.1 24.5 30.5 18.0 22.0 29.6 24.2 17.1 23.2 28.1 28.1 27.5 14.6 23.6 21.4 20.9 26.6 26.9 23.2 19.9 33.1 24.8 25.1 28.7 20.6 35.5 23.0 27.4 12.0 29.2 19.9 14.7 12.4 32.1 60.6 25.7 12.7 18.2 30.9 36.9 20.7 18.7 27.8 19.0 46.9 26.8 26.3 42.1 60.8 22.7 15.1 12.9 10.6 21.2 16.9 26.7 18.4 23.1 19.6 19.4 26.6 35.9 18.9 20.5 42.2 19.9 18.9 20.9 20.7 47.3 15.7 21.6 21.8 20.2 20.3 37.0 31.8 29.2 32.4 16.6 25.4 23.4 25.4 17.6 14.8 28.0 25.0 24.1 25.3 32.8 43.7 52.8 39.4 34.6 72.7 193.6 76.5 68.3 35.2 73.3 29.5 125.8 281.8 158.0 7.1 61.2 199.4 23.3 126.2 94.3 73.7 24.9 68.1 177.0 131.6 87.4 69.2 58.9 83.7 4.7 40.3 64.2 79.2 127.2 94.1 51.2 124.2 89.2 31.5 226.7 49.8 45.3 68.0 36.7 32.1 37.9 132.5 50.1 138.8 41.7 NDUFS3 CI-30 ENSG00000213619 "NADH:ubiquinone oxidoreductase core subunit S3" O75489 11 47565336-47584562 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Oxidoreductase, Translocase" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 100.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004484, CAB034894" Enhanced Supported "Nuclear bodies,Mitochondria" NA NA Mitochondria "Nuclear bodies" "CAB034894: AB_2151118, HPA004484: AB_1079464" "unprognostic (2.18e-1)" "unprognostic (7.42e-3)" "unprognostic (1.75e-1)" "unprognostic (5.01e-2)" "unprognostic (7.51e-2)" "unprognostic (3.13e-2)" "unprognostic (6.40e-2)" "unprognostic (6.24e-2)" "unprognostic (1.93e-1)" "unprognostic (1.41e-2)" "unprognostic (6.75e-3)" "unprognostic (7.73e-2)" "prognostic favorable (2.61e-6)" "unprognostic (2.77e-2)" "unprognostic (1.42e-1)" "unprognostic (1.88e-2)" "unprognostic (3.17e-3)" 13.4 22.9 29.7 13.2 46.3 25.5 18.1 23.9 35.0 16.6 28.4 16.5 16.1 31.4 12.7 16.0 19.1 17.3 16.3 45.8 26.0 24.8 34.1 32.0 12.0 13.9 29.4 24.9 12.2 23.0 21.4 17.0 12.0 26.0 13.9 30.9 14.4 20.1 17.4 100.9 15.1 28.9 15.9 17.1 14.2 18.9 15.1 15.4 20.5 16.1 51.6 18.8 14.5 11.7 25.0 36.1 18.7 31.2 16.4 23.8 31.5 11.5 22.0 18.6 19.4 16.1 16.7 15.9 11.0 18.8 27.2 25.9 32.3 20.4 25.8 11.0 15.7 19.3 21.4 26.3 19.8 22.2 13.8 42.5 15.6 30.9 31.2 16.6 38.1 20.3 16.3 14.3 10.3 17.0 11.6 17.1 21.3 22.7 17.8 17.6 35.4 26.1 49.4 26.4 32.0 31.2 31.8 26.9 21.2 23.3 18.1 20.9 15.1 14.1 24.2 24.9 11.6 27.0 36.4 11.9 16.3 18.3 18.9 24.8 20.5 27.1 28.5 16.5 29.3 16.1 12.2 28.6 18.7 18.7 31.2 19.8 25.0 19.7 20.3 33.7 23.1 18.8 20.1 7.5 16.4 25.0 36.1 23.8 31.5 29.7 46.3 23.9 35.0 26.0 24.8 29.4 24.9 26.0 15.4 50.6 35.2 47.4 60.2 58.3 41.3 154.2 96.8 75.0 45.5 66.3 39.3 103.3 343.2 99.0 93.6 59.9 204.6 23.3 97.2 97.6 64.9 43.1 56.6 108.3 166.7 57.2 81.3 52.8 54.3 46.0 62.5 73.9 113.1 83.8 120.8 100.0 80.5 103.7 65.0 231.7 51.0 103.5 79.3 76.9 75.2 66.4 74.5 62.9 167.5 58.5 NDUFS4 "AQDQ, CI-18" ENSG00000164258 "NADH:ubiquinone oxidoreductase subunit S4" O43181 5 53560633-53683340 "Disease related genes, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Distal tubular cells: 469.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003884 Supported Supported Mitochondria NA NA Mitochondria "HPA003884: AB_1079465" "unprognostic (1.25e-1)" "unprognostic (3.61e-3)" "unprognostic (3.44e-2)" "unprognostic (8.11e-2)" "unprognostic (1.46e-1)" "unprognostic (6.73e-3)" "unprognostic (6.93e-2)" "unprognostic (1.11e-1)" "unprognostic (3.93e-1)" "unprognostic (4.38e-1)" "unprognostic (1.72e-2)" "unprognostic (3.11e-1)" "prognostic favorable (3.85e-6)" "unprognostic (9.19e-2)" "unprognostic (1.24e-1)" "unprognostic (1.65e-1)" "unprognostic (1.81e-1)" 27.5 26.5 29.8 15.7 35.7 14.3 34.0 23.3 35.3 20.8 30.0 12.9 21.3 27.6 24.0 24.2 27.0 22.9 20.9 65.1 24.4 23.2 45.3 48.1 18.7 14.9 28.5 34.4 35.7 19.5 22.2 24.9 20.7 26.7 22.9 30.5 16.4 24.4 26.3 105.5 23.0 25.5 34.3 27.0 13.6 24.1 20.9 24.6 12.9 25.1 67.3 19.3 21.7 22.4 24.3 41.0 6.7 32.8 24.5 25.2 21.9 30.0 26.7 53.2 31.4 36.3 52.8 44.7 36.6 35.7 40.7 49.9 32.5 39.6 21.4 48.2 31.2 39.1 22.2 18.8 43.6 47.1 19.7 35.9 14.7 26.5 29.2 38.7 35.3 25.5 43.7 50.5 28.0 49.5 45.0 35.3 24.3 12.5 23.4 37.1 28.1 26.6 29.7 16.1 11.5 30.2 32.1 30.0 42.1 43.3 29.0 24.5 26.6 25.1 24.4 43.0 29.7 39.1 37.2 27.0 25.0 26.7 18.1 47.7 18.0 22.4 25.8 26.7 51.9 36.0 6.7 28.9 2.4 17.5 32.8 19.5 24.3 22.2 20.2 41.0 16.5 25.1 25.2 2.4 24.5 32.4 31.0 23.5 21.9 29.8 35.7 23.3 35.3 24.4 23.2 28.5 34.4 26.7 24.6 35.7 44.6 76.7 128.0 111.7 41.6 329.5 76.5 76.3 71.7 80.3 39.3 136.6 469.2 144.1 42.2 91.5 124.0 0.0 145.6 142.3 128.2 89.3 73.9 126.2 125.7 28.6 86.8 73.6 66.4 51.2 145.9 104.9 111.3 170.5 117.4 77.9 141.9 140.3 143.5 309.1 67.6 122.9 122.6 70.4 45.1 88.7 150.5 58.9 149.5 126.8 NDUFS5 CI-15k ENSG00000168653 "NADH:ubiquinone oxidoreductase subunit S5" O43920 1 39026318-39034636 "Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Cardiomyocytes: 1936.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042582 Supported NA NA "HPA042582: AB_2678062" "unprognostic (1.49e-2)" "unprognostic (2.62e-2)" "unprognostic (3.58e-1)" "unprognostic (1.41e-2)" "unprognostic (5.00e-2)" "unprognostic (2.93e-2)" "unprognostic (2.97e-3)" "unprognostic (8.96e-2)" "unprognostic (7.31e-2)" "prognostic favorable (3.54e-4)" "unprognostic (1.29e-1)" "unprognostic (7.07e-2)" "unprognostic (2.40e-1)" "unprognostic (7.87e-3)" "unprognostic (2.88e-1)" "unprognostic (2.52e-3)" "unprognostic (8.08e-2)" 56.0 62.1 98.7 34.3 84.4 44.5 55.4 48.6 83.7 36.6 62.0 33.7 49.0 42.8 49.4 114.5 59.2 40.9 40.3 166.0 76.3 69.5 61.5 71.3 30.3 35.4 71.6 65.5 49.1 45.8 36.8 46.3 33.0 49.3 44.8 66.9 35.7 72.6 62.9 150.9 36.9 38.2 64.4 46.9 25.1 44.6 22.4 31.9 30.2 47.2 85.8 43.9 55.3 35.1 38.7 64.7 28.4 53.2 36.4 74.4 59.0 42.8 74.8 56.6 68.3 62.4 66.5 74.8 51.2 42.0 50.7 51.6 89.6 57.9 48.1 70.5 54.7 25.2 30.0 72.3 70.0 56.4 52.8 85.1 47.4 134.8 148.5 43.4 95.6 36.5 66.3 80.3 53.6 48.1 50.5 86.1 50.5 75.7 43.9 24.2 95.5 45.4 123.6 98.3 64.9 77.5 61.5 81.1 76.5 99.9 139.1 79.2 73.1 60.0 75.9 66.1 128.0 51.0 77.5 53.2 41.0 48.5 42.0 86.0 35.4 69.2 68.2 45.1 106.9 55.1 26.1 50.8 28.4 46.1 53.2 52.9 38.7 71.9 53.5 51.7 30.0 74.4 63.5 9.7 36.4 48.9 64.7 66.1 59.0 98.7 84.4 48.6 83.7 76.3 69.5 71.6 65.5 49.3 31.9 154.9 172.8 250.2 316.5 409.4 120.7 1936.4 387.3 269.0 202.4 523.4 35.3 556.6 1158.9 487.9 110.4 342.3 536.4 46.7 470.4 522.0 402.8 334.4 205.5 539.4 482.2 93.8 391.7 255.9 289.3 92.4 326.0 334.5 433.6 373.3 534.7 142.1 537.4 534.4 397.4 1154.8 128.4 278.1 523.5 118.9 99.2 402.4 439.3 231.2 642.6 409.2 NDUFS6 CI-13kA ENSG00000145494 "NADH:ubiquinone oxidoreductase subunit S6" O75380 5 1801400-1816605 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 146.4" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 104.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064221 Supported NA NA 27000 "HPA064221: AB_2685217" "unprognostic (2.34e-1)" "unprognostic (1.43e-3)" "unprognostic (4.04e-1)" "unprognostic (9.74e-2)" "unprognostic (5.91e-2)" "unprognostic (6.27e-2)" "unprognostic (1.13e-2)" "unprognostic (5.67e-2)" "unprognostic (3.22e-1)" "unprognostic (9.99e-3)" "unprognostic (1.68e-3)" "unprognostic (8.57e-2)" "unprognostic (2.14e-2)" "unprognostic (1.16e-3)" "unprognostic (2.46e-1)" "unprognostic (9.08e-2)" "unprognostic (1.02e-1)" 25.0 20.6 19.8 18.9 20.9 23.7 23.9 13.3 26.8 10.6 26.2 11.5 13.6 34.2 13.6 14.4 20.3 10.9 18.8 59.8 17.6 16.5 28.1 43.1 13.5 26.2 19.9 12.9 13.0 29.7 10.5 13.6 17.1 16.1 15.4 12.6 14.7 22.3 19.0 146.4 13.0 27.1 17.8 16.5 16.4 25.4 13.3 9.3 25.5 14.7 36.6 14.1 15.5 12.7 38.7 55.7 35.8 52.8 32.4 40.2 36.7 20.7 28.6 14.0 21.2 5.1 4.6 38.4 17.7 6.3 9.6 8.3 31.5 20.3 28.7 49.1 7.3 18.3 20.7 10.5 14.1 5.2 32.4 34.6 22.1 104.2 26.5 10.3 26.0 19.6 6.5 9.1 9.1 6.5 5.7 9.3 17.2 27.1 22.0 10.3 34.6 37.2 47.6 18.5 23.0 40.3 27.7 18.2 33.6 9.8 23.2 17.3 17.4 57.5 36.9 22.2 8.0 24.6 30.9 18.7 15.2 35.3 15.6 28.7 26.6 40.8 36.7 19.2 37.9 17.2 31.4 46.5 35.8 35.1 52.8 34.9 38.7 37.2 35.5 55.7 31.0 31.5 35.2 20.2 32.4 45.7 54.5 40.2 36.7 19.8 20.9 13.3 26.8 17.6 16.5 19.9 12.9 16.1 9.3 62.5 105.5 111.7 113.4 111.5 87.6 652.0 214.0 129.8 83.0 197.1 45.2 314.0 824.0 224.3 170.3 151.7 605.8 93.5 294.9 176.7 145.1 148.1 103.7 453.3 357.1 62.0 256.5 163.9 217.4 213.8 143.2 152.8 207.5 168.7 287.4 119.2 250.9 375.2 147.8 647.4 112.5 161.7 147.6 204.0 175.7 146.4 205.0 122.2 358.9 170.2 NDUFS7 "CI-20, FLJ45860, FLJ46880, PSST" ENSG00000115286 "NADH:ubiquinone oxidoreductase core subunit S7" O75251 19 1383527-1395589 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Oxidoreductase, Translocase" "Disease mutation, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "skeletal muscle: 198.0" "Cell type enhanced" "Detected in all" 4 "Distal tubular cells: 688.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 42.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (7.36e-2)" "prognostic favorable (2.03e-4)" "unprognostic (5.30e-2)" "unprognostic (3.81e-2)" "unprognostic (1.12e-1)" "unprognostic (5.28e-2)" "unprognostic (2.41e-2)" "unprognostic (5.85e-2)" "unprognostic (4.88e-2)" "unprognostic (2.29e-1)" "unprognostic (1.99e-3)" "unprognostic (8.12e-2)" "prognostic favorable (4.90e-7)" "unprognostic (2.95e-1)" "unprognostic (2.82e-1)" "unprognostic (1.57e-1)" "unprognostic (2.34e-2)" 22.4 17.6 15.3 10.1 17.6 9.9 7.0 16.6 22.7 6.1 18.7 20.6 7.6 34.5 7.1 9.6 13.3 6.7 10.0 35.9 16.1 15.1 20.7 20.7 7.1 9.1 19.6 11.9 7.2 28.7 5.0 12.0 6.8 17.6 11.9 4.0 12.0 23.6 10.2 198.0 8.3 25.2 7.5 20.1 11.5 18.2 14.2 14.6 9.7 8.0 39.2 10.0 6.7 7.9 29.1 41.8 19.8 39.1 17.2 29.2 20.8 18.3 18.7 0.6 4.3 0.6 1.7 9.6 11.1 1.1 2.4 2.6 30.5 4.5 27.2 11.4 0.6 0.3 9.6 0.8 2.2 0.1 30.3 21.4 8.6 19.9 18.9 2.9 14.8 9.5 1.4 3.8 0.4 0.0 0.4 3.2 10.0 17.0 10.7 0.6 19.2 14.7 6.1 6.7 1.6 23.1 14.3 7.1 27.6 1.1 14.2 10.5 10.6 9.8 9.3 18.0 0.0 7.3 9.3 13.9 4.5 6.2 9.7 14.3 42.9 37.5 18.4 11.2 20.0 6.2 19.8 33.6 16.1 21.3 39.1 18.1 29.1 20.1 20.0 41.8 27.1 19.7 19.1 9.1 17.2 31.7 31.6 29.2 20.8 15.3 17.6 16.6 22.7 16.1 15.1 19.6 11.9 17.6 14.6 74.5 95.4 131.8 86.9 79.8 72.1 67.4 168.2 78.9 51.2 137.9 47.1 192.7 688.1 137.5 357.3 76.0 544.6 46.7 141.5 160.0 98.8 68.4 110.7 228.2 287.0 49.3 168.3 69.3 190.4 312.5 77.6 125.3 248.0 122.6 224.8 92.8 114.3 256.1 69.6 490.7 62.6 71.1 129.1 207.7 148.4 92.6 156.2 96.4 322.1 105.1 NDUFS8 "CI-23k, TYKY" ENSG00000110717 "NADH:ubiquinone oxidoreductase core subunit S8" O00217 11 68030617-68036644 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Oxidoreductase, Translocase" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 156.6" "Cell type enhanced" "Detected in many" 4 "Distal tubular cells: 706.2;Proximal tubular cells: 686.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018524, HPA067429" Enhanced Approved Mitochondria "Intracellular and membrane" NA NA Mitochondria "HPA018524: AB_1854355, HPA067429: " "unprognostic (2.90e-1)" "unprognostic (1.41e-3)" "unprognostic (2.41e-1)" "unprognostic (5.20e-2)" "unprognostic (1.37e-1)" "unprognostic (1.30e-3)" "unprognostic (1.36e-1)" "unprognostic (7.75e-2)" "unprognostic (3.15e-1)" "unprognostic (1.77e-2)" "unprognostic (3.81e-2)" "unprognostic (1.81e-1)" "prognostic favorable (3.27e-8)" "unprognostic (2.29e-1)" "unprognostic (1.38e-1)" "unprognostic (2.60e-2)" "unprognostic (9.45e-2)" 26.0 62.0 29.9 16.9 40.5 21.0 19.1 18.4 50.1 18.6 24.7 19.7 24.3 34.7 18.2 15.1 28.3 19.0 22.7 82.4 26.5 27.5 50.3 47.6 16.3 19.1 28.3 22.4 20.8 41.3 25.4 26.7 18.0 25.9 22.9 18.3 30.1 41.3 32.2 156.6 17.3 26.7 19.8 18.2 20.3 25.0 21.1 15.7 29.6 29.2 53.9 24.2 19.1 14.8 37.3 66.6 23.6 46.1 59.0 39.6 42.6 26.4 65.7 18.2 24.7 13.6 12.2 23.9 18.8 16.3 29.1 22.7 61.1 28.3 20.5 34.3 16.3 26.2 32.7 20.8 22.8 10.5 24.5 48.0 18.6 41.9 32.1 32.5 17.4 20.5 15.4 23.7 21.4 24.5 16.1 19.5 28.9 19.1 22.2 19.0 62.7 38.3 37.3 22.3 70.4 55.7 26.7 17.7 66.2 36.6 21.5 22.9 18.6 13.7 31.7 66.4 13.6 43.5 19.1 15.1 28.3 24.9 40.9 25.9 30.5 32.0 17.4 45.5 21.0 19.7 15.8 46.1 23.6 39.6 45.1 37.0 37.3 34.2 36.0 63.3 30.2 33.0 36.7 4.4 59.0 24.9 66.6 39.6 42.6 29.9 40.5 18.4 50.1 26.5 27.5 28.3 22.4 25.9 15.7 83.4 69.0 76.7 81.4 75.9 80.5 251.3 155.4 84.3 69.4 202.4 51.1 253.0 706.2 176.2 170.4 79.8 264.8 0.0 174.1 132.3 109.2 89.4 94.6 216.5 241.0 47.7 197.0 64.4 119.9 632.4 93.2 101.9 155.3 202.8 173.3 94.1 168.6 178.9 101.5 686.8 98.3 58.2 128.2 84.2 59.4 101.6 144.2 120.4 242.9 99.3 NDUFV1 CI-51K ENSG00000167792 "NADH:ubiquinone oxidoreductase core subunit V1" P49821 11 67606852-67612535 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Oxidoreductase, Translocase" "Disease mutation, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 150.8" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045211, HPA075051" Enhanced Supported Mitochondria,Cytosol No No Mitochondria Cytosol "HPA045211: AB_10962830, HPA075051: AB_2686732" "unprognostic (4.57e-2)" "unprognostic (2.17e-2)" "unprognostic (2.84e-1)" "unprognostic (7.07e-2)" "unprognostic (1.54e-1)" "unprognostic (4.54e-3)" "unprognostic (1.19e-1)" "unprognostic (3.31e-2)" "unprognostic (2.19e-1)" "unprognostic (4.95e-2)" "unprognostic (4.02e-2)" "unprognostic (3.03e-2)" "prognostic favorable (7.49e-10)" "unprognostic (1.12e-2)" "unprognostic (1.80e-1)" "unprognostic (2.12e-1)" "unprognostic (1.16e-1)" 23.3 28.9 27.3 20.7 33.9 20.3 18.9 32.9 48.8 18.5 33.0 23.1 19.2 40.6 19.4 21.5 25.5 22.5 23.4 93.0 26.5 24.1 39.0 41.5 15.9 20.6 31.5 40.5 24.6 38.3 49.2 18.8 15.7 34.8 16.1 25.1 17.6 27.3 27.0 150.8 28.4 30.3 22.7 23.1 21.5 28.2 30.2 24.3 18.3 23.4 67.9 20.3 18.7 18.6 23.8 41.2 13.5 30.7 36.2 28.2 24.3 25.9 27.9 14.2 28.5 17.8 17.9 26.6 16.2 15.6 25.4 17.0 52.8 31.5 48.0 34.2 13.9 20.7 35.0 30.0 25.3 8.0 24.4 23.7 19.6 37.9 26.0 25.2 26.7 22.0 26.5 24.6 20.6 18.5 16.1 22.5 35.2 35.7 39.3 15.4 39.0 31.2 52.9 13.9 59.1 35.2 36.3 27.6 77.9 20.6 19.5 22.7 21.4 20.5 71.8 54.1 9.9 36.4 27.2 17.8 24.7 18.4 35.1 17.0 38.4 21.8 23.9 28.7 28.3 23.7 12.6 26.7 13.5 25.9 30.7 28.2 23.2 21.7 24.5 41.2 23.8 20.2 25.1 4.8 36.2 17.4 26.5 27.8 24.3 27.3 33.9 32.9 48.8 26.5 24.1 31.5 40.5 34.8 24.3 56.6 80.9 64.0 70.8 71.3 67.0 408.9 66.2 72.3 67.1 82.0 47.1 180.6 336.5 96.7 57.0 53.7 205.0 23.3 97.8 127.6 79.5 47.7 59.0 122.2 121.6 60.4 94.7 53.4 67.1 159.3 60.7 67.5 108.0 83.8 141.7 63.1 68.4 126.7 55.5 398.9 60.4 45.3 98.9 77.2 78.1 70.4 158.1 71.2 225.4 78.9 NDUFV2 CI-24k ENSG00000178127 "NADH:ubiquinone oxidoreductase core subunit V2" P19404 18 9102630-9134345 "Enzymes, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Oxidoreductase, Translocase" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003404, HPA077896" Supported Supported Nucleoplasm,Mitochondria,Cytosol No No Mitochondria "Nucleoplasm, Cytosol" "HPA003404: AB_1079466, HPA077896: AB_2686866" "unprognostic (1.18e-1)" "unprognostic (3.89e-2)" "unprognostic (2.89e-1)" "unprognostic (8.22e-2)" "unprognostic (1.32e-2)" "unprognostic (6.72e-3)" "unprognostic (1.36e-2)" "unprognostic (1.18e-1)" "unprognostic (6.72e-3)" "unprognostic (1.32e-3)" "unprognostic (2.39e-1)" "unprognostic (6.84e-2)" "unprognostic (1.70e-1)" "unprognostic (5.51e-2)" "unprognostic (1.31e-1)" "unprognostic (6.56e-2)" "unprognostic (1.95e-3)" 20.0 34.5 25.2 18.0 23.7 31.1 25.6 20.6 37.3 15.6 26.1 13.1 20.3 23.1 14.7 21.5 27.5 13.9 17.6 82.6 22.7 23.8 40.7 89.1 17.2 29.9 26.7 19.4 11.2 36.3 14.9 14.9 21.6 26.2 20.8 27.8 17.8 20.1 20.2 122.6 17.4 24.4 23.5 20.8 19.3 25.2 19.0 12.7 20.5 20.5 59.5 22.7 20.4 14.1 55.6 74.7 49.3 45.1 27.0 53.5 48.1 18.6 19.6 22.7 21.1 16.8 24.0 19.2 23.5 37.4 31.1 29.6 36.6 15.4 28.8 21.6 22.0 28.7 9.5 22.0 24.4 29.8 14.5 19.4 18.4 20.2 49.3 19.4 51.2 22.9 20.1 20.5 19.2 20.8 22.5 33.5 26.0 29.3 91.0 28.5 23.4 35.7 44.9 18.9 103.3 24.4 17.0 16.8 109.2 49.6 30.3 23.8 17.7 23.2 26.5 29.5 16.9 24.8 39.0 20.5 39.7 28.2 28.4 30.5 26.3 39.0 32.2 28.3 22.7 25.6 49.3 39.9 44.1 30.2 45.1 37.6 55.6 45.5 35.7 56.6 43.6 40.0 36.9 18.0 27.0 41.6 74.7 53.5 48.1 25.2 23.7 20.6 37.3 22.7 23.8 26.7 19.4 26.2 12.7 74.5 120.4 122.8 254.8 131.4 96.8 61.3 175.8 207.5 127.4 143.1 82.5 309.8 742.8 337.2 214.8 108.5 232.3 46.7 461.4 265.4 107.6 372.3 115.7 324.6 267.7 89.0 102.4 92.7 98.1 135.7 113.1 187.8 219.4 393.1 177.0 104.6 465.3 175.4 95.8 576.3 143.4 103.5 138.2 182.6 170.4 129.0 242.0 118.9 207.0 348.6 NDUFV3 CI-10k ENSG00000160194 "NADH:ubiquinone oxidoreductase subunit V3" P56181 21 42879644-42913304 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 129.5" "Cell type enhanced" "Detected in all" 9 "Cardiomyocytes: 701.2;Late spermatids: 1042.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019791, HPA020463, HPA030427, CAB034142" Enhanced Enhanced Mitochondria NA NA Mitochondria "CAB034142: AB_2298212, HPA019791: AB_1854357, HPA020463: AB_1854358, HPA030427: AB_10603024" "unprognostic (1.62e-1)" "unprognostic (2.17e-3)" "unprognostic (1.31e-1)" "unprognostic (1.04e-1)" "unprognostic (1.10e-1)" "unprognostic (1.11e-2)" "unprognostic (4.69e-1)" "unprognostic (2.97e-2)" "unprognostic (1.05e-1)" "unprognostic (3.13e-1)" "unprognostic (3.85e-3)" "unprognostic (1.54e-1)" "unprognostic (1.45e-1)" "unprognostic (6.56e-2)" "unprognostic (9.30e-3)" "unprognostic (2.14e-1)" "unprognostic (1.94e-1)" 18.1 14.1 16.9 11.1 17.2 15.8 14.6 11.8 23.2 12.0 15.9 11.9 14.6 15.2 15.1 15.7 15.6 12.7 15.4 54.9 14.2 11.0 15.1 24.3 10.8 12.5 14.0 18.6 16.0 17.7 13.2 13.1 11.6 19.2 13.6 11.4 12.2 19.4 21.8 129.5 15.4 13.5 16.9 16.0 13.3 14.3 20.3 13.3 6.6 11.6 18.5 10.6 13.3 11.8 9.9 22.9 16.0 22.8 10.5 8.8 10.3 9.6 11.4 11.0 18.0 13.6 11.9 13.6 19.2 11.0 11.5 9.6 20.7 11.9 10.7 15.2 7.2 15.6 10.5 12.8 16.9 7.5 6.1 15.5 35.3 13.3 16.2 21.4 12.0 18.5 13.3 14.7 11.6 18.4 10.4 14.4 7.4 27.9 14.0 13.1 18.9 8.0 18.2 14.4 21.5 22.4 13.9 8.0 33.4 15.4 12.8 8.1 8.4 19.3 22.8 12.7 6.2 19.6 15.9 16.9 10.8 7.5 13.8 13.6 20.8 13.7 12.2 14.1 21.6 16.2 3.7 21.4 16.0 8.0 22.8 8.1 8.1 7.6 6.7 22.9 9.9 8.8 7.7 3.8 10.5 19.6 11.3 8.8 10.3 16.9 17.2 11.8 23.2 14.2 11.0 14.0 18.6 19.2 13.3 50.6 37.7 43.0 46.0 17.6 69.1 701.2 89.2 92.3 27.3 85.5 64.8 46.1 195.6 69.0 416.9 34.9 128.4 140.2 87.3 49.8 41.1 75.6 30.1 285.4 97.8 54.0 75.1 62.0 81.5 1042.9 61.5 68.7 35.4 67.7 73.4 56.3 83.6 77.2 58.7 265.4 102.6 71.1 47.2 216.7 86.2 20.6 75.2 34.6 82.9 49.3 PPA1 "IOPPP, PP, PP1, Ppase, SID6-8061" ENSG00000180817 "Pyrophosphatase (inorganic) 1" Q15181 10 70202830-70233911 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "monocytes: 942.2;Muller glia cells: 982.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019878, HPA020096" Supported Supported Vesicles NA NA 110000 Vesicles "HPA019878: AB_1855601, HPA020096: AB_1855600" "unprognostic (1.50e-1)" "unprognostic (2.85e-1)" "unprognostic (4.71e-2)" "unprognostic (2.85e-1)" "unprognostic (1.42e-1)" "unprognostic (4.47e-2)" "unprognostic (2.86e-2)" "unprognostic (9.43e-2)" "unprognostic (3.34e-1)" "unprognostic (1.62e-1)" "unprognostic (2.13e-2)" "unprognostic (3.60e-2)" "unprognostic (1.82e-3)" "unprognostic (5.36e-2)" "unprognostic (2.37e-1)" "unprognostic (3.53e-2)" "unprognostic (2.74e-1)" 46.6 55.5 41.3 36.8 56.0 24.2 88.7 66.8 62.2 34.8 45.7 25.2 43.7 33.2 30.4 59.6 48.6 38.1 31.5 30.0 46.7 54.2 40.7 59.0 39.1 54.6 74.3 47.5 17.9 72.6 23.3 29.5 34.6 60.7 24.4 53.4 26.1 36.8 42.1 37.0 24.6 41.0 32.8 72.7 22.4 32.5 25.1 47.2 20.4 52.0 35.8 44.4 32.7 40.2 21.5 48.9 1.0 17.7 15.5 35.6 25.3 58.1 24.1 21.6 63.7 58.8 51.9 20.3 21.8 41.1 34.2 36.1 73.5 30.9 84.3 19.9 21.7 22.3 47.1 63.2 42.5 35.0 79.2 60.1 23.0 24.4 41.9 37.2 56.7 14.6 34.0 50.9 27.4 73.1 37.6 41.4 42.8 53.7 45.5 32.2 34.1 54.8 53.2 22.5 80.7 67.0 33.6 24.8 49.3 71.4 36.6 65.0 21.9 24.0 94.1 18.6 15.8 23.5 25.5 18.7 9.5 36.2 31.2 41.3 15.0 32.8 61.8 14.7 79.6 8.3 0.0 17.7 0.4 13.3 13.8 35.6 21.5 30.8 23.1 48.9 13.8 34.2 28.9 1.0 15.5 14.5 11.3 30.1 25.3 41.3 56.0 66.8 62.2 46.7 54.2 74.3 47.5 60.7 47.2 208.4 123.3 139.4 261.1 238.0 182.7 75.4 170.7 77.6 178.6 102.9 163.0 265.6 170.8 481.5 21.2 172.8 203.5 23.3 678.8 222.3 156.3 255.5 36.8 132.9 92.5 81.0 156.1 38.1 69.1 22.2 101.5 81.2 172.1 942.2 201.5 982.7 518.3 210.2 110.3 442.0 227.9 64.7 156.5 149.9 174.8 224.7 205.5 113.0 280.4 496.2 PPA2 FLJ20459 ENSG00000138777 "Pyrophosphatase (inorganic) 2" Q9H2U2 4 105369077-105474081 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Hydrolase "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030888, HPA031671, HPA031672" Supported Approved Mitochondria NA NA 8300 Mitochondria "HPA030888: AB_2673646, HPA031671: AB_10603986, HPA031672: AB_2673988" "prognostic unfavorable (2.98e-4)" "unprognostic (5.64e-2)" "prognostic favorable (6.60e-4)" "unprognostic (9.26e-3)" "unprognostic (2.93e-2)" "unprognostic (5.10e-2)" "unprognostic (1.15e-1)" "unprognostic (2.44e-1)" "unprognostic (1.50e-1)" "unprognostic (1.20e-1)" "unprognostic (7.05e-2)" "unprognostic (9.54e-2)" "prognostic favorable (1.27e-11)" "unprognostic (3.69e-1)" "unprognostic (1.94e-1)" "unprognostic (2.00e-1)" "unprognostic (1.10e-1)" 9.2 18.0 18.4 17.2 15.4 24.0 20.6 12.3 17.6 10.2 19.8 9.3 20.3 18.1 13.3 20.7 14.8 10.7 18.7 42.5 15.6 15.3 23.7 21.2 23.1 34.8 17.2 12.1 9.5 25.0 10.4 15.0 9.3 15.4 16.1 16.7 12.6 21.4 26.8 29.6 15.0 16.8 22.8 12.4 12.1 15.0 9.7 10.7 9.4 14.3 28.2 10.6 12.2 9.5 20.0 35.3 14.7 20.8 22.0 17.0 14.6 11.4 5.4 10.6 18.0 6.8 5.4 7.7 6.5 8.5 8.0 5.7 12.1 16.8 9.4 8.6 5.2 6.4 5.7 21.2 10.3 9.4 13.3 7.6 8.4 8.8 11.0 5.3 19.9 8.2 5.2 10.6 5.5 4.3 9.1 7.6 16.5 14.0 13.0 7.2 14.5 17.0 14.4 7.7 22.3 18.5 15.1 6.5 9.3 26.3 8.8 11.0 6.5 4.4 26.6 9.4 6.5 13.9 16.3 4.0 5.7 11.2 6.2 11.2 11.5 14.5 9.8 10.1 10.8 7.7 14.7 15.0 9.7 15.3 20.8 13.3 20.0 16.0 16.2 35.3 16.6 15.5 17.0 6.4 22.0 16.2 17.7 15.9 14.6 18.4 15.4 12.3 17.6 15.6 15.3 17.2 12.1 15.4 10.7 8.9 50.5 30.0 71.8 44.4 30.3 55.7 53.5 57.6 43.3 31.4 15.7 106.7 223.8 100.3 91.0 35.1 73.1 23.3 104.8 78.8 31.9 70.3 43.9 59.7 73.9 20.6 63.1 23.4 36.7 95.8 25.6 65.5 72.6 46.9 86.9 28.4 66.2 97.6 30.4 222.1 16.9 38.8 49.5 16.1 9.4 50.4 70.8 45.8 109.9 75.5 PRUNE1 "DRES-17, H-PRUNE, HTCD37, PRUNE" ENSG00000143363 "Prune exopolyphosphatase 1" Q86TP1 1 151008420-151035713 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease mutation, Mental retardation, Neurodegeneration, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 7 "Alveolar cells type 2: 8.8;Collecting duct cells: 10.4;Proximal tubular cells: 6.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 62.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028411 Uncertain Supported Cytosol NA NA 210000 Cytosol "HPA028411: AB_10603229" "unprognostic (6.24e-2)" "unprognostic (2.24e-1)" "unprognostic (4.17e-2)" "prognostic unfavorable (3.86e-4)" "unprognostic (6.91e-2)" "unprognostic (2.02e-1)" "unprognostic (2.12e-3)" "unprognostic (7.05e-2)" "unprognostic (4.08e-2)" "unprognostic (5.92e-2)" "unprognostic (1.73e-1)" "unprognostic (2.65e-1)" "prognostic unfavorable (3.48e-4)" "unprognostic (2.18e-1)" "unprognostic (3.21e-2)" "unprognostic (2.42e-2)" "unprognostic (1.36e-1)" 9.3 9.7 9.3 8.8 11.6 3.7 16.0 15.7 16.4 15.0 12.5 10.9 16.2 11.7 17.9 15.7 11.5 15.6 12.8 31.3 10.5 10.3 18.0 12.8 10.1 11.8 11.9 9.2 17.1 16.2 16.5 16.2 7.2 8.8 12.2 14.0 12.7 13.3 18.2 24.4 10.5 11.8 14.7 7.9 11.0 10.5 16.3 8.6 15.0 41.6 8.5 12.9 13.8 13.6 12.1 9.5 14.7 8.9 14.3 19.0 18.3 3.9 4.2 7.5 7.2 9.4 2.6 4.2 1.9 4.1 7.0 6.1 5.1 4.7 8.1 8.2 2.5 2.0 5.7 7.3 4.9 5.6 8.7 8.3 9.5 4.4 7.4 5.1 6.2 4.8 3.2 9.3 3.7 3.6 5.8 3.3 10.7 7.4 6.8 3.3 9.4 9.5 5.1 7.0 14.3 5.5 8.7 4.8 7.7 5.0 5.4 10.9 8.9 6.3 8.8 5.8 11.1 12.1 9.4 2.3 2.5 3.0 2.7 2.9 16.6 14.0 62.0 2.4 4.7 6.2 12.5 6.4 13.4 14.0 6.0 16.9 12.1 15.5 15.7 9.5 11.6 19.0 15.0 14.7 14.3 8.9 5.1 14.5 18.3 9.3 11.6 15.7 16.4 10.5 10.3 11.9 9.2 8.8 8.6 6.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 5.3 5.7 10.4 0.0 3.6 0.0 4.9 0.0 0.0 0.0 0.0 4.9 3.8 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 2.8 0.0 0.0 5.1 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 SDHC "CYB560, cybL, PGL3" ENSG00000143252 "Succinate dehydrogenase complex subunit C" Q99643 1 161314257-161375340 "Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Transport, Tricarboxylic acid cycle" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Distal tubular cells: 658.2;Proximal tubular cells: 706.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.48e-2)" "unprognostic (6.88e-2)" "unprognostic (6.38e-3)" "unprognostic (1.86e-2)" "unprognostic (1.90e-2)" "unprognostic (5.02e-2)" "unprognostic (7.08e-2)" "unprognostic (2.33e-1)" "unprognostic (7.38e-2)" "unprognostic (1.35e-1)" "unprognostic (2.43e-2)" "unprognostic (1.29e-1)" "prognostic favorable (2.20e-4)" "unprognostic (9.14e-2)" "unprognostic (1.52e-1)" "unprognostic (4.19e-3)" "unprognostic (3.77e-1)" 36.8 49.7 25.6 17.1 27.3 14.1 24.1 14.4 36.2 20.6 29.1 31.2 17.0 34.3 22.1 19.7 35.2 21.4 19.3 35.5 21.5 21.8 65.9 75.3 17.8 20.9 28.6 20.1 20.1 17.2 28.8 17.0 19.2 28.0 20.8 28.4 23.9 28.5 21.9 98.0 21.6 33.4 23.2 24.9 21.2 24.3 17.0 16.2 25.7 35.9 45.4 22.4 20.6 19.2 31.3 60.4 28.3 48.2 29.0 38.6 47.9 29.6 21.7 30.6 26.4 40.4 32.3 33.8 32.9 26.2 25.5 19.8 32.1 36.9 8.8 42.8 33.2 22.9 34.7 40.8 34.6 29.7 31.5 40.0 20.4 20.8 32.9 23.0 37.7 21.9 34.1 28.5 29.7 20.0 31.6 26.6 31.4 28.7 8.3 41.1 28.6 26.8 21.8 30.1 66.8 23.0 28.1 29.9 37.4 53.8 29.5 21.4 36.4 39.6 74.6 47.0 38.0 60.9 47.3 23.4 17.8 27.2 25.1 28.4 43.4 53.0 52.2 26.0 24.7 34.4 27.7 48.2 28.3 36.0 44.9 38.6 31.3 32.3 35.5 60.4 30.6 36.3 35.7 23.9 29.0 38.8 44.8 35.2 47.9 25.6 27.3 14.4 36.2 21.5 21.8 28.6 20.1 28.0 16.2 41.7 50.7 84.8 120.9 55.0 71.4 87.7 163.1 97.7 59.1 143.1 60.9 207.5 658.2 185.1 14.4 65.2 106.6 23.3 127.6 211.0 62.7 94.7 56.6 206.9 208.7 68.3 64.2 75.5 101.7 25.9 95.3 83.6 123.2 205.6 95.6 90.0 123.2 105.2 102.6 706.4 61.9 51.8 92.0 89.9 105.2 66.9 257.2 81.0 139.7 129.5 UQCR10 "HSPC051, QCR9, UCCR7.2, UCRC" ENSG00000184076 "Ubiquinol-cytochrome c reductase, complex III subunit X" Q9UDW1 22 29767369-29770413 "Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 144.4;skeletal muscle: 144.7" "Cell type enhanced" "Detected in all" 9 "Cardiomyocytes: 4128.5;Distal tubular cells: 1946.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.09e-1)" "unprognostic (2.96e-3)" "unprognostic (1.56e-1)" "unprognostic (2.60e-2)" "unprognostic (2.01e-1)" "unprognostic (2.73e-2)" "unprognostic (1.25e-1)" "unprognostic (1.75e-3)" "unprognostic (3.05e-2)" "unprognostic (9.24e-3)" "unprognostic (2.94e-1)" "unprognostic (1.12e-2)" "prognostic favorable (5.45e-5)" "unprognostic (1.34e-1)" "unprognostic (2.00e-1)" "unprognostic (1.73e-1)" "unprognostic (1.80e-3)" 23.0 37.0 42.5 18.2 42.9 20.1 23.8 25.2 48.5 17.2 35.5 14.7 24.3 35.9 12.6 24.9 23.7 23.7 19.9 97.9 38.3 30.2 38.3 43.6 22.6 25.2 39.8 25.8 16.1 39.4 19.3 22.5 17.5 25.4 22.2 29.1 21.6 25.2 25.6 144.7 14.7 33.1 17.6 24.2 19.8 29.9 28.5 20.6 20.9 23.6 62.9 20.8 22.8 15.0 132.9 126.0 141.5 118.4 73.9 123.2 144.4 30.9 32.5 31.4 24.4 29.5 19.5 17.5 17.2 21.6 30.9 32.4 41.9 17.9 23.4 18.8 27.3 22.7 31.0 37.2 40.4 19.3 29.2 78.3 29.2 39.5 91.6 21.2 37.5 32.0 32.5 24.8 32.2 21.8 26.0 22.9 25.3 19.9 31.7 30.3 78.1 28.1 44.1 18.0 74.7 43.1 30.7 25.2 42.4 53.2 59.2 34.7 17.5 20.1 43.1 27.1 20.8 30.6 36.0 18.0 32.0 38.7 19.6 25.4 23.9 24.1 31.1 28.8 29.1 20.1 112.9 118.4 141.5 71.0 115.5 77.6 132.9 98.0 90.9 123.1 107.0 106.8 91.6 82.2 73.9 102.8 126.0 123.2 144.4 42.5 42.9 25.2 48.5 38.3 30.2 39.8 25.8 25.4 20.6 229.3 250.2 242.5 180.2 161.5 158.1 4128.5 537.6 353.3 215.0 594.9 72.6 608.3 1946.4 397.6 222.6 157.6 904.3 373.8 481.7 445.1 188.1 297.9 145.6 1099.7 633.2 108.1 365.2 164.5 360.2 448.1 217.1 268.7 295.3 421.2 634.0 208.4 426.1 624.3 194.1 1057.8 204.8 207.0 152.7 328.9 185.1 246.2 486.6 198.4 623.5 323.4 UQCR11 "QCR10, UQCR" ENSG00000127540 "Ubiquinol-cytochrome c reductase, complex III subunit XI" O14957 19 1597172-1605490 "Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 125.4;skeletal muscle: 149.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" NA NA "unprognostic (1.90e-1)" "unprognostic (6.67e-3)" "unprognostic (1.78e-1)" "prognostic favorable (1.23e-4)" "unprognostic (5.62e-2)" "unprognostic (1.32e-1)" "unprognostic (2.06e-1)" "unprognostic (5.42e-3)" "unprognostic (9.10e-2)" "unprognostic (1.14e-1)" "prognostic favorable (1.86e-4)" "unprognostic (1.03e-1)" "prognostic favorable (1.65e-4)" "unprognostic (2.40e-1)" "unprognostic (1.43e-1)" "unprognostic (2.22e-2)" "unprognostic (1.06e-2)" 24.9 23.6 35.1 15.8 29.5 20.3 18.5 13.2 25.1 12.5 28.5 13.1 20.3 34.4 12.4 18.2 22.9 14.1 21.7 106.4 26.9 21.1 24.4 46.1 11.9 17.2 31.0 19.2 9.8 30.0 8.8 16.7 15.4 18.5 18.3 13.3 14.5 29.6 23.6 149.2 11.5 27.5 16.8 21.5 18.3 27.6 8.8 15.1 10.9 22.0 47.1 12.9 15.8 14.1 63.8 78.6 88.2 75.6 43.8 67.9 125.4 22.5 21.2 10.5 23.8 17.5 12.0 25.5 16.3 12.8 16.0 14.3 34.2 15.2 13.3 16.9 11.5 4.1 14.4 15.4 17.3 7.5 21.8 47.1 11.7 26.2 32.1 18.2 19.3 18.3 18.5 17.9 10.1 11.8 8.3 14.5 19.5 25.8 24.2 10.1 31.0 19.2 23.4 27.4 18.2 51.0 11.6 11.0 44.4 20.9 45.5 20.8 22.3 11.2 27.1 28.7 8.2 19.2 23.1 20.2 15.6 10.1 41.1 18.9 34.2 28.1 16.3 27.4 20.2 21.1 83.7 75.6 87.0 52.6 61.8 52.9 63.8 64.3 58.2 63.1 54.1 61.7 59.3 88.2 43.8 57.4 78.6 67.9 125.4 35.1 29.5 13.2 25.1 26.9 21.1 31.0 19.2 18.5 15.1 250.1 365.3 312.4 147.9 0.0 116.7 1545.7 580.9 491.2 293.5 601.9 37.3 421.8 1518.6 593.8 133.9 281.1 1267.5 350.4 708.1 511.1 324.6 312.1 183.7 1781.4 835.4 84.2 436.5 444.4 741.4 307.4 234.1 456.9 0.0 926.1 940.5 193.7 712.8 958.2 244.0 853.5 119.2 219.9 179.7 157.0 128.1 0.0 428.8 332.1 797.4 248.2 UQCRB "QCR7, QP-C, UQBP, UQCR6" ENSG00000156467 "Ubiquinol-cytochrome c reductase binding protein" P14927 8 96225920-96235634 "Disease related genes, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 234.1" "Cell type enhanced" "Detected in all" 7 "Cardiomyocytes: 4932.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA043060 Approved NA NA 380000 "HPA043060: AB_10806376" "unprognostic (5.48e-2)" "unprognostic (1.10e-1)" "unprognostic (2.21e-1)" "unprognostic (9.47e-3)" "unprognostic (2.15e-1)" "unprognostic (8.41e-2)" "unprognostic (2.79e-1)" "unprognostic (9.20e-2)" "unprognostic (3.98e-1)" "unprognostic (1.94e-1)" "unprognostic (1.08e-1)" "unprognostic (3.92e-1)" "prognostic favorable (2.90e-4)" "unprognostic (1.01e-1)" "unprognostic (7.54e-2)" "unprognostic (1.07e-1)" "unprognostic (5.66e-3)" 37.8 51.7 52.1 27.8 54.3 31.3 27.9 25.5 44.0 31.1 37.7 17.9 28.5 35.2 30.7 41.3 38.6 25.5 27.9 156.1 42.3 39.6 57.3 45.1 22.0 28.1 52.2 35.6 48.7 35.2 25.5 45.5 20.3 41.9 35.6 33.8 19.4 42.0 31.7 234.1 16.8 31.7 57.8 44.3 26.9 30.6 15.5 30.8 22.9 33.0 90.0 31.9 51.2 33.8 50.3 38.5 31.9 65.4 30.3 64.4 46.4 52.7 25.3 32.8 20.9 47.5 48.6 21.4 42.7 32.6 23.7 25.5 22.9 25.5 23.0 64.9 34.2 24.6 26.0 29.9 39.8 31.8 34.6 23.8 75.7 48.6 37.9 34.9 41.9 32.4 56.7 35.7 26.7 42.6 77.4 34.3 38.8 39.8 40.1 36.3 34.2 66.6 64.2 19.3 109.5 38.9 29.9 21.7 42.5 46.4 42.4 30.2 30.1 25.8 9.9 64.7 45.8 40.8 70.3 41.7 15.6 23.7 27.3 45.5 34.7 26.0 53.3 25.6 56.6 16.9 26.6 34.8 31.9 32.2 56.4 39.5 50.3 52.0 40.2 38.5 38.7 64.4 58.8 24.7 30.3 65.4 33.7 56.8 46.4 52.1 54.3 25.5 44.0 42.3 39.6 52.2 35.6 41.9 30.8 413.9 522.6 695.6 387.7 268.5 266.1 4932.0 861.1 515.3 513.0 315.8 110.0 494.8 2105.5 666.2 870.6 469.6 871.3 210.2 806.3 418.8 464.2 366.1 567.6 867.4 984.6 119.2 702.2 585.0 1469.2 177.7 799.9 759.0 777.7 959.4 915.4 233.9 819.0 855.1 677.5 1659.4 303.1 530.3 608.7 264.6 241.0 254.4 500.5 684.9 974.2 501.5 UQCRC1 "D3S3191, QCR1, UQCR1" ENSG00000010256 "Ubiquinol-cytochrome c reductase core protein 1" P31930 3 48599002-48610976 "Enzymes, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 172.7" "Cell type enhanced" "Detected in all" 4 "Cardiomyocytes: 576.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 65.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002815, HPA003525, CAB033782" Enhanced Supported Mitochondria NA NA 1300000 Mitochondria "CAB033782: AB_2213631, HPA002815: AB_1080486, HPA003525: AB_1080484" "unprognostic (1.29e-1)" "unprognostic (3.15e-3)" "unprognostic (6.91e-3)" "unprognostic (1.06e-1)" "unprognostic (1.66e-1)" "unprognostic (9.91e-2)" "unprognostic (8.53e-2)" "unprognostic (1.99e-1)" "unprognostic (3.11e-2)" "unprognostic (9.14e-2)" "unprognostic (3.37e-1)" "unprognostic (7.20e-2)" "prognostic favorable (2.35e-10)" "unprognostic (5.37e-2)" "unprognostic (2.35e-1)" "unprognostic (1.02e-1)" "unprognostic (6.72e-2)" 18.1 13.7 11.1 9.8 12.5 9.4 11.8 12.5 20.5 11.0 33.7 6.9 10.4 20.0 9.1 9.7 15.8 12.4 10.8 66.7 10.8 11.2 23.0 30.5 7.7 9.3 13.3 13.5 6.3 14.4 20.4 7.8 11.5 13.3 12.5 12.3 7.8 19.5 21.9 172.7 14.0 20.9 12.0 8.7 8.4 23.0 18.4 7.4 9.4 9.1 39.9 9.8 10.3 9.1 23.3 52.7 28.1 57.8 15.1 22.0 74.3 10.1 16.5 6.0 3.6 8.8 8.1 27.1 18.8 15.2 15.6 14.2 25.6 3.0 26.3 11.9 8.4 18.3 9.8 7.5 21.8 2.9 15.6 35.9 27.0 14.3 27.7 17.5 16.9 11.7 11.1 24.8 10.6 17.5 7.4 15.5 17.4 14.5 1.8 9.4 17.7 12.2 19.3 15.0 15.0 65.5 8.3 16.0 21.5 16.1 11.1 6.4 11.4 25.4 3.1 15.0 1.7 6.5 2.7 15.5 4.3 16.5 13.6 19.3 16.0 14.1 15.2 9.6 19.5 13.9 17.6 57.8 28.1 18.9 56.9 17.9 23.3 18.9 19.0 52.7 18.6 17.1 16.4 14.1 15.1 48.5 21.0 22.0 74.3 11.1 12.5 12.5 20.5 10.8 11.2 13.3 13.5 13.3 7.4 53.6 50.3 63.6 133.4 104.5 38.0 576.9 142.7 78.9 46.6 115.1 27.5 292.1 310.0 150.4 116.4 44.8 496.0 46.7 145.4 266.4 68.1 72.4 80.8 173.2 214.8 38.1 138.8 44.2 110.4 218.8 54.1 87.6 113.1 113.6 228.6 55.4 138.8 252.6 66.4 309.3 39.8 58.2 92.9 102.7 76.4 92.1 281.6 56.5 307.7 117.4 UQCRC2 "QCR2, UQCR2" ENSG00000140740 "Ubiquinol-cytochrome c reductase core protein 2" P22695 16 21952660-21983660 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007998, HPA019146" Enhanced Enhanced Mitochondria NA NA 4000000 Mitochondria "HPA007998: AB_1858648, HPA019146: AB_1858649" "unprognostic (1.33e-1)" "unprognostic (1.32e-1)" "unprognostic (1.49e-3)" "unprognostic (3.35e-1)" "unprognostic (1.26e-2)" "unprognostic (6.91e-2)" "unprognostic (2.71e-2)" "unprognostic (1.32e-1)" "unprognostic (1.72e-1)" "unprognostic (8.87e-2)" "unprognostic (1.67e-2)" "unprognostic (2.43e-2)" "prognostic favorable (6.58e-9)" "unprognostic (2.33e-1)" "unprognostic (9.78e-3)" "unprognostic (4.67e-3)" "unprognostic (7.36e-2)" 22.7 26.8 20.6 17.1 32.7 20.5 21.3 29.2 33.7 17.7 38.4 17.4 19.5 45.0 20.8 18.6 28.7 20.0 19.1 94.9 19.8 19.3 35.1 35.8 15.9 23.6 20.9 28.5 21.9 20.8 36.6 20.2 17.8 29.6 17.7 40.5 18.5 22.1 20.2 103.9 22.2 42.0 30.4 16.5 16.5 29.3 10.3 19.2 25.2 21.4 70.0 22.9 27.9 20.0 20.0 30.6 14.3 29.3 18.7 25.7 27.4 19.3 21.2 13.1 8.7 14.7 20.6 18.6 18.8 15.3 17.2 17.5 34.3 19.1 38.3 16.9 16.1 12.8 35.3 21.3 18.8 19.9 17.5 19.7 21.7 18.7 48.4 15.5 27.5 54.9 24.0 23.6 13.4 18.5 17.6 22.5 21.3 23.4 20.1 18.6 25.6 28.6 17.9 14.4 24.5 16.4 33.5 30.5 41.9 25.8 22.8 18.2 13.3 26.6 33.6 20.2 16.6 38.4 29.3 19.9 12.2 11.5 11.9 16.7 14.5 10.5 34.0 20.0 29.3 13.9 14.3 24.7 12.8 16.9 29.3 21.9 20.0 20.5 18.6 30.6 15.8 22.8 20.8 9.1 18.7 27.6 13.2 25.7 27.4 20.6 32.7 29.2 33.7 19.8 19.3 20.9 28.5 29.6 19.2 59.6 42.0 98.3 164.9 80.5 95.9 481.5 84.1 72.3 54.6 68.0 82.5 196.5 386.3 104.6 67.7 84.2 282.6 23.3 96.2 128.0 82.0 92.1 91.1 104.1 172.2 65.2 109.2 63.3 130.3 64.8 63.3 104.5 124.9 144.3 181.4 81.7 88.0 175.6 91.2 254.0 122.1 77.6 118.3 52.3 51.5 77.2 232.7 106.2 298.0 149.1 UQCRFS1 "RIP1, RIS1, RISP, UQCR5" ENSG00000169021 "Ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1" P47985 19 29205321-29213541 "Enzymes, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" Translocase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 112.3" "Cell type enhanced" "Detected in all" 6 "Cardiomyocytes: 1206.2;Distal tubular cells: 877.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA041863, HPA050339" Enhanced Approved Mitochondria NA NA Mitochondria "HPA041863: AB_10794638, HPA050339: AB_2681095" "unprognostic (4.00e-2)" "unprognostic (2.23e-3)" "prognostic favorable (3.29e-4)" "unprognostic (7.91e-3)" "unprognostic (3.93e-2)" "unprognostic (8.68e-2)" "unprognostic (1.84e-1)" "unprognostic (7.53e-2)" "unprognostic (3.53e-2)" "prognostic unfavorable (3.84e-4)" "unprognostic (1.73e-2)" "unprognostic (1.66e-1)" "prognostic favorable (3.92e-9)" "unprognostic (6.11e-2)" "unprognostic (2.96e-1)" "unprognostic (1.45e-1)" "unprognostic (1.92e-2)" 15.2 27.1 20.1 10.8 18.3 25.4 28.2 18.3 33.4 11.9 27.3 9.1 9.8 24.3 10.5 14.3 16.9 11.9 14.2 95.3 19.4 14.8 34.9 33.8 12.0 21.2 18.3 13.1 9.1 26.4 15.9 10.6 10.8 17.6 11.8 30.3 11.5 17.0 13.9 112.3 12.9 27.0 19.6 11.5 11.3 18.8 16.6 6.5 17.7 12.9 55.0 14.5 13.7 10.0 18.5 35.6 14.9 29.9 15.0 22.1 45.1 21.8 37.0 13.8 12.4 22.6 17.3 15.3 17.1 17.9 23.7 26.3 22.4 13.6 19.9 18.1 19.3 19.4 23.3 30.1 20.4 28.7 13.5 30.1 28.2 14.6 20.3 19.2 26.8 24.8 20.8 22.1 16.2 24.7 14.0 18.9 24.9 20.0 12.5 25.4 20.2 18.7 20.1 14.4 46.7 14.4 17.1 18.4 15.1 29.5 26.4 16.8 8.2 15.6 30.9 19.6 16.1 14.4 22.4 11.9 16.1 24.5 11.0 17.7 6.0 11.3 18.4 14.2 23.3 11.4 14.9 29.9 14.0 17.9 29.3 17.8 18.5 19.2 18.3 35.6 15.7 20.4 19.4 9.1 15.0 24.3 19.7 22.1 45.1 20.1 18.3 18.3 33.4 19.4 14.8 18.3 13.1 17.6 6.5 50.6 43.5 83.4 229.0 131.1 67.3 1206.2 170.7 48.2 45.5 108.2 15.7 255.3 877.0 208.2 176.6 94.4 303.4 70.0 204.7 204.0 122.3 162.8 88.9 250.4 234.4 49.3 153.7 93.9 135.6 102.8 85.4 113.1 156.9 178.5 238.4 96.8 186.1 196.4 76.7 532.4 58.7 97.0 163.6 296.9 77.1 140.0 319.3 108.3 325.0 307.9 UQCRH "QCR6, UQCR8" ENSG00000173660 "Ubiquinol-cytochrome c reductase hinge protein" P07919 1 46303631-46316776 "Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA042574 Supported NA NA "HPA042574: AB_10960998" "unprognostic (2.24e-2)" "unprognostic (6.48e-2)" "unprognostic (5.62e-2)" "unprognostic (1.06e-3)" "unprognostic (6.34e-2)" "unprognostic (6.58e-2)" "prognostic unfavorable (4.63e-5)" "unprognostic (1.31e-1)" "unprognostic (3.15e-2)" "unprognostic (2.56e-1)" "unprognostic (8.95e-2)" "unprognostic (2.02e-2)" "unprognostic (1.95e-3)" "unprognostic (2.07e-2)" "unprognostic (3.77e-1)" "unprognostic (5.14e-2)" "unprognostic (1.04e-1)" 31.3 25.8 57.4 29.5 56.6 52.2 36.7 59.1 73.9 28.4 63.4 11.6 37.1 61.3 23.6 32.8 48.5 18.3 28.9 140.9 48.8 48.6 52.5 38.8 22.2 37.0 55.9 57.0 36.5 66.4 33.4 25.3 21.2 52.9 23.1 64.2 18.9 60.5 40.4 132.5 26.3 44.2 38.4 42.7 24.6 37.3 14.0 26.7 23.9 20.5 76.0 49.4 29.6 30.1 82.4 72.4 35.8 56.4 30.5 57.7 82.4 49.1 28.8 34.4 61.4 35.2 47.9 71.4 32.7 19.5 28.2 24.2 55.6 27.2 48.4 43.5 30.3 52.8 35.4 47.6 50.0 42.0 36.2 82.0 120.2 83.2 74.2 20.7 118.2 34.4 54.1 28.6 46.7 23.5 43.2 39.5 60.5 113.1 54.0 42.8 37.9 53.1 120.6 205.3 61.1 59.0 56.0 56.4 150.6 61.7 105.1 66.8 79.4 53.6 100.9 100.5 95.0 33.5 146.3 35.5 27.5 36.0 39.4 60.7 37.0 73.3 76.2 39.9 92.0 41.1 20.4 56.4 35.8 35.2 47.9 45.1 82.4 50.8 46.2 72.4 61.5 57.7 51.5 10.7 30.5 40.8 49.6 50.5 82.4 57.4 56.6 59.1 73.9 48.8 48.6 55.9 57.0 52.9 26.7 98.3 125.7 583.3 503.9 406.7 272.2 1846.1 557.9 152.6 193.3 373.4 157.1 587.0 1779.0 451.3 50.7 322.9 766.9 210.2 303.5 704.1 295.5 485.5 281.3 508.0 631.3 96.9 482.7 305.1 657.1 51.7 286.0 422.8 464.0 348.9 986.2 177.1 370.2 653.5 267.3 1048.7 322.7 323.4 420.5 100.7 334.1 460.6 543.7 320.4 1157.3 702.1 UQCRQ "QCR8, QP-C, UQCR7" ENSG00000164405 "Ubiquinol-cytochrome c reductase complex III subunit VII" O14949 5 132866560-132868031 "Disease related genes, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 174.9" "Cell type enhanced" "Detected in all" 7 "Cardiomyocytes: 3256.1;Hepatocytes: 4283.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046693, HPA053323" Approved Enhanced Mitochondria NA NA Mitochondria "HPA046693: AB_10968453, HPA053323: AB_2682112" "unprognostic (3.22e-1)" "unprognostic (1.06e-1)" "unprognostic (4.92e-2)" "prognostic favorable (4.23e-4)" "unprognostic (1.09e-1)" "unprognostic (9.03e-2)" "unprognostic (1.02e-1)" "unprognostic (3.45e-2)" "unprognostic (1.37e-1)" "unprognostic (3.72e-2)" "unprognostic (7.31e-2)" "unprognostic (3.49e-1)" "unprognostic (1.81e-3)" "unprognostic (1.06e-1)" "unprognostic (1.84e-1)" "unprognostic (2.33e-1)" "unprognostic (3.37e-2)" 26.4 38.4 43.2 24.5 34.2 20.9 30.9 18.0 37.5 22.5 49.7 13.8 44.0 42.5 15.4 41.8 32.1 15.3 42.7 111.1 33.2 31.7 48.8 112.5 18.8 21.5 42.0 30.4 12.3 64.6 14.0 23.1 17.0 30.5 32.0 44.8 19.7 44.6 39.6 174.9 16.4 40.5 21.2 25.4 15.2 37.4 16.1 20.8 14.3 24.6 71.5 16.8 22.6 20.5 56.6 95.8 67.9 99.9 53.8 56.7 106.3 45.5 63.7 37.6 91.0 56.4 45.9 32.6 33.1 46.7 53.0 66.1 89.7 53.3 18.7 70.0 43.3 67.4 46.2 34.3 80.6 45.6 34.2 72.0 24.8 100.5 70.5 49.0 28.1 42.8 48.9 56.2 37.8 52.2 35.5 41.3 40.4 31.7 60.4 55.5 86.2 64.6 64.9 26.7 85.4 57.6 42.4 41.7 80.5 68.5 89.0 63.1 52.5 40.9 46.2 70.6 27.0 68.8 64.9 25.7 48.6 61.4 39.8 66.8 66.8 88.7 33.5 64.6 52.5 48.3 67.9 99.9 61.1 47.0 76.6 48.3 56.6 54.9 53.5 87.4 46.0 53.6 51.5 47.4 53.8 70.2 95.8 56.7 106.3 43.2 34.2 18.0 37.5 33.2 31.7 42.0 30.4 30.5 20.8 232.3 318.2 275.9 309.6 309.4 83.7 3256.1 1189.8 321.2 221.8 746.8 113.9 633.7 1536.9 621.2 357.1 305.7 1715.1 233.6 826.7 362.7 374.6 615.6 285.5 4283.6 668.1 68.3 527.7 324.1 428.0 786.4 261.5 374.1 678.2 396.8 861.3 232.4 704.3 1273.0 271.5 1804.0 170.0 181.1 456.8 296.8 123.0 449.3 470.6 222.6 1052.4 401.6